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Aim: There is a requirement for an expansive and up to date review of the management 
of emergency colorectal conditions seen in adults. The primary objective is to provide 
detailed evidence- based guidelines for the target audience of general and colorectal sur-
geons who are responsible for an adult population and who practise in Great Britain and 
Ireland.
Methods: Surgeons who are elected members of the Association of Coloproctology of 
Great Britain and Ireland Emergency Surgery Subcommittee were invited to contribute 
various sections to the guidelines. They were directed to produce a pathology- based 
document using literature searches that were systematic, comprehensible, transparent 
and reproducible. Levels of evidence were graded. Each author was asked to provide a 
set of recommendations which were evidence- based and unambiguous. These recom-
mendations were submitted to the whole guideline group and scored. They were then 
refined and submitted to a second vote. Only those that achieved >80% consensus at 
level 5 (strongly agree) or level 4 (agree) after two votes were included in the guidelines.
Results: All aspects of care (excluding abdominal trauma) for emergency colorectal con-
ditions have been included along with 122 recommendations for management.
Conclusion: These guidelines provide an up to date and evidence- based summary of the 
current surgical knowledge in the management of emergency colorectal conditions and 
should serve as practical text for clinicians managing colorectal conditions in the emer-
gency setting.
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INTRODUC TION
Although guidelines exist for the management of emergency 
colorectal conditions in adults, there are areas of practice that 
require up to date review. The Emergency General Surgery (EGS) 
Subcommittee of the Association of Coloproctology of Great Britain 
and Ireland (ACPGBI) has therefore commissioned a set of guide-
lines that are pathology based and cover the most common colorec-
tal emergencies seen in day to day clinical practice.
In 2016 The Future of Emergency General Surgery— a Joint 
Document was produced by the ACPGBI, the Association of Upper 
Gastrointestinal Surgeons and the Association of Surgeons of Great 
Britain and Ireland (ASGBI) [1]. It contains 16 key recommendations 
covering all aspects of emergency general surgery but specifically 
ambulatory care, early senior decision- making, infrastructure and 
the importance of a dedicated and recognized emergency compo-
nent in job planning. This was followed in 2018 when the Royal 
College of Surgeons of England produced the report The Higher 
Risk General Surgical Patient: Raising the Standard [2], an update of 
the 2011 report, The Higher Risk General Surgical Patient [3]. It lists 
12 new key recommendations which include consultant leadership, 
frailty, risk assessment, National Early Warning Score (NEWS), 
sepsis, radiology and quality assurance and improvement. It is the 
opinion of the expert group who produced the document that all 
12 should be mandatory in all acute hospitals with adult general 
surgical services on site. These guidelines aim to complement these 
recommendations.
Emergency surgery has for too long been seen as the Cinderella 
specialty within general surgery. However, the landscape is chang-
ing. Emergency surgery is becoming an ever- increasing part of each 
and every service. Many units are now providing specialist rotas 
with specific lower gastrointestinal (GI), hepatobiliary and upper GI 
cover. Clearly this is only truly possible in those units big enough to 
provide the number of individual surgeons to staff such rotas.
Recent publications [4] have shown that the outcomes for those 
patients with acute colorectal problems are best when dealt with 
by a colorectal specialist. The same is true for upper GI problems. 
The National Laparotomy Audit (NELA) report 2016– 17 reveals that 
almost 50% of all emergency laparotomies are performed because 
of colorectal pathology [5].
However, the reality in many smaller District General Hospitals 
is that all members of the surgical team are required to provide out 
of hours emergency cover. It is impossible for all individuals to be 
completely up to speed with developments in every area of general 
surgery and so up to date evidence- based guidelines are an essential 
part of an individual's armamentarium. As such, these emergency 
colorectal guidelines will support those individuals who are required 
to provide emergency cover for a wide variety of problems when on 
call. They will also act as a clear reference guide for others. It should 
be noted that as there are adequate pre- existing national guidelines 
for the management of abdominal trauma this topic has been pur-
posely omitted.
The primary objective is to provide detailed evidence- based 
guidelines that are practical and easily applicable in the clinical set-
ting, for the target audience of surgeons undertaking adult emer-
gency colorectal surgery in Great Britain and Ireland.
Patient summary
There is a requirement for the Association of 
Coloproctology of Great Britain and Ireland (ACPGBI) to 
regularly prepare an up to date review of the management 
and treatment of emergency colorectal conditions seen 
in adults and produce detailed guidelines for general and 
colorectal surgeons who are responsible for this group of 
patients. The responsibility for drawing up these guidelines 
was given to experienced surgeons who are elected mem-
bers of the ACPGBI’s Emergency Surgery Subcommittee. 
They were invited to contribute various sections of the 
guidelines, which include diverticular disease, colorectal 
cancer, postoperative problems and pregnancy, anorectal 
problems, the open abdomen and stomas.
A document based on published articles in journals that 
had been properly reviewed and that were understandable, 
transparent and reproducible, and what they contained, 
was produced. The evidence was then graded. Each au-
thor was asked to provide a set of recommendations which 
were clear and unambiguous. These recommendations 
were then submitted to the whole group and scored. They 
were then refined and submitted to a second vote. Only 
those that achieved a consensus marked ‘strongly agree’ 
or ‘agree’ after two votes were included in the guidelines.
All aspects of emergency colorectal conditions (except 
abdominal trauma) have been included along with 122 
recommendations. These guidelines provide an up to date 
review of the current surgical knowledge in the treatment 
of emergency colorectal conditions and should serve as an 
important guide for surgeons managing colorectal condi-
tions in the emergency setting. As the guidelines point out, 
it is impossible for all individuals to be completely up to 
speed with new developments in all areas of surgery, so up 
to date guidelines play an essential role. These guidelines 
will support those surgeons who are required to provide 
emergency cover for a wide variety of problems when on 
call and will also act as a clear reference guide for others.
Patients are best served if the profession regularly reviews 
important patient conditions such as emergency colorectal 
problems. An up to date review means that new develop-
ments, new techniques that are based on research and the 
experiences of colorectal surgeons from throughout the 
world are included.
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METHODOLOGY
Consultant surgeons who are elected members of the ACPGBI 
Emergency General Surgery (EGS) Subcommittee (ASM, BB, MDC, 
SED, RJG, DAJS together with PJT) were invited to contribute vari-
ous sections to the guidelines. They were directed to produce a 
pathology- based document using literature searches that were 
systematic, comprehensible, transparent and reproducible. Senior 
trainees (KB, NMF, LHM, GR, DW) who were affiliate members of 
the ACPGBI contributed fully to several of the sections. A consult-
ant radiologist (JAS) provided advice and guidance regarding the ra-
diological aspects of the guidelines.
A critical appraisal of the guidelines using the AGREE II instru-
ment was undertaken. All domains scored >70% [6].
Evidence- based and unambiguous recommendations were 
developed by the section authors. Each recommendation was 
submitted to the whole EGS Subcommittee. The Subcommittee 
cross- reviewed each of the individual recommendations in order 
to ensure consistency of style, presentation and quality. They 
were refined. Voting was carried out on a five- point Likert scale 
of 1 (strongly disagree) to 5 (strongly agree, SA). Any statement 
scoring 1– 3 on the Likert scale could have suggestions made 
with the intention to rephrase recommendations if specific ob-
jections were raised during the first round. Only those recom-
mendations achieving 80% consensus at level 5 (SA) and level 4 
(agree, A) after two rounds of voting have been included in the 
final guidelines.
In accordance with the EGS ACPGBI format, they have been 
published in a Question, Recommendation, Background format for 
maximal ease of use in the clinical sphere.
Randomized controlled trials (RCTs), systematic reviews and 
meta- analyses were included where available. Multi- centre and 
single centre observational reviews were included if relevant. Case 
reports were excluded unless they provided the only published evi-
dence in a particular area. This is made clear in the text.
This work does not therefore concentrate on future areas of 
research or ground- breaking novel technologies but rather offers 
practical recommendations for the clinical management of these 
conditions.
The recommendations were then submitted to the ACPGBI 
patient liaison group. A patient summary was produced and is 
included.
The guidelines adhere to the published ACPGBI guidelines 
on consensus statements [7]. The level of evidence and grad-
ing for each recommendation [8] are listed in Tables 1 and 2. 
These guidelines represent work ongoing from May 2019 to 
September 2020. They contain 122 recommendations. We hope 
that they will provide an updated and evidence- based summary 
of the current surgical knowledge in the management of emer-
gency colorectal surgery and as such will serve as a useful prac-
tical summary for clinicians undertaking emergency colorectal 
procedures.
DIVERTICUL AR DISE A SE
Introduction
An increase in the incidence and prevalence of diverticular disease 
has resulted in a rise in the overall number of emergency admissions 
for complications [9– 16]. In England, Hospital Episode Statistics 
(HES) data analysis estimated an increased incidence of hospitaliza-
tion (total inpatient and day- case admissions) for diverticular disease 
from 0.56 to 1.2 per 1000 population/year from 1996 to 2006 [9]. 
In the USA an increase in incidence from 89.8 to 113.9 per 100 000 
population was seen between 2006 and 2013 [10,11]. The preva-
lence of diverticular disease increases with age and 85% of patients 
are over 50 [13,15]. There is an increasing proportion of younger 
TA B L E  1  Level of evidence
I Evidence obtained from a single randomized controlled 
trial or from a systematic review or meta- analysis of 
randomized controlled trials
II Evidence obtained from at least one well- designed 
controlled study without randomization or at least one 
other well- designed quasi- experimental study
III Evidence obtained from well- designed non- experimental 
descriptive studies, correlation studies and case studies
IV Evidence obtained from expert committee reports or 
opinions and/or clinical experiences of respected 
authorities, or case reports
TA B L E  2  Grade of recommendation
A Evidence from Level I studies or consistent findings from 
evidence Levels IIA, IIB or III
B Evidence from Level II or III studies and generally consistent 
findings
C Evidence from Level II or III studies but inconsistent findings
D Little or no systematic evidence
GP Recommended good practice based on clinical experience of 
the expert group and other professionals
TA B L E  3  Modified Hinchey Classification of complicated acute 
diverticulitis [49,54,55]
Stage Description
Stage Ia Confined pericolic 
inflammation— phlegmon
Stage Ib Confined pericolic abscess (within sigmoid 
mesocolon)
Stage IIa Pelvic, distant intra- abdominal or 
intraperitoneal abscess amenable to 
percutaneous drainage
Stage IIb Complex abscess associated with fistula
Stage III Generalized purulent peritonitis
Stage IV Faecal peritonitis
    | 479MILLER Et aL.
patients presenting with acute diverticulitis (AD) requiring surgery 
[9,15,17], although a theory that younger patients have more viru-
lent or frequent episodes of disease has not been proven [18– 26]. In 
patients over 50 presenting with diverticulitis, most are women; the 
opposite is true in those under 50 [12,15,18,19,23].
Diverticular disease is most prevalent in the Western world and 
is still relatively rare in Asia or Africa. A higher incidence in indus-
trialized areas and in immigrants to Western countries implies life-
style factors in the development of diverticulosis [27– 29]. Whilst 
diverticula are more common overall in the left side of the colon, 
right- sided diverticulosis is more likely to be seen in Asians [30,31]. 
Low fibre diets— and their association with a relatively constipated 
high pressure colon— are implicated in the development of left- 
sided diverticulosis [32,33], but the role of diet remains unclear in 
AD; there is some evidence that vegetarians with high fibre diets 
have decreased admissions with AD [16,34]. There is no evidence 
that consumption of corn, nuts or popcorn makes diverticulitis 
more likely [35].
The pathological mechanisms leading to diverticula formation re-
main unclear and a complex interaction between diet, gut microbi-
ome, genetic factors, colonic motility and structure over time is likely 
[16,36,37]. Alterations in colonic muscle properties, collagen metab-
olism and in the interactions of the extracellular matrix components 
may play a role in remodelling of the gut wall in diverticular disease 
[33]. Collagen deposition in the colon wall of patients operated for sig-
moid diverticulitis is higher compared to patients without the disease 
[38]. A number of rare hereditable disorders of collagen and elastin 
are associated with complicated diverticular disease at an early age 
[39,40].
AD is a common cause of acute abdominal pain [41]. 
Complicated AD refers to AD with abscess formation, perfora-
tion or fistula formation and there is a wide spectrum of symp-
toms that can arise [42]. Seasonal variation in admissions has been 
shown [43– 46] and lower socioeconomic status is also more likely 
to be associated with more frequent presentations and more se-
vere disease [47].
Question 1.1
The most useful classification is the Modified Hinchey 
Classification. This categorizes patients with AD into four major 
categories (I, II, III, IV) with two additional subcategories (a and 
b), depending on the severity of the disease (Table 3). Initially 
intended for use intra- operatively, it is a convenient and repro-
ducible descriptor and allows comparison of treatment modalities 
across patient populations.
There are multiple other classification systems available for 
AD which include the American Association for the Surgery of 
Trauma, modified Neff, Ambrosetti, Kohler, Hansen/Stock, Siewart, 
Boostrom and the Cleveland Clinic diverticular disease propensity 
score [48– 54], but they are in less common usage.
Question 1.2
Initial evaluation of a patient with suspected AD must include a 
problem- specific history, physical examination and blood tests, in-
cluding C- reactive protein (CRP), to determine severity and progno-
sis. The diagnostic accuracy of clinical evaluation for AD is low but 
a symptom triad of left lower quadrant pain, fever and absence of 
vomiting is suggestive of AD [16,42,56– 60]. Urinalysis and a preg-
nancy test may be helpful in excluding other diagnoses that can 
mimic the presentation of AD, such as urinary tract infections, ure-
teric calculi and ectopic pregnancy [61].
Laboratory tests should include full blood count, renal func-
tion, amylase and CRP [16]. CRP can be used as an indicator of the 
presence of complications in AD: patients with CRP >150 mg/l have 
an increased risk of complicated AD [61– 64]; a CRP >200 mg/l is 
a strong indicator of perforation [58]. CRP has both diagnostic 
and prognostic value for patients with AD, and a CRP value higher 
than 150 mg/l is associated with an increased risk of postoperative 
mortality if surgery is undertaken [62]. Leucocytosis is also related 
to complicated AD and risk of surgical intervention [65,66], but 
How is complicated acute diverticulitis classified?
Recommendation: Severity of acute diverticulitis should 
be classified according to a reproducible grading system 
such as the Modified Hinchey Classification.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
Which patients with acute diverticulitis can be managed 
on an ambulatory outpatient basis and which patients 
need hospital admission?
Recommendation: Most patients with Hinchey Ia and Ib 
acute diverticulitis, and selected patients with Hinchey IIa 
acute diverticulitis, should be managed on an ambulatory 
basis if possible, provided that facilities for rapid review 
are in place; Hinchey IIb, III and IV patients will require 
admission.
Level of evidence: II
Grade of recommendation: C
Consensus: 88.9% (SA 66.7%, A 22.2%)
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patients with fever and leucocytosis that resolve within the first 
48 h of initiating treatment have improved outcomes [67].
Uncomplicated AD or Hinchey Stage I disease can almost univer-
sally be treated on an ambulatory outpatient basis, with a 6%– 10% 
risk of readmission, very low rates of complications and an oppor-
tunity for substantial financial savings [68], but patient selection is 
key. For patients selected for ambulatory management, any imaged 
abscess should be <3 cm, there should be no signs of systemic sepsis, 
and patients should be able to tolerate oral intake and have an ade-
quate social support [49,69– 71]. Risk factors for failure of outpatient 
management include CT findings of free fluid or extraluminal air, or 
more than two previous episodes of AD [69,70]. Patients should be 
admitted if other risk factors are present such as age >65 years, sig-
nificant comorbidities or immunosuppression [68,72].
Question 1.3
Plain chest and abdominal radiographs may provide a diagno-
sis of perforation or bowel obstruction [9]. Superior diagnostic ac-
curacy for AD is achieved with CT— or sometimes ultrasound (US) 
in expert hands [73]. CT and US have shown similar sensitivity and 
specificity for uncomplicated AD. However, although US avoids the 
risk associated with ionizing radiation [74– 77], CT is more universally 
recommended.
Severe abdominal pain, obesity and obscuring bowel gas can 
preclude a satisfactory US examination and therefore the use of US 
is limited in complicated AD [8]. Missing a complicated diverticu-
litis can have important clinical implications and, if diverticulitis is 
suspected, a contrast- enhanced CT scan to confirm diagnosis and 
exclude complications is recommended [78].
The diagnostic benefits of CT include easier identification of alter-
native diagnoses [79] assessment of the severity of AD and extent of 
AD- associated extra- colonic abnormalities. The latter include pericolic 
inflammation (phlegmon or fat stranding), abscess or extraluminal gas 
or contrast [55,57,79] or presence of obstruction, which is more likely 
to be associated with malignancy than with AD [80]. Historically water- 
soluble contrast enema examination may be helpful in assessment of 
obstructed cases; however, it is inferior to CT in detecting complicated 
AD, particularly associated abscess, and has fallen out of use [51,81]. 
CT is essential for therapeutic planning if abscess drainage is being 
considered [51,75] and can be used to grade severity. MRI has high 
sensitivity and specificity for diagnosing AD and is comparable to CT; 
however, availability and cost limits its use [82,83].
Question 1.4
There is no evidence mandating the use of routine antibiotics in un-
complicated AD. Conservative treatment strategy without antibiotics in 
patients with uncomplicated AD has proven to be safe, with long- term 
outcomes, in terms of recurrence, complications and need for surgery, 
being similar to those treated with antibiotics [84– 88]. However, CRP 
level >170 mg/l is a risk factor for non- antibiotic treatment failure [89] 
and selective, rather than routine, omission of antibiotics is still recom-
mended [90].
There is no evidence to support a particular antibiotic regime, route or 
duration for complicated AD. Antibiotics are indicated in all cases of com-
plicated AD. If a drainage procedure is indicated, there is no evidence to 
support a prolonged course of antibiotics after source control is achieved.
Approximately 20% of patients with AD will have complicated dis-
ease and the majority can be treated conservatively with antibiotics, in-
cluding many cases with abscesses and pericolic extraluminal air [91– 95]. 
Mesocolic abscesses (Modified Hinchey 1b) are more likely than pelvic 
or intra- abdominal abscesses to respond to antibiotics alone [96,97] and 
Hinchey II patients with abscesses smaller than 4 cm in size can also usu-
ally be treated with antibiotics alone. Simultaneous abscess and perfo-
ration occur in around 18% of patients and the presence of an abscess 
increases the risk of failure of non- operative management. Isolated peri-
colic extraluminal gas— defined as free gas no more than 5 cm from the 
site of inflammation— is found in up to 15% of patients with complicated 
AD, and 6% of patients with isolated pericolic extraluminal air will need 
emergency surgery (ES) with a 2% 30- day mortality rate. Even in patients 
with free gas, provided there is an absence of severe peritonitis or sepsis, 
up to one- third can be successfully managed non- operatively [66,68,93]. 
The decision to persist with non- operative therapy in complicated AD 
must take into account the patient's physiological state, response to treat-
ment through regular review and associated comorbidities [98].
What imaging should be used in acute diverticulitis?
Recommendation: Contrast- enhanced CT imaging should 
be undertaken in all suspected cases of acute diverticu-
litis in order to confirm the diagnosis, to assess severity 
and to plan therapy.
Level of evidence: I
Grade of recommendation: B
Consensus: 100% (SA 100%)
Can acute diverticulitis be managed non- operatively?
Recommendation: Antibiotics may be omitted in un-
complicated acute diverticulitis. Patients with com-
plicated acute diverticulitis should be administered 
broad- spectrum antibiotics and most can be treated non- 
operatively, but regular clinical re- evaluation must be 
undertaken to determine success or failure of treatment.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 88.9%, A 11.1%)
    | 481MILLER Et aL.
Question 1.5
When technically feasible, patients with abscesses larger than 4 cm 
should be managed with imaging guided percutaneous drainage and 
systemic antibiotic therapy. When percutaneous drainage is technically 
difficult or hazardous in Hinchey II AD, antibiotic therapy alone may be 
necessary. Reported failure rates for percutaneous diverticular abscess 
drainage range from 15% to 30%. Drainage is considered a failure if signs 
of persistent sepsis develop, abscess or fistula recurs within 4 weeks of 
drainage, or when emergency surgical resection has to be performed. ES 
for Hinchey II AD is associated with an 80% colostomy rate and high mor-
tality rate and so percutaneous drainage should be pursued if at all possible 
[96,97,99]. The commonest routes for percutaneous drainage are trans-
abdominal and transgluteal [100– 102], and imaging before percutaneous 
drain removal is associated with a reduction in the rates of abscess recur-
rence and requirement for additional drainage procedures or surgery [103].
The current DAMASCUS study aims to determine the interna-
tional variability in the presentation and index management of AD.
Link: DAMASCUS study
Question 1.6
Although there are specific US and CT criteria which help to 
differentiate AD from colon cancer, for decades the management 
of AD has included early endoscopic evaluation to exclude malig-
nancy, as it has been shown that there is an age- related increase 
in the prevalence of colonic neoplasia in patients with diverticular 
disease [80,104– 106]. The incidence of colonic neoplasia is low in 
uncomplicated AD, between 1.6% and 1.9%; therefore routine in-
terval colonoscopy may be unnecessary in this group, unless there 
is clinical suspicion of malignancy. The incidence of colonic neo-
plasia is higher in complicated AD, between 7.8% and 10.9%, and 
so interval colonoscopy remains mandatory following an episode 
of complicated AD [107,108]. Other indications for endoscopy in-
clude age over 50 years, rectal bleeding or concerning features 
on imaging, if not done previously [93,105,108]. The absence of 
diverticulae in combination with shouldering at either end of an 
area of stricturing has 0.91 and 0.95 sensitivity and specificity for 
colonic cancer [109]
There is no indication for routine outpatient follow- up of pa-
tients who have recovered from conservatively managed acute un-
complicated or complicated AD. Following successful non- operative 
management of AD, the proportion of patients having at least one 
subsequent readmission is between 8% and 21% and the risk of 
readmission decreases with time. Of those patients who are re-
admitted, approximately 22% will subsequently undergo surgery 
[110,111].
Question 1.7
Higher body mass index (BMI) and larger waist circumference 
and waist- to- hip ratio significantly increase the risks of diverticu-
litis and diverticular bleeding [112,113]. Morbidly obese patients, 
BMI ≥ 40 kg/m2, undergoing surgery for diverticulitis are nearly 
10 years younger than normal weight patients and are more likely 
to require ES, ostomy creation and open surgery and to undergo 
procedures without an anastomosis. They also tend to have a more 
pronounced systemic inflammatory response [114], the pathophys-
iology being poorly understood but possibly due to high levels of 
circulating inflammatory mediators associated with increased lipid 
metabolism [115,116]. Physical activity of greater than 30 min/
day and particularly running significantly decrease the risk of 
complicated diverticulitis [113,117]. Although the mechanisms are 
Which patients with complicated acute diverticulitis can 
be treated by percutaneous drainage?
Recommendation: Pelvic abscesses should be assessed 
by an experienced interventional radiologist and drained 
percutaneously if a safe route into the abscess can be 
negotiated.
Level of evidence: I
Grade of recommendation: B
Consensus: 100% (SA 66.7%, A 33.3%)
What follow- up should patients undergo after successful 
non- operative management of acute diverticulitis?
Recommendation: There is no requirement for routine co-
lonoscopic or radiological follow- up of patients who have re-
covered from conservatively managed acute uncomplicated 
acute diverticulitis, unless there are suspicious features on 
CT scans or other risk factors for malignancy coexist.
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 77.8%, A 22.2%)
Recommendation: Following recovery from an attack 
of complicated acute diverticulitis, the colon should be 
imaged after a delay of 6 weeks by either optical or vir-
tual colonoscopy, unless imaging has already taken place 
within the preceding 2 years.
Level of evidence: I
Grade of recommendation: B
Consensus: 100% (SA 77.8%, A 22.2%)
What advice should be given to patients after hospital ad-
mission for acute diverticulitis?
Recommendation: Obese patients should be strongly 
advised to lose weight. All patients should be advised to 
increase physical activity and improve diet quality, whilst 
avoiding smoking and non- steroidal anti- inflammatory 
drugs (NSAIDs).
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 66.7%, A 33.3%)
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not fully understood, long- term physical activity decreases intra- 
colonic pressure and colonic transit time, and results in alterations 
to intestinal autonomic activity, gut hormone secretion, microbi-
ome and immune function [117– 119]. Smoking is associated with 
an increased risk of complications in patients with diverticular dis-
ease [119– 123]. Use of aspirin or NSAIDs increases the risk of di-
verticulitis and diverticular bleeding [16,124,125]. NSAIDs— but not 
aspirin— are strongly associated with an increased risk of divertic-
ular perforation [126]. Impaired prostaglandin synthesis compro-
mises mucosal integrity, increases permeability and allows bacterial 
translocation, which promotes inflammation [125]. Diverticulitis is 
defined by the presence of micro- or macro- perforation leading to 
abscess formation, and is believed to be the result of an impaired 
mucosal barrier and increased intra- colonic pressure [119]. Use of 
opiates or corticosteroids increases the risk of diverticular per-
foration [127] with opiates slowing colonic transit and increasing 
intra- colonic pressure which contributes to the increased risk of 
perforation [128]. Statins have been shown to reduce the risk of 
complicated diverticulitis and perforation [127,129], but there is 
conflicting evidence as to whether calcium channel blockers also 
reduce the risk of perforation [119,127,128].
Treatment with mesalazine, rifaximin or probiotics has not been 
found to prevent recurrent episodes of diverticulitis or even control 
persistent symptoms after an episode of AD [130– 136]. An increase 
in dietary fibre or supplemental fibre is widely accepted to be of ben-
efit for general health and should be recommended, but there is little 
evidence that it reduces current symptoms or recurrence of symp-
toms. Patients should be provided with written advice on discharge.
Question 1.8
Perforation associated with AD represents 75% of diverticular 
emergencies requiring surgery [137]. Complementary to estimates 
of inflammatory parameters and CT findings, good decision- making 
and clinical judgement determine the need for surgery, depending 
upon the patient's clinical status, comorbidities, immunosuppres-
sion, signs of peritonitis and sepsis [93,138].
The optimal management of Hinchey III AD has been the focus 
of much debate. Studies of laparoscopic lavage (LL) in Hinchey III 
AD without visible perforation have shown that LL is a safe alter-
native to resection but in these studies patients with high American 
Society of Anesthesiologists (ASA) score were excluded. Patients 
undergoing LL tend to be younger and have a higher BMI. Patient 
factors that would contraindicate LL include shock, need for inotro-
pic support and immunosuppression. Findings at operation that pre-
clude LL are persistent perforation— actively sought by underwater 
air distention test— or faecal peritonitis.
Outcomes from studies show a three times greater chance of 
ongoing intraperitoneal sepsis with LL than with open resectional 
surgery, with significantly increased rates of postoperative intra- 
abdominal abscess and higher reintervention rate, including emer-
gency reoperations. Morbidity and mortality are not significantly 
different between LL and open surgery. LL has a significantly 
shorter operating time, fewer stomas, fewer postoperative cardiac 
and wound complications and a shorter length of hospital stay [136– 
148]. Published studies have made no attempt to standardize the 
surgical technique for LL but, after laparoscopic confirmation of 
Hinchey III AD, variable amounts of fluid were used to perform the 
lavage (mean 15 L), active searching for diverticular perforation was 
variable and there was no surgical credentialling or specialization 
[149,150]. Limitations of LL include the risk of missing a persistent 
perforation (30%), faecal peritonitis enclosed within a sigmoid loop 
(10%) and overlooking a sigmoid cancer (10%) [151].
Question 1.9
Hartmann's procedure (HP) or primary anastomosis with or 
without diverting ileostomy are the two surgical techniques used 
in patients undergoing ES for perforated AD, HP being performed 
most often [152,153]. Surgeon and patient factors influence the 
type of operation performed. Surgeon- specific factors include 
colorectal sub- specialization, with non- colorectal surgeons more 
likely to perform HP. Patients undergoing HP tend to be older, 
have higher Charlson Comorbidity Index and ASA scores and are 
more likely to be immunosuppressed [154– 156]. Primary anasto-
mosis can be performed in haemodynamically stable and immu-
nocompetent patients with Hinchey III or IV [157– 160]. Recent 
studies and meta- analysis have shown significantly lower overall 
mortality in patients with primary anastomosis compared with 
HP. Surgical site infection (SSI) rates, reoperation and stoma non- 
reversal rates are significantly lower in primary anastomosis, but 
at the expense of a longer mean operating time for primary anas-
tomosis compared with HP [161– 165].
Which patients with acute diverticulitis should be consid-
ered for laparoscopic lavage?
Recommendation: Laparoscopic lavage is currently not 
recommended for treatment of complicated acute di-
verticulitis but may be an acceptable alternative to avoid 
major resection in high risk patients provided its limita-
tions are communicated to patients.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 55.6%, A 44.4%)
Which patients should undergo emergency sigmoid re-
section for acute diverticulitis?
Recommendation: Patients who have failed conserva-
tive management or those with frank perforation or large 
bowel obstruction should undergo emergency sigmoid 
resection for acute diverticulitis.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 55.6%, A 44.4%)
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Primary anastomosis without diverting ileostomy may be pre-
ferred under suitable conditions in order to avoid the potential 
difficulties associated with a column of colonic stool when contem-
plating ileostomy reversal, and in 27% of those patients assigned to 
primary anastomosis in the LADIES trial no stoma was constructed 
[157]. There is no consensus on the value of antegrade colonic la-
vage under these circumstances but, provided care is undertaken to 
avoid spillage and colonic mobilization is undertaken when neces-
sary, there may be some advantages.
Evidence to support or refute the safety and effectiveness of 
a laparoscopic vs. open approach in complicated AD is insufficient 
and laparoscopic surgery should only be undertaken by suitably 
trained surgeons. The operating time is longer than open surgical 
resection, although laparoscopic surgery may improve postopera-
tive pain control and reduce the duration of paralytic ileus.
Laparoscopic and open surgery have comparable postoperative 
mortality, morbidity and reoperations due to anastomotic leakage 
[144,151,166,167].
The use of a damage control strategy involving resection without 
anastomosis, temporary abdominal closure (TAC), planned re- look 
and delayed stoma formation— or even delayed anastomosis— 
should be considered in the septic unwell patient at initial laparot-
omy [168– 171]. Fully informed consent is essential, particularly in 
those patients in whom a primary anastomosis is considered a viable 
option [156].
Question 1.10
There are no studies evaluating the extent of sigmoid resection 
in the emergency setting, but limiting the resection to the segment 
that is acutely affected without compromising blood supply of 
the remnant bowel is sensible for HP. If a primary anastomosis is 
undertaken, the distal resection level should be at the top of the 
rectum and the proximal resection level at a point where there are 
no or minimal diverticula in order to try to minimize anastomotic 
events. Mobilization of the splenic flexure may be necessary selec-
tively in order to ensure reduced tension on a colorectal anastomo-
sis or an end colostomy, but it does risk spread of contamination in 
Hinchey III and IV patients. Mesenteric division close to the bowel 
wall is likely to decrease the risk of ureteric injury, particularly in 
the presence of an inflammatory mass, at the expense of potentially 
troublesome bleeding. If a sigmoid cancer is suspected, oncological 
resection with higher ligation of the inferior mesenteric artery/su-
perior rectal artery and dissection in a mesocolic/mesorectal plane 
should be undertaken if possible.
There are no studies giving guidance on the management of the 
rectal stump in the emergency setting, but division of healthy lower 
sigmoid or rectum below the affected segment is likely to be asso-
ciated with a lower risk of stump closure dehiscence. Rectal stump 
washout may be performed in order to try and minimize the effect 
of rectal stump dehiscence. The length of the remaining rectum and 
its suitability for future reversal are useful to record in the operation 
note.
Whilst rectal catheters are in widespread use, there are no stud-
ies demonstrating specific benefit. Similarly, there is no evidence 
to support the use of abdominal drains following surgery for perfo-
rated diverticulitis.
COLOREC TAL C ANCER
Introduction
Colorectal cancer presents as an emergency in 20% of cases in the 
UK. Emergency presentation is associated with a poorer outcome, 
high levels of morbidity, mortality and reduced overall survival. 
This may be explained partly by the association of emergency 
presentation with increasing age, lower socioeconomic status, in-
creased comorbidity, higher stage of disease and lower rates of 
treatment with curative intent: 52% for emergency presentation, 
compared with 69% and 86% referred from general practitioner 
(GP) and screening services respectively [172]. Perioperative mor-
tality for ES continues to reduce in European countries [172,173]. 
However, in the UK, 90- day mortality following ES for colorec-
tal cancer is nearly six times greater than that of elective surgery 
(11.5% vs. 2.0%). Consequently, optimization of treatment strate-
gies for these patients is a priority to improve clinical outcomes 
[161]. The National Health Service (NHS) long- term plan states 
What are the essential operative steps for sigmoid resec-
tion in complicated diverticular disease?
Recommendation: Resection of acutely inflamed and 
perforated bowel should be undertaken, avoiding dam-
age to adjacent structures and minimizing tension on an 
anastomosis or colostomy by selective mobilization of 
the splenic flexure. Primary anastomosis with or with-
out diverting ileostomy should be considered by suitably 
trained surgeons under favourable conditions.
Level of evidence: IV
Grade of recommendation: GP
Consensus 100% (SA 66.6%, A 44.4%)
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that one of its priorities for the next 10 years is diagnosis of Stage 
I and II disease for 75% of cancer patients. If this is achieved, it 
would reduce the rate of emergency presentation of colorectal 
cancer [174].
Emergency presentation can occur as the initial event leading 
to diagnosis, but may also occur during the course of the disease, 
as a consequence of its treatment or as a terminal event at the end 
of life. These recommendations will focus on the most common de 
novo emergency presentations of colorectal cancer which are with 
obstruction (up to 80%), perforation (up to 20%) and, less com-
monly, acute lower GI bleeding (ALGIB).
Large bowel obstruction
Question 2.1
The sensitivity and specificity of abdomino- pelvic contrast- 
enhanced CT scan in the diagnosis of large bowel obstruction is high 
(sensitivity 96%, specificity 93%) and it outperforms other imaging 
modalities including US scan and plain abdominal radiography [175]. 
Performing a plain abdominal radiograph may delay time to CT and 
a definitive diagnosis. A CT provides effective local and distant stag-
ing information to inform treatment decisions [175– 178]. When CT 
is equivocal about the cause of obstruction, endoscopic assessment 
may be helpful.
In a stable patient, endoscopic evaluation can confirm a radio-
logical diagnosis, define the aetiology when CT is inconclusive, 
provide tissue biopsies for histological assessment and be used for 
combined endoscopic/fluoroscopic placement of a stent for ob-
struction. However, use of endoscopy is not mandatory where the 
diagnosis is not in doubt and surgical treatment is planned.
The role of self- expanding metal stents (SEMSs)
Question 2.2
National guidelines concur that the SEMS is the treatment of 
choice for malignant large bowel obstruction (MLBO) in the pallia-
tive setting due to its reduction in stoma rates, hospital length of 
stay, inpatient mortality and intensive care unit admission rates, and 
time to chemotherapy [177,179,180].
The use of SEMSs as a bridge to surgery (BTS) has short- term 
benefits. It can downgrade the emergency situation by relieving 
obstruction, enabling medical optimization of the patient, and 
giving time for staging and planning of definitive treatment. This 
enables an early planned resection with higher rates of primary 
anastomosis, lower rates of stoma formation, increased use of 
laparoscopic techniques and reduced morbidity and mortality 
[181– 183].
The use of SEMSs in the presence of perforation or peritoni-
tis is contraindicated [177]. SEMSs in patients who would benefit 
from anti- angiogenic therapy (e.g., bevacizumab) are relatively 
contraindicated, due to the higher rates of perforation seen in 
this group, although the evidence for this is debated [184– 186]. 
There does not appear to be an increased risk of SEMS- related 
perforation with other newer chemotherapeutic agents such as 
cetuximab [187].
What is the optimum imaging modality for patients 
presenting with signs and symptoms of malignant large 
bowel obstruction?
Recommendation: To diagnose malignant large bowel ob-
struction a contrast- enhanced CT scan is the imaging modal-
ity of choice. A plain abdominal radiograph is unnecessary.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 77.8%, A 22.2%)
What are the indications and contraindications for self- 
expanding metal stents?
Recommendation: Self- expanding metal stents can be used for 
the treatment of malignant large bowel obstruction as either a 
definitive procedure for palliation or as a bridge to surgery.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 88.9%, A 11.1%)
Recommendation: Self- expanding metal stents should definitely 
not be used in the presence of perforation, peritonitis or systemic 
toxicity and low rectal lesions. Self- expanding metal stents are rel-
atively contraindicated when the patient is taking anti- angiogenic 
chemotherapy and for benign causes of large bowel obstruction.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 77.8%, A 22.2%)
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SEMSs can be used in patients with MLBO due to extraluminal 
malignant disease and peritoneal carcinomatosis but with lower suc-
cess rates [188– 190], increased technical difficulty [189], reduced 
patency rates [191] and increased complication rates [192]. SEMSs 
are being used more frequently in benign causes of obstruction, in 
particular in benign strictures; however, this is associated with in-
creased complication rates and lower clinical success rates [193]. In 
addition, the use of stents to cover anastomotic leaks and fistulas 
is increasing and a meta- analysis of small retrospective cases se-
ries by Arezzo et al. showed a short- term success rate of 73% but a 
longer- term success rate of only 57% with complications occurring 
in 41.5% [194].
Question 2.3
Concerns about tumour cell dissemination and perforation by 
stent insertion as possible contributors to recurrence and poorer 
survival have led to doubts regarding this technique as a panacea 
for all cases of MLBO. Early studies showed an increase in local 
recurrence in patients receiving a SEMS as a BTS [195] and early 
termination of several RCTs because of increased morbidity in the 
stented arms [196– 198] and subsequent poorer oncological out-
comes in those experiencing SEMS- related perforations reinforced 
these concerns [199]. These concerns have meant that SEMSs have 
largely been used for patients with metastatic disease or serious 
comorbidities precluding surgical resection. National guidelines 
have not recommended their routine use, reserving it as an op-
tion for those with metastatic disease or at high risk of mortality 
from ES [179]. More recent American and UK guidelines recom-
mend SEMSs as a BTS on an individualized patient basis, but there 
is significant variation in international guidance on this issue [200] 
which will continue to change with evolution and maturation of the 
data.
Accumulating evidence and increased experience with the SEMS 
technique has shown more reassuring oncological outcome data. A re-
cent meta- analysis of RCTs examining SEMSs compared with ES found 
a higher risk of overall cancer recurrence in the SEMS as a BTS group 
(37% vs. 25.9%), but no difference in 3- year disease- free and overall sur-
vival [201]. Equivalent 5- year oncological outcomes have been shown in 
a retrospective cohort study [202] and two systematic reviews [182,203]. 
The Dutch Colorectal Audit showed equivalent 3- year oncological re-
sults between patients with left- sided colonic obstruction undergoing ES 
or SEMS as a BTS. However, the 17 patients who experienced SEMS- 
related perforations had non- statistically significant higher recurrence 
rates (18.0% and 11.0%, P = 0.432) and poorer 3- year disease- free (49% 
and 59.6%, P = 0.717) and overall survival (61% and 75.1%, P = 0.529) 
[183].
The early poorer oncological results seen may have been due to 
inexperience with the technique and in particular the use of balloon 
dilatation, which is not recommended [204]. Increasing expertise 
and familiarity with SEMSs has led to increased success rates with 
lower perforation rates which is likely to be crucial to the improve-
ment in oncological outcomes seen.
Question 2.4
The use of SEMSs has increased due to the lower morbidity as-
sociated with endoscopic intervention compared with ES. The short- 
term success rates in large prospective trials are good, with technical 
and clinical success rates in excess of 90% [184,205– 209]. Although 
some studies report somewhat lower clinical success rates, these still 
remain greater than 80% [210– 212]. In addition, success rates for 
SEMSs tend to be higher in those stented as a BTS rather than for 
palliation [191,207]. Real- world data are probably reflected better in 
national audit data rather than clinical trials and they tend to be lower 
than those seen in the trials. The Dutch Colorectal Audit includes 222 
stented patients and reports technical success rates of 194 of 222 
(87.4%) and clinical success rates of 177 of 222 (79.7%) [183].
Overall complication rates for SEMS placement are up to 35% 
including early short- term and later longer- term complications. The 
main complications include perforation (0%– 12%), failure to stent, 
stent migration and re- obstruction. Reintervention rates after 
Are self- expanding metal stents as a bridge to surgery for 
malignant large bowel obstruction oncologically safe for 
patients?
Recommendation: Self- expanding metal stents appear to 
be as oncologically safe as emergency surgery. The 3- and 
5- year loco- regional recurrence rates, disease- free sur-
vival rates and overall survival rates are comparable for 
these two groups of patients on the basis of current data. 
However, there is a risk of perforation and perforated 
cancers are at a higher risk of local recurrence. A fully in-
formed consent process is mandatory.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 77.8%, A 22.2%)
What is the expected success rate for a self- expanding 
metal stent?
Recommendation: Units should be aiming for a clinical 
and radiological success rate of the order of 90%. All units 
should audit their figures and include complications.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 88.9%, A 11.1%)
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SEMSs can be up to 20%. Less frequent complications include pain, 
bleeding, tenesmus (particularly for rectal SEMSs), fistula, late per-
foration, incontinence and fever [212].
Perforation by SEMSs can take several forms. It may be clinically 
overt, guide- wire- related, silent, or due to micro- perforation. An overt 
perforation results in symptoms and leads to a subsequent decision to 
proceed to ES or palliative care. Guide- wire- related perforations are ra-
diologically detectable but may be clinically asymptomatic and are usually 
managed conservatively. At surgery, a clinically occult SEMS perforation 
may be seen, or later picked up by the pathologist on examination of 
the resected specimen. Perforation rates are higher if a stricture is pre- 
dilated and this practice is not recommended. In the Dutch Colorectal 
Audit, the overall SEMS perforation rate was 7.7% [183]. Given the pos-
sible detrimental effect on oncological outcomes, it is essential that the 
SEMS- related perforation rate is low and this is related to operator expe-
rience. The perforation rate should be audited at an institutional level. In 
the UK, the Joint Advisory Group for Endoscopy have set a key perfor-
mance indicator for perforation following SEMS placement of <10% and 
an aspirational target of <5% [213]. High perforation rates in the early 
trials led to their premature termination [196]. The perforation rate in the 
more recently published prospective trial is much lower, between 1.6% 
and 5%, probably reflecting increased expertise [207,209,211,214– 216].
For palliative patients, re- obstruction becomes a significant risk 
but can often be managed by further stent placement [217].
Question 2.5
A 2011 Cochrane review found higher clinical success rates in pa-
tients undergoing ES compared with SEMSs for MLBO [218]. The clini-
cal success rates at relieving obstruction do still seem to be better with 
palliative surgery in comparison with SEMSs (96% vs. 86.1%, P = 0.02) 
[217]. However, since 2011, further studies have shown a significant 
benefit with SEMSs in terms of quality of life, reduction in stoma rates, 
length of hospital stay, lower intensive care unit admission rates and 
shorter time to commencement of chemotherapy albeit with conflict-
ing effects on morbidity and mortality compared with palliative sur-
gery [217,219,220]. SEMSs have become the treatment of choice for 
palliation, when local expertise exists, for left- sided MLBO, and this 
is incorporated into several clinical guidelines [177,179,180,221,222]. 
Proximal colonic stenting is technically more challenging and the rec-
ommendations have differed between guidelines and will depend on 
the local expertise in performing SEMSs. The American Society of 
Colon and Rectal Surgeons (ASCRS) guidelines now recommend con-
sidering SEMSs as a palliative treatment for right- sided MLBO [180]. 
SEMSs have definite favourable short- term outcomes compared with 
ES in the palliative setting. As a palliative measure, SEMSs should be 
considered the first line of treatment.
Question 2.6
The choice between SEMSs as a BTS or ES is finely balanced and 
must involve open discussion and shared decision- making between 
the surgeon and patient. This process should balance individual surgi-
cal risk with the relatively immature data on long- term oncological 
outcome (discussed above). Even in an average surgical risk patient, 
of ASA I or II, ES still has higher rates of morbidity and mortality and 
anastomotic leak rates than elective surgery and postoperative com-
plications can negatively affect oncological outcomes. The choice of 
SEMSs as a BTS or ES is an individualized decision and should be ac-
companied by a detailed documentation of individual surgical risk and 
the consent discussion. International guidance is highly variable in its 
recommendations of whether SEMSs should be used as a BTS [200] 
with current UK National Institute for Health and Care Excellence 
Is a self- expanding metal stent the treatment of choice 
for malignant large bowel obstruction in patients with ir-
resectable primary and/or metastatic disease?
Recommendation: A self- expanding metal stent should 
be the treatment of choice for patients with irresectable 
primary and/or metastatic disease and malignant large 
bowel obstruction as it is associated with better quality 
of life, shorter hospital stay and lower stoma rates com-
pared with palliative surgery.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 66.7%, A 33.3%)
When should self- expanding metal stents be used as a 
bridge to surgery in symptomatic malignant large bowel 
obstruction for potentially curable disease?
Recommendation: There is good evidence to support the 
use of self- expanding metal stents as a bridge to surgery 
in malignant large bowel obstruction (distal to the splenic 
flexure) prior to definitive surgical intervention, particu-
larly in high risk patients. There should be a discussion 
with patients about the role of self- expanding metal 
stents as an alternative to emergency surgery and the 
risks and benefits highlighted for both approaches.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 100%)
Recommendation: Self- expanding metal stents as a 
bridge to surgery can be used in right- sided malignant 
large bowel obstruction, although this may have more 
limited application in practice. The use of self- expanding 
metal stents in curable rectal cancers within 5 cm of the 
dentate line is not recommended.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 100%)
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(NICE) guidance recommending that SEMSs as a BTS should be dis-
cussed with patients as an equivalent alternative to ES [177].
Meta- analyses have shown that SEMSs as a BTS are associated 
with lower morbidity rates than ES [201,223,224], lower stoma 
rates and increased rates of primary anastomosis [182,223] and 
similar mortality rates [201,223]. Most studies have concentrated 
on left- sided MLBO, but similar results have been shown in cohort 
studies including proximal colonic malignancy [206,208,209]. Right- 
sided tumours made up between 7.8% and 23.2% in these cohorts 
[207– 209] and these authors support the use of SEMSs as a BTS in 
both left- sided and more proximal tumours. Current UK [177] and 
European guidance [179] does not support the use of SEMSs as a 
BTS for right- sided colonic lesions although the American guidance 
does [180]. A systematic review focusing on right- sided MLBO and 
SEMSs as a BTS has shown much lower morbidity and mortality in 
the BTS group but with the caveat that the 14 studies included were 
all cohorts and mainly retrospective [225].
SEMSs have been used in published case series for obstruct-
ing rectal malignancy; however, in the majority of cases this has 
been as a palliative measure and not as a BTS. The use of SEMSs 
in rectal cancer appears to be less successful than for left- sided 
cancers [215]. In addition, the rectum tends not to be well defined 
in studies examining the use of SEMSs, with one study defining 
the stented rectum as being greater than 5 cm from the verge but 
with no definition of the proximal extent [192]. In general, SEMSs 
should not be placed within 5 cm of the dentate line because of the 
risk of stent- related symptoms of tenesmus, pain and incontinence. 
The more recent larger prospective Eastern studies have included 
SEMSs as a BTS in rectal cancer; however, the overall numbers are 
quite small (Saito et al. [n = 11], Tomita et al. [n = 13]) [208,209] and 
there is insufficient data from these papers regarding the location 
within the rectum at which the SEMS was used. At present there is 
not sufficient evidence to support the use of SEMSs as a BTS in ob-
structing rectal cancers. In a palliative setting, SEMSs may be suit-
able in selected obstructing upper rectal cancers, albeit with lower 
success rates and higher complication rates than left- sided SEMSs.
Question 2.7
The European Society of Gastrointestinal Endoscopy (ESGE) 
guidelines recommend operating within 5– 10 days of SEMS 
placement [179], but the evidence to support this interval is 
weak. Broholm et al. [226] found an increased risk of recurrence 
associated with a longer wait to surgery in 112 SEMS patients 
(range of time to surgery 0– 165 days, median 18 days), of whom 
18% required ES due to SEMS- related complications of migra-
tion and perforation. The larger prospective studies have rela-
tively short durations of 1– 3 weeks from stenting to surgery 
[201,208,209].
Question 2.8
Both covered and uncovered stents have been used for SEMSs; 
however, the majority of studies have used uncovered stents. 
There is no difference in the technical and clinical success or pa-
tency rate between the two [227]. The main type of stent used 
is the Wallflex, an uncovered flared stent with both through the 
scope and over the wire delivery systems. The other commonly 
used stent is the Niti- S, which is an uncovered, non- flared stent. 
Covered stents are associated with higher stent migration rates in 
retrospective case series [228,229]. Covered stents can be either 
fully covered or partially covered; however, even partially covered 
stents are associated with migration in retrospective case series 
[230]. The higher stent migration rate seen with covered stents is 
thought to be due to less tumour ingrowth which can provide an-
choring. The larger prospective trials to date have used uncovered 
stents [206,207,209].
The ESGE guidelines do not recommend one type of stent 
over another [179]. However, the earlier American Society of 
Gastrointestinal Endoscopy guidelines recommend the use of un-
covered stents [231] this may simply be a reflection of the fact that 
the majority of the stents available in the US market at the time 
were uncovered [232].
For palliative stenting, where the stent is likely to be in situ for 
a longer duration and ingrowth of tumour a significant risk, con-
sideration should be given to the use of a covered stent. However, 
the evidence supporting the use of one stent design over another 
Should covered or uncovered self- expanding metal stents 
be used?
Recommendation: Uncovered stents should be used in 
the bridge to surgery setting as they are less likely to 
migrate. In the palliative setting, participation in a clini-
cal trial to determine the optimal stent design should be 
considered.
Level of evidence: III
Grade of recommendation: B
Consensus: 100 (SA 100%)
When is the optimal time for resectional surgery after 
using a self- expanding metal stent as a bridge to surgery?
Recommendation: In the absence of strong evidence, it 
seems sensible that resectional surgery should be sched-
uled immediately following medical optimization of the 
patient's clinical conditions, full radiological staging of 
disease and multidisciplinary team discussion.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 66.7%, A 33.3%)
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is weak. The ongoing CReST2 study aims to answer the question of 





For stable patients with a proximal colonic obstruction and low sur-
gical risk, it is a reasonable and safe option to perform a resection and 
primary anastomosis [233– 236]. There are a number of anastomotic 
variations including handsewn or stapled techniques and different 
methods of constructing stapled anastomoses. The European Society 
of Coloproctology (ESCP) right hemicolectomy audit of 3208 patients 
reported a slightly increased anastomotic leak rate from stapled anas-
tomoses after adjustment for cofactors (OR 1.43, 95% CI 1.04– 1.95, 
P = 0.03) [237] but no difference in the leak rate between different 
types of stapled anastomotic configurations [238]. However, the anas-
tomotic leak rate for right colonic resection in ES is not insignificant 
[239,240] with a rate of 14.3% reported in the recent ESCP right 
hemicolectomy snapshot audit [237]. In this audit, 19.5% of patients 
undergoing emergency right hemicolectomy did not have a primary 
anastomosis. Frago et al. reported an overall anastomotic leak rate 
of 16.4% in 377 emergency colectomies for obstruction, with proxi-
mal anastomoses more likely to leak than distal [241]. A large national 
Japanese database reported a much lower anastomotic leak rate (1.7%) 
but a higher rate of adverse outcomes with ES [242]. Amelung et al. in a 
retrospective study examined three treatment modalities for obstruct-
ing proximal tumours [224]. The majority of patients were treated with 
emergency resection (compared with stoma or SEMS). For the 85.6% 
of emergency resections with primary anastomosis, the leak rate was 
7.4%. Tan and Sim have identified advanced age, ASA Grades III– IV and 
preoperative renal impairment as factors associated with worse perio-
perative outcome in obstructed colorectal malignancy, albeit in a solely 
Asian population [233]. Consequently, in patients with poor surgical 
risk or at higher risk of anastomotic leak, it is reasonable not to perform 
a primary anastomosis and to consider resection and ileostomy [224]. 
There has been one meta- analysis of laparoscopic vs. open approach 
for obstructing right- sided cancers [243]; however, only five studies 
were included with small numbers overall and anastomotic leak rate 
was not reported in some of the studies which limits the interpretation 
of the data.
For obstructing left- sided cancer, there are multiple surgical 
options, the appropriate approach again depending largely on the 
physiological and comorbid status of the patient. A Cochrane re-
view in 2004 addressing primary or staged resections found the 
evidence at the time was too weak to determine the best surgical 
management strategy [244]. Potential surgical options for obstruct-
ing left- sided cancers include resection and primary anastomosis 
with or without a covering stoma, HP or defunctioning stoma alone. 
Breitenstein et al. [245] in a large meta- analysis showed no ben-
efit from two- or three- stage resection vs. one- stage resection. 
Staged procedures do inevitably result in longer overall hospital 
stays and the reversal rate for HP in colon cancer is low at 20% 
[246]. Resection and primary anastomosis is a safe technique which 
has been used for many years and should be the preferred option 
if the patient’s clinical condition allows [247,248] and can also be 
used safely in selected elderly patients [249]. Where possible, a 
segmental resection is preferred over a subtotal colectomy because 
of better functional results [250] although some authors show no 
difference in outcomes between segmental resection, HP or subto-
tal colectomy [251]. Subtotal colectomy can be reserved for cases 
of proximal colonic damage from distal obstruction or synchronous 
tumours and, when employed, a minimal amount of distal ileum 
should be resected. Anastomotic leak rates vary in retrospective 
case series between 2.2% and 12% [222,246,252– 254]. Subtotal 
colectomy may have a lower anastomotic leak rate than segmental 
colectomy [255]. Individual risk stratification in terms of predict-
ing risk of anastomotic leak and outcome is crucial for safe surgical 
decision- making.
What are the surgical options for malignant large bowel 
obstruction?
Recommendation: The choice of surgical procedure 
should be guided by the physiological condition of the pa-
tient, the site of obstruction and the state of the proximal 
colon. For proximal colonic obstruction (up to the distal 
transverse colon), resection and primary anastomosis is 
preferred, but in a patient with markedly deranged physi-
ology, resection, mucus fistula and end ileostomy is sensi-
ble. For left- sided obstruction (from the distal transverse 
colon), in a patient with stable physiology a resection and 
primary anastomosis is preferable. Worsening clinical 
condition and comorbidity dictates resection with an end 
colostomy.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
Recommendation: Where patient physiology is mark-
edly deranged and significant comorbidities exist, a 
proximal defunctioning loop stoma alone is reasonable 
to allow medical optimization prior to elective resection. 
Obstructing rectal cancer is best managed with a proxi-
mal loop colostomy to allow full radiological staging and 
neoadjuvant treatment if required.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 66.7%, A 33.3%)
    | 489MILLER Et aL.
Staged resections should be considered for obstructing rectal can-
cers, when a diverting stoma or SEMS placement (where appropriate) 
allows time for accurate local staging and consideration of neoadjuvant 
therapies [256]. Where SEMSs are not appropriate and a defunctioning 
stoma is performed as a BTS in rectal cancers, a right- sided transverse 
loop colostomy should be considered, as it is unlikely to interfere with 
the subsequent surgical approach [222,257], unless a definitive abdom-
inoperineal excision of the rectum can be predicted, when a left- sided 
colostomy should be formed. A loop stoma is preferred to allow venting 
of the distal limb [256]. A defunctioning stoma as a BTS is an option for 
some patients instead of using a SEMS [258– 260]. Patient preference 
and uncertainty of the long- term oncological results of SEMSs due to 
immaturity of the data make this a valid surgical option after discussion 
of the risks and benefits of the different management strategies with 
the patient. In general, however, this option is likely to be reserved for 
those who would benefit from optimization prior to semi- elective sur-
gery or for those where SEMSs have failed or are not available due to 
local resources.
Retrospective studies have reported on- table lavage to be safe in 
obstructed colorectal cancers; however, it also prolongs the surgery 
and does not appear to confer any specific advantage over decom-
pression alone [261,262]. On- table lavage is at the discretion of the 
operating surgeon as it does not increase the morbidity or mortality 
rate. However, there have been no RCTs to date showing a benefit 
in the emergency situation over manual decompression alone [263].
Question 2.10
Palliative surgery in patients with peritoneal carcinomatosis is 
associated with high morbidity and mortality rates [264]. However, 
patients with advanced malignancy are at high risk of obstruc-
tive symptoms (10%– 28% of colorectal cancers) so this is not an 
uncommon situation [265]. Carcinomatosis from GI malignancy com-
pared with ovarian primaries is associated with worse outcomes [266]. 
Negative prognostic indicators for surgery in these cases include 
older age, poor nutritional state, poor performance status, extent of 
malignancy, small bowel as opposed to large bowel obstruction and 
prior abdominal or pelvic radiotherapy [267]. Even in patients who 
undergo surgery, the re- obstruction rate can be as high as 50% [268].
Surgery is generally reserved for patients with an obvious ob-
struction point, which cannot be managed endoscopically (e.g., with 
SEMS), and when no major barriers to surgical intervention exist 
such as significant comorbidity, extensive carcinomatosis, multi- 
level stenoses or invasion of the root of the mesentery [267,269]. 
When surgery is performed, the operative approach must be tai-
lored to the clinical and radiological findings, with the primary goal 
of relieving the obstruction, alleviating symptoms and sometimes 
allowing progression to palliative treatment which may prolong sur-
vival [270]. Surgery will usually take the form of a palliative loop 
stoma. A shared model of decision- making is important in these clin-
ical scenarios, particularly in identifying the goals of care. In general, 
survival is poor. Median survival in established cases of untreatable 
MLBO is only approximately 4– 5 weeks, although up to a third of 
patients show spontaneous resolution of acute symptoms with 
medical management [269]. In patients undergoing surgery, a meta- 
analysis showed that resection was associated with the longest 
survival (7.2 months) with stoma and bypass surgery having shorter 
survival times (3.4 and 2.7 months respectively) albeit in highly se-
lected populations with small numbers of patients [270]. In addition, 
major complication rates among those who had surgery were high 
at 37%. The type of resection performed in the studies was not re-
ported, which limits interpretation of the results.
Question 2.11
International guidelines suggest that the laparoscopic approach 
for MLBO due to colorectal cancer should be reserved for selected 
favourable cases and in specialized centres [222]. Retrospective 
cohorts and case– control studies have shown that laparoscopic 
surgery for emergency colorectal surgery (of varying aetiologies) 
is safe and has similar benefits to laparoscopic surgery in the elec-
tive setting with shorter length of stay and lower postoperative 
What is the optimal surgical approach for irresectable 
Stage IV colorectal malignancy or peritoneal carcinoma-
tosis causing malignant large bowel obstruction?
Recommendation: A self- expanding metal stent is the 
preferred intervention for irresectable Stage IV disease 
or peritoneal carcinomatosis causing large bowel obstruc-
tion. Surgery should be reserved for patients with good 
performance status and with isolated areas of disease 
that can be surgically relieved. Success rates for stents are 
lower if the obstruction is due to extrinsic compression.
Patients should be counselled about high rates of re- 
obstruction, morbidity and mortality. The goals of treat-
ment together with patient and family expectations need 
to be discussed realistically.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 88.9%, A 11.1%)
What is the role of laparoscopic resection in emergency 
surgery for colorectal cancer?
Recommendation: Due to a shorter hospital stay and 
lower postoperative morbidity and mortality, laparo-
scopic resection is recommended where patient and tu-
mour characteristics are favourable.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 77.8%, A 22.2%)
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morbidity. However, it is likely that case selection biases these re-
sults, with younger, fitter, less comorbid and less physiologically 
deranged patients being selected for a laparoscopic approach.
The recent LaCeS trial has demonstrated that randomization of 
a cohort of ES patients between laparoscopic and an open surgical 
approach is feasible, acceptable and safe, albeit with a conversion 
rate of 39% [271]. Vallance et al. [272] have examined patient and 
institutional factors associated with the laparoscopic approach for 
urgent surgery for colorectal cancer in the English National Bowel 
Cancer Audit. The proportion of urgent laparoscopic resections dou-
bled across the study period (2010– 2016) from 15.1% to 30.3% with 
no change in the conversion rate, which remained stable at 18.7%. 
After multivariable logistic regression analysis, patient characteristics 
associated with the use of a laparoscopic approach were a lower ASA 
grade and earlier T stage. The use of laparoscopic surgery was associ-
ated with a reduced length of stay and lower 90- day mortality.
Perforation
The majority of studies report retrospective, single centre experi-
ences of emergency presentations of colorectal cancer; in these 
cohorts the perforated cancers represent 18.6%– 28.4% of cases 
[272– 276]. In population- based cohorts, 1.6%– 4.1% of the total 
number of colorectal cancers presented with perforation [277,278]. 
Perforation occurs at the site of the cancer in 65%– 92% and proxi-
mal to the cancer in 3%– 35% [279].
Reported early perioperative mortality rates from perforated 
colorectal cancer vary widely and have been as high as 62% [279]. 
However, more recent reports show perioperative mortality in the 
range 0%– 20% [273,274,276– 280]. Mortality rates may depend 
on the site of perforation. It has been thought that perforation 
proximal to the tumour site in an obstructed colon tends to lead 
to diffuse peritoneal contamination and septic shock resulting in 
an increased risk of perioperative mortality. A perforation at the 
tumour site results in local contamination and a lower risk of se-
vere peritonitis, although the literature is contradictory. Mortality 
is associated with age, comorbidity and Stage IV disease [173,281].
Question 2.12
The influence of perforation on oncological outcomes remains 
unclear [279]. It is difficult to draw conclusions from relatively small, 
single centre, retrospective studies with variable lengths and com-
pleteness of follow- up and with varying rates of perioperative mor-
tality. The heterogeneity of groups within studies (all perforations 
vs. local or proximal perforations; the inclusion of all ES patients in-
cluding those with obstruction and perforation; urgent, expedited 
surgery vs. emergency, immediate surgery) also makes conclusions 
unreliable.
Poorer cancer outcomes for patients undergoing curative ES 
in comparison with elective groups are reported [282,283] but it 
is suggested that these dismal outcomes are largely due to differ-
ences in patient and tumour characteristics and statistical adjust-
ment for differences and propensity score matching eliminates 
these differences [284]. In the context of perforated tumours alone, 
the poorer outcomes in patients presenting with perforation may 
be due to early deaths from perioperative mortality and advanced 
disease stage [277,285]. Once adjustment is made for perioperative 
mortality, similar 5- year overall survival rates seem to be seen for 
perforated cancers undergoing complete resection compared with 
non- perforated controls [280].
Evidence regarding the incidence of peritoneal carcinomatosis 
after curative surgery for colorectal cancer is poor, but a perforated 
primary tumour may be an important factor [286]. Population- based 
studies or registries with more complete data are more likely to be 
reliable than single centre studies. Cheynel et al. showed that, in 
a population- based study, locally perforated cancers had a higher 
rate of local recurrence (15.7% vs. 7.8%, P = 0.021) and peritoneal 
carcinomatosis (13.8% vs. 6.3%, P = 0.036), but no difference in the 
rate of distant metastases (17.7% vs. 18.6%, P = 0.99). Perforation 
was an independent risk factor for local recurrence or peritoneal 
carcinomatosis (OR 2.17; 95% CI 1.27– 3.69, P = 0.004) but, despite 
this, after exclusion of postoperative mortality perforation was not 
a significant prognostic factor for survival on multivariate analysis 
(OR 1.16, 95% CI 0.72– 1.9, P = 0.54) [277]. The Erlangen Colorectal 
Cancer Registry showed lower disease- free 5- year survival (42.9% 
vs. 72.8%) and overall survival (47.3% vs. 66.9%) in 52 patients with 
perforated colon cancer in comparison to 1206 patients with non- 
perforated colon cancer and showed that perforation was an inde-
pendent negative prognostic factor [256].
There does not appear to be a significant oncological difference 
in the longer term between curatively treated patients presenting 
as an emergency with obstruction or perforation. When emergency 
cases are examined together as a group, Chen et al. found on mul-
tivariate analysis that although patients with locally perforated co-
lonic cancer had a lower disease- free survival (P = 0.005) than those 
with obstructed cancers there was no difference in overall survival 
[275] whereas Biondo et al. showed no differences at all between 
curatively treated emergency patients with perforated (locally or 
proximally) or obstructed colonic tumours with respect to tumour 
recurrence, type of recurrence, overall survival, 5- year disease- free 
survival and cancer- related survival [274]. More recently, the same 
authors analysed a cohort of patients collected over 18 years, show-
ing that local recurrence was predicted by the presence of diffuse 
How should patients who present with a perforated can-
cer be counselled?
Recommendation: Patients with a perforated cancer 
should be advised of the higher rate of local recurrence 
and peritoneal carcinomatosis but that there is no dif-
ference in the rate of development of distant metasta-
ses. The long- term oncological outcomes for curatively 
treated patients presenting as emergencies with either 
obstruction or perforation are equivalent.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 77.8%, A 22.2%)
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peritonitis, but no significant difference was identified in local recur-
rence rates between patients presenting with obstruction or perfo-
ration [276].
Question 2.13
The goals of emergency treatment of perforated colorectal can-
cer are to avert the immediate negative impacts of the complication 
(e.g., death, sepsis), achieve the best possible tumour control, and 
ensure timely recovery to permit initiation of appropriate adjuvant 
or systemic treatment [180]. Given the dilemma surrounding long- 
term oncological outcomes in patients treated for perforated cancer, 
it is important that, where possible, patients should be treated with 
a standard oncological resection to optimize tumour control. A bal-
ance has to be struck between patient safety with prompt control of 
sepsis and optimizing oncological outcome.
Patients who present with perforated colonic cancer are less likely 
to have a primary anastomosis [276,278– 280]. This is mirrored by the 
ASA grade of the patient; patients with higher ASA grades having a 
lower rate of primary anastomosis [278]. This is entirely appropriate 
as the choice of surgical operation depends on the clinical condition 
of the patient; the risk of primary anastomosis and possible anasto-
motic leak has to be weighed against the option of a stoma which may 
not be reversed. Anastomotic leak rates in patients undergoing ES and 
having a primary anastomosis may be higher than those in elective sur-
gery. Biondo et al. [276] showed an anastomotic leak rate of 15.8% in 
patients undergoing a primary anastomosis following emergency col-
orectal cancer presentation. However, similar to oncological outcomes, 
this may again be due to confounding factors related to patient char-
acteristics as others have found similar leak rates in primarily anasto-
mosed patients [278]. Primary anastomosis (with or without proximal 
diversion) can be considered in patients with minimal contamination, 
clinical stability and healthy tissues. In general, resection should follow 
established oncological principles but there should be a low thresh-
old for performing a staged procedure, accepting that stomas formed 
in the emergency situation are often not reversed [280], although 
considering the use of double- barrelled stomas where possible and 
avoiding split site stomas increases the chances of stoma reversal.
In the case of right- sided perforation, a right hemicolectomy 
should be performed. Whether an anastomosis is formed or not de-
pends on the condition of the patient bearing in mind that anasto-
motic leak rates can be high. The recent 2015 ESCP snapshot audit 
of 3208 patients undergoing right hemicolectomy showed that 
the overall anastomotic leak rate is 8.1% but can be up to 14.3% 
in patients presenting as an emergency, although emergency pre-
sentation was not a risk factor for anastomotic leak on multivariate 
analysis [237].
For perforated distal colonic tumours, an oncological resection 
and anastomosis, with or without ileostomy, should be the option 
of choice if the condition of the patient allows, as a Hartmann's 
resection has a low rate of stoma reversal. A Hartmann's resection 
is preferred where the clinical condition of the patient is poor. 
For diastatic perforation (proximal to the site of an obstructing 
tumour) formal tumour resection and management of the prox-
imal perforation is needed, frequently in the form of a subtotal 
colectomy with a subsequent negative impact on function [250]. 
Ideally, minimal resection of the terminal ileum and leaving at 
least 10 cm of colon remnant above the peritoneal reflection im-
proves function.
Perforation of the extraperitoneal rectum is uncommon. The prior-
ity is control of sepsis by drainage of any collection, ideally intralumi-
nally, broad- spectrum antibiotics and a proximal defunctioning stoma 
to allow full staging and multidisciplinary planning of neoadjuvant 
therapy.
Bleeding
Rectal bleeding is a symptom of colorectal cancer in about half of 
patients [287] but it is less common for patients to present with an 
ALGIB. A lower GI malignancy was the ultimate diagnosis in 6.1% 
of patients presenting as an emergency admission secondary to an 
ALGIB in the recent UK acute lower GI bleed audit, although this 
may be an underestimate because 22.8% of 2528 patients with 
ALGIB had no formal diagnosis at discharge [288]. This is comparable 
to the rate demonstrated in a prospective population- based study in 
Iceland of 7.4% of ALGIB being due to colorectal malignancy [289]. 
As the rate of underlying colorectal malignancy is at least twice that 
deemed appropriate for urgent referral and investigation by NICE 
[289], all patients (if fit enough to benefit from it) should be inves-
tigated to determine, and plan any treatment for, the underlying 
aetiology of an ALGIB. In the recent UK ALGIB audit, 328 patients 
(13%) were discharged with no investigations and, of the 4.4% of 
patients readmitted with a further ALGIB within 28 days, more than 
half (53.2%) had had no inpatient investigation during their initial 
presentation [288]. The urgency of investigation depends on the se-
verity of the initial bleed, either as an inpatient for unstable or stable 
What are the surgical options for perforated colorectal 
cancer?
Recommendation: Operations should be individualized 
taking into account existing physiological derangement, 
comorbidity and tumour characteristics. Oncological 
resection should be performed wherever possible: for 
perforation at the tumour site, formal resection with or 
without anastomosis, with or without stoma. For proximal 
perforations, simultaneous tumour resection and man-
agement of the proximal perforation is necessary.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 66.7%, A 33.3%)
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major bleeds or as an urgent outpatient within 2 weeks for stable 
minor bleeds [290].
Question 2.14
The British Society of Gastroenterology (BSG) guidelines for the 
diagnosis and management of ALGIB detail a risk- stratified approach 
to the management of ALGIB. Patients are classified into stable or 
unstable categories. Stable patients are then subdivided into minor 
or major groups using a validated risk assessment tool (Oakland 
score). Minor self- terminating bleeds without other indications for 
hospital admission can be discharged and managed on an urgent 
outpatient basis with investigations within 2 weeks [291].
Link: Oakland score calculator
Question 2.15
Colonoscopy is the most effective initial intervention for stable 
patients allowing a diagnosis to be made, the site of a malignancy to 
be tattooed and giving an opportunity for therapy in cases of active 
bleeding. Patients who have had a major bleed should be admitted 
to hospital and undergo colonoscopy on the next available list [291]. 
Bowel preparation, either orally or by nasogastric administration, 
should be used to increase the diagnostic yield and caecal intubation 
rate [292].
As the majority of ALGIB settle spontaneously, using radiolog-
ical investigations to form a diagnosis is not necessary in all cases; 
only 25.9% of patients required a CT or CT angiogram in the UK 
audit, which was diagnostic for the source of bleeding in 55.8% 
and 49.7% respectively [288]. CT angiogram is preferred in an un-
stable patient due to its speed of access and assessment of the 
whole GI tract; in general this will be a triple phase examination 
(unenhanced, arterial and portal venous/delayed phase) from dia-
phragm to below the inferior pubic ramus in order to ensure that 
the anorectum is covered [293]. Radionuclide imaging is unlikely to 
be helpful in the context of ALGIB due to a colorectal malignancy 
as colonoscopy and CT/CT angiogram will nearly always be able to 
localize a tumour.
Question 2.16
Therapeutic interventions, other than resuscitation and trans-
fusion of red cells, are rarely required for ALGIB, 80% of which 
cease spontaneously [294]. Studies and guidelines that address 
the management of ALGIB consider all cases and aetiologies, 
but only a small proportion will have ALGIB due to colorectal 
malignancy.
Colonoscopy is the mainstay of diagnosis but can also provide 
therapeutic options for bleeding malignancy such as vasoconstric-
tor injection, application of clips, heater- probe or radiofrequency 
ablation [295]. Whichever technique is used, rebleeding from col-
orectal malignancy is common. Although uncommonly required, 
angiographic embolization is an effective method to treat ALGIB; 
it was performed in 19 (0.8%) of the 37 (1.5%) patients undergo-
ing angiography in the UK ALGIB audit [288]. However, rebleeds 
are not uncommon although re- embolization can be considered 
[295,296]. Embolization- related ischaemia may occur (4%– 11%) 
and can require surgical intervention. Patients experiencing ALGIB 
due to colorectal malignancy are likely to continue to bleed or re-
bleed after intervention. Colonoscopic or angiographic therapeu-
tic interventions, if required, should be considered an emergency 
temporizing measure to allow full radiological staging of disease, 
optimization of the patient's clinical condition and multidisciplinary 
Can acute lower gastrointestinal bleeding be managed on 
an outpatient basis?
Recommendation: A proportion of patients with acute 
lower gastrointestinal bleeding can be managed safely on 
an outpatient basis if appropriately risk- stratified.
Level of evidence: III
Grade of recommendation: B
Consensus: 88.9% (SA 66.7%, A 22.2%)
What are the optimal diagnostic techniques for lower 
gastrointestinal bleeding and when should these differ-
ent techniques be employed?
Recommendation: Colonoscopy is the preferred initial 
investigation for minor or major acute lower gastrointes-
tinal bleeding in stable patients. CT angiography is pre-
ferred in unstable patients.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 66.7%, A 33.3%)
What therapeutic approaches should be considered for 
bleeding colorectal malignancy?
Recommendation: Patients should be resuscitated and 
transfused according to standard protocols. Therapeutic 
options should be individualized according to clinical con-
dition and include colonoscopic therapeutic intervention, 
angiographic embolization, surgical resection and, very 
rarely, endovascular stent techniques.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
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team discussion to plan urgent multidisciplinary treatment of the 
underlying malignancy.
ES for acute lower GI bleeding is very rarely needed. Only six pa-
tients of 2528 in the UK lower GI bleeding audit required laparotomy 
(0.2%), only two of which were due to malignancy [288] and none 
of 1134 patients in a prospective population- based study [289]. ES 
for a bleeding colorectal malignancy is likely to be required if there 
is haemodynamic instability despite a 6- unit blood transfusion, slow 
bleeding requiring more than 3 units/day blood transfusion, inability 
to stop bleeding despite endoscopic and endovascular techniques 
or recurrent episodes of significant haemorrhage. In these rare situ-
ations, oncological principles should be followed wherever possible. 
The choice of surgical procedure should be individualized depend-
ing on the patient's clinical condition but a low threshold should be 
given to the use of stomas in these rare, life- threatening cases.
In uncommon situations where irresectable malignancy may 
cause dramatic ALGIB due to major vascular involvement by the tu-
mour, the use of endovascular stents, where anatomically feasible, 
may improve quality of life and provide successful palliation [297].
INFL AMMATORY BOWEL DISE A SE
The emergency management of inflammatory bowel disease (IBD) 
has been considered extensively recently by the ACPGBI and is 
comprehensively covered in the ACPGBI IBD Guidelines.
Link: ACPGBI IBD Guidelines
ACUTE BOWEL ISCHAEMIA AND 
INFARC TION
Introduction
Acute mesenteric ischaemia (AMI) is defined as the sudden interrup-
tion of the blood supply, or venous drainage, to a section of bowel, 
leading to ischaemia, cellular damage and/or intestinal necrosis 
[298– 300]. It has an estimated prevalence of 1:1000 European and 
US hospital admissions [301– 303] and is associated with a high 
mortality rate, particularly if detected late and decompensated aci-
daemia has ensued. Bowel ischaemia is observed in approximately 
11.8% of cases within the NELA and has an associated 23.9% 30- day 
and 27.7% 90- day mortality rate [298]. AMI clinical management is 
therefore time sensitive and associated with a high mortality risk. It 
requires a high index of suspicion by the clinical team and thus is a 
key challenge to the on- call general surgeon.
Previous work has demonstrated variable mortality rates of 
patients with AMI between centres [303,305]. One reason for this 
may be the variability in management as observed between centres 
contributing to NELA [299]. There is also likely to be an element of 
intra- clinician variability of practice. This could partly be a result of 
the paucity of guidelines available on this subject.
AMI can be divided into four broad categories [306]
1. arterial embolization, occurring in 40%– 50% of cases;
2. arterial thrombosis, in 25%– 30% of patients;
3. non- occlusive mesenteric ischaemia (NOMI) in approximately 
20% of patients;
4. mesenteric venous thrombosis in 10%.
Where appropriate, the management of these conditions is com-
bined in these recommendations with any variation pertaining to 
the management of individual subcategories stated.
Question 4.1
The diagnosis of AMI can be difficult. Sudden onset of abdominal 
pain and symptoms out of keeping with the clinical signs elicited should 
raise concern, the site and extent of the pain being variable. Peritonism 
is a late clinical sign, as is per rectal bleeding, fever or haemodynamic in-
stability. AMI can cause extreme pain and patients may have substantial 
analgesic requirements. Pain out of context with clinical signs is often 
described as being the typical presentation of AMI [301]. However, this 
clinical finding has a poor negative sensitivity [307]. Guaiac- positive 
stools, atrial fibrillation, heart failure, diffuse tenderness and peritoneal 
signs may be present [307]. Vomiting, nausea, diarrhoea are early clini-
cal signs with peritonism, haemodynamic instability and shock occurring 
later [307]. Large bowel ischaemia presenting with per rectal bleeding 
is common and typically has a more benign course than small bowel is-
chaemia [308].
Given the diverse nature of aetiologies causing AMI, and the dy-
namic process of bowel ischaemia, no specific spectrum of clinical signs 
can be relied upon to establish the diagnosis. A high index of suspicion 
with a low threshold to perform further investigations in a timely man-
ner is recommended in order to ensure diagnosis. Mortality is associ-
ated with delayed diagnosis and thus early investigation is important 
[309].
One epidemiological study showed that AMI is more common than 
appendicitis in the elderly cohort [310]. As such, the diagnosis should be 
suspected in elderly patients, particularly those with other cardiovascular 
comorbidities, presenting with abdominal pain [310,311]. Alcohol intake, 
sex and comorbidity history of hypertension, hyperlipidaemia, diabetes, 
atrial fibrillation, stroke, heart failure, chronic renal disease, ischaemic 
heart disease, chronic obstructive pulmonary disease and cirrhosis have 
all been reported to be risk factors [302,312– 314]. Post cardiac and aor-
tic aneurysm surgery (particularly in the context of emergency repair for 
How is the diagnosis of acute mesenteric ischaemia made?
Recommendation: As there are no reliable clinical symp-
toms or signs that are pathognomonic a high index of sus-
picion is vital in detecting intestinal ischaemia. Untreated 
atrial fibrillation, underlying vascular disease and risk fac-
tors for atherosclerosis should raise suspicion.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 100%)
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rupture) and any other vascular intervention increases the risk of bowel 
ischaemia [315– 320]. AMI should also be considered in patients admitted 
to critical care with septic shock in whom an infective cause has not been 
demonstrated 24 h after admission [321].
Some patients present with AMI without any obvious aetiolog-
ical risk factor being present. Embryological malrotations, for ex-
ample, can lead to volvulus and subsequent ischaemia without any 
concomitant risks [322– 324].
Question 4.2
Although several risk- stratification tools have been proposed 
[304,316,319,320], none has been validated in large volume clinical 
practice [301]. Outcome is based on pathology, physiological distur-
bance and underlying comorbidity [309]. However, the use of risk calcu-
lators available for emergency laparotomies has been shown to reduce 
variability in the perception of risk by surgeons [325]. Such tools may 
be useful when counselling patients and their families about the risk of 
adverse outcome in this setting.
Predictive factors for necrosis (and thus poorer outcome) include a 
combination of organ failure, a lactate >2 mmol/l and bowel loop dilata-
tion on CT [326]. Although pneumatosis intestinalis on CT or plain X- ray 
tests is a sign of bowel ischaemia, caution should be used in interpreta-
tion and clinical correlation remains vital. Isolated pneumatosis intesti-
nalis does not always require operative intervention [327– 329]. The site 
of intestinal ischaemia is also a risk- stratifier. The right side of the colon 
has a worse survival profile than left- sided colonic ischaemia [330– 332].
Question 4.3
AMI is an evolving process from multiple aetiologies. With inad-
equate perfusion, to ischaemia and then infarction blood tests such 
as pH or lactate will become increasingly abnormal. The outcomes are 
best for those with early pathology [306,314] and thus management 
decisions, including further investigations, should not be delayed due 
to the lack of positive evidence in blood tests where AMI is suspected 
[301,333].
Most recent evidence assessing the accuracy of blood tests in 
detecting mesenteric ischaemia and infarction is poor [333– 359]. On 
meta- analysis review [334,335] of the predictive biochemical and hae-
matological markers in AMI, D- dimer was found to have the highest 
sensitivity (93.4%– 96%). It was non- specific, however (36.4%– 40%). 
As a result, it cannot be used to discriminate AMI cases. Lactate and 
acidaemia will rise during the pathophysiological processes involved 
in AMI. However, neither are sensitive or specific markers for AMI. 
Investigations to diagnose AMI should not be delayed until the 
presence of a high serum lactate level or increased levels of acidae-
mia are noted, if the clinical suspicion is high. Although tests such 
as urinary intestinal fatty- acid binding protein levels show promise, 
they cannot be recommended at present to discriminate AMI cases 
[333,334,346,350]. As such there are no key blood biomarkers recom-
mended for the diagnosis of AMI.
Whilst there have been multiple recent publications assessing 
the radiological diagnostic modalities in AMI, they are mainly review 
articles and baseline evidence is poor; however, only CT angiogra-
phy had adequate accuracy to establish the diagnosis of AMI in lieu 
of a laparotomy [360]. Plain abdominal X- rays have no clinical value 
in this setting. A multiphase phase CT is the modality of choice; 
classically this is a dual phase examination, with arterial and portal 
venous phases. The addition of an unenhanced scan is beneficial 
as unenhanced bowel hyperdensity is highly specific of ischaemia 
[361] and improves sensitivity, diagnostic confidence and interob-
server agreement [362]. Findings on CT depend on the underlying 
cause of AMI, whether it is arterial, venous or NOMI; however, 
reduced bowel wall enhancement has high sensitivity [363], with 
appreciable inter- reader agreement of CT features of AMI [364]. 
Finally, CT is able to differentiate spontaneous intramural intestinal 
haemorrhage from AMI [365].
What are the important factors in determining outcome 
in ischaemic bowel?
Recommendation: Prognosis should be based on physi-
ological parameters which include comorbidity together 
with the length of bowel affected and extent of bowel 
infarction. There are no validated scoring systems that 
can predict outcome.
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
What investigations are required for the management of 
acute mesenteric ischaemia?
Recommendation: A multiphase CT should occur urgently 
in any patient suspected of acute mesenteric ischaemia 
where active treatment is appropriate.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 100%)
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Intravenous contrast increases diagnostic accuracy. The impact 
of contrast on acute nephropathy is controversial and may be lower 
than initially perceived [366,367]. If AMI is suspected, a CT scan 
with intravenous contrast should not be delayed in order to com-
mence fluid resuscitation and improve renal function. Oral contrast 
is not required and can limit the ability to assess wall density and 
enhancement.
Question 4.4
There is little role for diagnostic laparoscopy in the initial manage-
ment of AMI [301]. Colonic ischaemia typically has a more indolent 
course with a better prognosis compared with small bowel ischaemia 
[308,368,369]. Colonic ischaemia can be detected by careful use of 
flexible sigmoidoscopy. CT in large bowel ischaemia is less accurate 
than in small bowel ischaemia. If the patient remains stable an un-
prepped flexible sigmoidoscopy is recommended. It should take place 
within 48 h of presentation [369]. If the patient deteriorates with signs 
of peritonism then surgical intervention should be considered. A sec-
ond opinion from an experienced colleague is recommended because 
this group of patients are often elderly, frail and comorbid.
Question 4.5
The key pathology in AMI is inadequate blood supply to the 
bowel or lack of venous drainage. The European Society of Trauma 
and Emergency Surgery recommendations of the three ‘Rs’ are rel-
evant here:
1. resuscitation,
2. rapid diagnosis and
3. urgent revascularization.
Intravenous fluids should be administered to optimize blood 
pressure and end organ perfusion. A balanced crystalloid admin-
istration is the preferred fluid choice [301,370,371]. Supplemental 
oxygen should also be provided [301]. Small numbers will benefit 
from revascularization and where identified these patients should 
be discussed with the vascular team.
Vasopressor support can decrease splanchnic vessel perfusion 
and should be avoided where possible [301,372]. The use of vaso-
pressin rather than noradrenaline has been proposed in patients with 
NOMI [372]. Critical care support is strongly recommended. Broad- 
spectrum antibiotics should be given to patients with suspected 
AMI to reduce the risk of sepsis secondary to bacterial transloca-
tion [298,301]. All resuscitation actions should be given in a timely 
manner as revascularization or resection is the definitive treatment 
and should occur as soon as feasible. Extended preoperative optimi-
zation in AMI is of limited value as the progressive ischaemic insult 
normally exceeds the ability of resuscitative efforts to improve con-
dition until the ischaemic tissues are either removed or reperfused.
Question 4.6
The definitive management for patients with AMI depends on 
the underlying cause of the reduction of perfusion to the bowel, 
and whether the bowel is ischaemic or infarcted. Any patient with 
a clinical suspicion of bowel infarction with peritonitis will require 
immediate laparotomy and resection of bowel, if active treatment 
is to be pursued [301]. Any bowel that is resected should be sent 
for histological analysis. In patients with no likelihood of infarcted 
bowel but features in keeping with AMI, the treatment options for 
revascularization are open or endovascular in nature. Open vascular 
revascularization has traditionally been the optimal treatment op-
tion [301,373– 377]. More recently, endovascular treatments have 
gained traction [373,376– 384]. However, there is a lack of RCTs 
What role do laparoscopy and endoscopy have in the di-
agnosis of mesenteric ischaemia?
Recommendation: There is no strong evidence to support 
diagnostic laparoscopy in acute mesenteric ischaemia, 
but its use may prevent an unnecessary laparotomy. A 
limited flexible sigmoidoscopy is the most accurate means 
of assessment of left- sided colonic ischaemia if diagnosis 
is uncertain.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
What is the initial management of acute mesenteric 
ischaemia?
Recommendation: Immediate resuscitation with intrave-
nous fluids, supplemental oxygen and antibiotics should 
be administered as preliminary treatment whilst arrange-
ments are made for definitive care.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 55.6%, A 44.4%)
What are the definitive treatment options available for 
acute mesenteric ischaemia?
Recommendation: Infarcted bowel should be resected 
at emergency laparotomy. In those patients who do not 
have evidence of infarction, a discussion with a vascular 
specialist should occur regarding the option of revas-
cularization. The revascularization technique depends 
on the underlying pathology and vascular anatomy and 
should be assessed on an individual patient basis in a mul-
tidisciplinary approach.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 88.9%, A 11.1%)
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comparing these approaches [374] with most evidence being of 
poor quality [375]. Meta- analyses of the poor quality data show 
better early outcomes associated with endovascular approaches 
[373,376,378]. However, the long- term mortality is equivalent [373]. 
Venous thrombosis can be treated with systemic anticoagulation 
[374,385,386] albeit with a risk of a sequela of portal hypertension.
Re- canalization depends on the nature of the pathology. 
If arterial revascularization is to be considered, the evidence is 
too heterogeneous to currently recommend an endovascular 
approach in preference to an open approach. At present, early 
discussion with interventional radiology and vascular surgery 
and providing a revascularization approach that is based on local 
availability, patient morbidity and clinician expertise is the recom-
mended approach.
Question 4.7
Patients with bowel infarction or peritonism are critically unwell. 
As such, if active management is to be pursued, urgent resection of 
all obviously affected bowel should occur. No anastomoses should 
be considered in this setting (unless an obvious precipitant for the 
bowel infarction can be identified) at the time of the first laparotomy 
and a damage control approach should be adopted [387]. This in-
cludes emergency resection of obviously infarcted bowel, consid-
eration for an open abdomen (OA) and management in the critical 
care scenario [388– 399]. Intra- abdominal hypertension (IAH) is a 
significant risk in patients with such intra- abdominal catastrophe 
and therefore a laparostomy approach is safe, timely and allows 
early return to critical care for further management. The primary 
laparotomy should be considered as source control of the infarcted 
bowel. Unless an obvious precipitant can be identified, the resected 
bowel should be sent to histopathology for assessment of conditions 
such as vasculitis.
Consideration of anastomosis of bowel ends and re- 
vascularization should occur after the initial resection and appro-
priate critical care in these scenarios. The timing of the second 
laparotomy should be within 48 h of the initial procedure [301]. 
Bowel ends should be pink, peristalsing and have an obviously 
healthy mesentery if any anastomosis is to be considered.
Question 4.8
In- hospital mortality rate has not changed in the last decade 
[391,392]. As such, the in- hospital mortality rates remain high (up 
to 63%) [112]. Patients with arterial mesenteric infarction or with 
NOMI are three times more likely to die during the first hospital ad-
mission compared with those with venous mesenteric infarction.
Mortality is associated with the mechanism of ischaemia, with 
arterial origin being associated with a higher morbidity and mortal-
ity than venous engorgement [393]. The goal of optimal manage-
ment should be rapid identification and revascularization of viable 
GI tissues [301,394] which requires early recognition. Thus, a low 
threshold for investigating patients at high risk of AMI is likely to 
increase the detection of the condition and therefore initiate earlier 
treatment. There is also likely to be inter- hospital variability in prac-
tice [395] in UK centres. Regular audit of clinical practice to reduce 
these variabilities, such as that undertaken in NELA [299] offers an 
opportunity to improve outcomes of patients with these conditions.
Many of this group of patients who survive and are stable will have sig-
nificant ongoing problems. They may have short bowel lengths remaining, 
stomas, possibly an OA or entero- atmospheric fistula (EAF). An early dis-
cussion with an intestinal failure unit is recommended, and in some cases 
may prevent some of the morbidity associated with this condition.
Question 4.9
What is the role of abbreviated laparotomy in acute mes-
enteric ischaemia treatment?
Recommendation: Patients with peritonism or bowel 
infarction need immediate laparotomy and resection of 
affected bowel segments. Further resections over con-
secutive days may be required. Interim management of 
the open abdomen with a negative pressure dressing sys-
tem is recommended.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 100%)
How can morbidity and mortality rates be improved fol-
lowing acute mesenteric ischaemia?
Recommendation: Improving morbidity and mortality 
rates will involve early detection and expedited manage-
ment. Early discussion with an intestinal failure unit to 
judge prognosis and agree treatment strategy is essential 
for patients with acute severe intestinal failure or long- term 
intestinal failure following acute mesenteric ischaemia.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 77.8%, A 22.2%)
What is the postoperative management of patients who 
have had acute mesenteric ischaemia?
Recommendation: Postoperative management is depend-
ent on the underlying aetiology of the bowel ischaemia. 
Treatment involves reduction in risk factors and optimiza-
tion of atrial fibrillation. Patients unable to maintain calo-
rie, fluid or electrolyte levels due to stoma losses should 
be referred to the regional intestinal failure service.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 55.6%, A 44.4%)
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Mortality rates for AMI remain high. Those patients who survive 
these conditions should be managed taking into account the cause 
of the AMI, their baseline comorbidity and their frailty levels after 
their ESs. Vascular risk factors should be optimized in those patients 
with embolic disease, arterial thrombus or NOMI [396]. This should 
include assessment and management of atrial fibrillation if present. 
The choice of anticoagulation postoperatively should be balanced 
against the risk of bleeding. Reports of the use of the novel antico-
agulants are widespread and appear to be safe [396– 398]. Patients 
should be anticoagulated if the precipitant cause of the ischaemic 
bowel is pro- coagulation and clot formation. Discussion with the 
local haematology team is recommended if this is identified. Patients 
without obvious precipitating causes, particularly in venous throm-
bosis, should be investigated for vasculitis and thrombophilia [399], 
with advice and guidance provided by the haematology team.
Patients who have had extensive bowel lengths resected, have 
short gut and are suitable for consideration of further procedures 
should be referred to the regional intestinal failure unit. Nutritional 
failure caused by any significant length bowel resection should be 
considered, screened for in the at- risk patient and managed proac-
tively. Multi- visceral transplantation after widespread bowel isch-
aemia has been reported and may be considered in select cases [400].
COLONIC VOLVULUS AND PSEUDO - 
OBSTRUC TION
Introduction
The term ‘volvulus’ is used to describe an abnormal twist of the 
stomach, small intestine or colon [401]. This can lead to impaired 
blood supply, ischaemia, infarction and/or perforation. Volvulus of 
any aspect of the GI tract is a general surgical emergency. The most 
common area of the GI tract to develop volvulus in adults is the 
colon, with the sigmoid and caecum being particularly at risk [401]. 
Volvulus leads to between 2% and 15% of all large bowel obstruc-
tions in the developed world but the incidence varies greatly across 
the globe [401– 403].
The evidence base for volvulus of the colon is poor and there 
are few evidence- based recommendations available to guide clini-
cal practice. A similar lack of synthesized evidence is available for 
pseudo- obstruction, a functional distention of the colon without 
an underlying structural blockage [404]. There is an estimated in-
cidence of 100 cases in 100 000 admissions to US hospitals [405]. 
Pseudo- obstruction can occur after other non- GI insults such as 
burns, cardiac and orthopaedic procedures, intercurrent illnesses 
or after caesarean section [406,407]. As such, pseudo- obstruction, 
also known as Ogilvie's syndrome, is a common reason for inter- 
specialty referrals to the general surgical team.
Previous literature has demonstrated variability in the clinical 
management of patients with these conditions [408] and there are 
few UK standards or recommendations. However, there is recently 
published guidance from the ASCRS [409].
Colonic volvulus
Question 5.1
The clinical presentation of sigmoid and caecal volvulus is that of 
large bowel obstruction. Abdominal distention, cramping abdominal 
pain, vomiting and nausea are commonplace [401,409,411,412,414– 
418]. Volvulus appears to be associated with a wide, long mesocolon 
compared with control patients, rendering a mesenteric twist easier 
to occur [419]. The specific mechanism by which the twist occurs, 
however, is unclear. Sigmoid volvulus is more common than caecal 
and transverse colonic volvulus is rare [401].
Sigmoid volvulus is more common in male patients whilst cae-
cal volvulus is more frequent in female patients [410,414,420,421]. 
Sigmoid volvulus is associated with increasing age and comorbidity 
unlike caecal volvulus. However, both are more common in the el-
derly population [409]. Neuro- psychological conditions increase the 
incidence of volvulus, as does constipation and medical comorbidity 
[402,413,416,422].
Question 5.2
Are there any diagnostic clinical features of colonic 
volvulus?
Recommendation: A combination of abdominal disten-
tion, complete/absolute constipation and known risk 
factors (elderly, frail, comorbidity, constipation and neu-
rological conditions) should alert the clinician to the pos-
sibility of a colonic volvulus.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 100%)
What is the imaging modality of choice for volvulus?
Recommendation: A contrast- enhanced abdominal/pel-
vic CT should be performed on index admission or where 
diagnostic uncertainty exists.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 66.7%, A 33.3%)
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The differential diagnoses for colonic volvulus are pseudo- 
obstruction, large bowel obstruction and severe constipation. 
An accurate diagnosis is vital to ongoing care. A plain abdomi-
nal radiograph can often determine the diagnosis of both sigmoid 
[423,424] and caecal volvulus [425,426] with high specificity. 
Assessing for a coffee bean sign (which occurs when the closed 
loop obstruction fills with gas and the medial walls of the adjoin-
ing bowel oppose) establishes the diagnosis. However, plain radi-
ography has a low diagnostic sensitivity and is unable to assess 
blood supply or the identification of coexistent relevant patholo-
gies [427,428] which is of utmost importance in determining ap-
propriate management. Therefore, contrast- enhanced CT scan is 
the gold standard allowing, in addition, the viability of the bowel 
to be assessed [429]. It would be reasonable to perform an ab-
dominal X- ray in a stable patient with a known recurrent sigmoid 
volvulus. However, if there is any diagnostic uncertainty then a 
CT should be performed. Although diagnosis with barium enema 
has been historically described, there is little evidence for its use 
in current practice.
Question 5.3
Torsion of the sigmoid colon can be readily accessed by a flex-
ible or rigid sigmoidoscope. As such, these approaches have both 
been described in management. Delay increases the risk of com-
plications with resultant increase in mortality. Urgent flexible or 
rigid sigmoidoscopy should therefore be undertaken to achieve 
two aims; to facilitate detorsion of the colon, which has a relatively 
high success rate [430– 433] and to assess the health and viability 
of the mucosa. Where possible a flexible rather than a rigid sig-
moidoscopy should be performed, as this approach increases the 
visualization of the colon. There is also some low quality evidence 
to indicate that flexible sigmoidoscopy has better detorsion suc-
cess rates [432]. A flatus tube can be used to facilitate flatus and 
faecal passage and reduce immediate recurrence. Adequate care 
of these tubes is required, however [434]. The tube should remain 
in situ for 1– 3 days [409,412,426,435]. Some reports describe the 
use of a flexible sigmoidoscope for reduction followed by discharge 
and elective resection [431] as a safe approach in these cases. An 
endoscopic approach should not be considered in patients with 
peritonism. If flexible sigmoidoscopy is unsuccessful, urgent opera-
tive approach should be performed to reduce the risk of further 
complications if clinically appropriate.
The use of colonoscopy in caecal volvulus has been described 
but has a low success rate [426,436,437]. There are too few data on 
the use of colonoscopy in transverse colon volvulus.
Question 5.4
Patients with sigmoid volvulus tend to be poly- morbid and 
frail. A conservative approach after detorsion of the colon rather 
than an operative approach is often desirable. However, on re-
view of case series level analysis, the recurrence rates in patients 
without further intervention are as high as 85% [431,438– 440]. 
Recurrence will again be associated with the risks of ischaemia, 
infarction or perforation. Further intervention should be consid-
ered [440].
Question 5.5
What is the role of endoscopy for colonic volvulus?
Recommendation: Flexible or rigid sigmoidoscopy can 
be used in sigmoid volvulus to facilitate detorsion of the 
colon. Flexible sigmoidoscopy can be used to assess vi-
ability of the colonic mucosa. Colonoscopy is not rec-
ommended in caecal or transverse colon volvulus, for 
which surgical resection is the recommended treatment 
option.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
What is the long- term management after detorsion of a 
sigmoid volvulus?
Recommendation: As a high proportion of sigmoid volvu-
lus recurs after detorsion a definitive management plan 
should be considered at the time of the index admission.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 66.7%, A 33.3%)
What are the optimal methods of definitive management 
in volvulus?
Recommendation: Operative management is individual-
ized to each patient, their comorbidities and their pathol-
ogy. Resection of the component of the colon subject to 
volvulus is the optimal approach in patients whose physiol-
ogy would sustain an operative intervention. Where frailty 
is identified there should be documentation of a best inter-
est meeting, where possible, when planning definitive care.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 66.7%, A 33.3%)
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The management of volvulus depends on multiple factors. Caecal 
volvulus generally requires an operative approach whereby resection 
has better outcomes than caecopexy procedures [402,409,425]. Sigmoid 
volvulus can be managed by sigmoid resection, with or without anasto-
mosis. Operative sigmoidopexy and caecopexy cannot be recommended 
as an option of choice in adult practice as recurrence rates are too high. 
Mesopexy has no evidence to support its use. The use of a percutaneous 
endoscopic colostomy tube has been described extensively in the litera-
ture [413,438,441,442]. It requires preferably the placement of two tubes 
to secure the sigmoid and avoid rotation of the sigmoid around a single 
tube. The procedure is not without risk but in a frail high risk patient may 
be considered less risky than conservative or surgical intervention.
There is an increasing awareness of the impact of frailty upon out-
comes. The decision to perform one procedure over another depends on 
the fitness of the individual patient. Adverse outcomes from intervention 
(and non- intervention) are common and a multidisciplinary approach and 
documentation of a best interest meeting are recommended to support the 
work of the clinical team. However, the sixth NELA report revealed that 
only 28.8% of frail patients over 65 had input from a specialist for care of 
the elderly [443]. The ELF study reported that over 37% of patients over 
65 years of age needed an increased level of care on discharge following ES.
Link: ELF study
The diagnosis of colonic volvulus requires a low index of suspicion 
as no aspect of risk factor assessment or history and examination will be 
discriminatory. Any patient with evidence of peritonism or sepsis should 
be managed in an emergency manner as the complications of volvulus 
such as infarction or perforation may have occurred. Sigmoid resection 
confers the lowest risk of recurrence [401,409,410,444– 446]. The deci-
sion to perform a colostomy or an anastomosis depends on the individual 
patient and the findings during the operation [418,441]. Anastomosis in 




Acute colonic pseudo- obstruction is a functional distention of 
the colon without any structural obstruction. The presenting fea-
tures, like colonic volvulus, are those of large bowel obstruction with 
severe or complete constipation, abdominal distention, discomfort 
and nausea being common [404,409].
Often patients have been admitted with a pathology outside the 
GI tract such as patients who have had orthopaedic [407], gynaeco-
logical [450] cardiac [406,451] procedures, or have been admitted 
with medical (non- surgical) diagnoses [406,441,452– 454]. Patients 
with pseudo- obstruction are frequently significantly poly- morbid and 
frail [404,405,409] and have electrolyte disturbance or acute renal 
failure. The condition is also described after caesarean section [455].
There is a high in- hospital mortality rate associated with this condi-
tion (up to 8%) [405]. Thus, these patients need to be closely monitored 
and managed urgently. This may include serial abdominal X- rays which 
allow assessment of caecal diameter, a crucial aspect to guide further 
management. A caecal diameter of 9– 12 cm is concerning for impending 
perforation [456]. Given the high association with renal dysfunction and 
electrolyte disturbance, monitoring of serum biochemistry can provide 
indications that the diagnosis might be that of pseudo- obstruction but 
risk profile analysis alone is insufficient to diagnose this condition.
In order to establish the diagnosis of pseudo- obstruction and 
exclude any mechanical cause a CT with intravenous contrast may 
be required. In this setting oral and rectal contrast are not used rou-
tinely in the UK and offer little benefit. If rectal contrast is used then 
a water- soluble contrast agent such as Gastrografin should be used, 
because of the risk of perforation.
Question 5.8Are there any diagnostic clinical features for 
pseudo- obstruction?
Recommendation: The diagnosis is one of exclusion. It 
is imperative to exclude mechanical bowel obstruction. 
The diagnosis should be suspected in an elderly or frail 
comorbid patient who presents with a distended tym-
panic abdomen with reduced or absent bowel action/fla-
tus and a capacious rectum on digital rectal examination. 
Frequently the patient will have a recent acute diagnosis 
not within the gastrointestinal tract. They may have un-
dergone other recent surgery.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 100%)
How is the diagnosis of pseudo- obstruction made?
Recommendation: CT with intravenous contrast is 
diagnostic.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 55.6%, A 44.4%)
What are the initial treatment options in 
pseudo- obstruction?
Recommendation: Identification and correction of any 
renal dysfunction or electrolyte abnormality and review 
of prescribed medications is appropriate. Provided the 
patient remains stable with no peritonism or tenderness 
over the caecum and the caecal diameter is <12 cm, con-
servative management can be continued for 48– 72 h.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 55.6%, A 44.4%)
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Pseudo- obstruction is associated with electrolyte disturbance and 
acute renal failure. Careful correction of these disturbances can be 
associated with resolution of the pseudo- obstruction in the absence 
of any further management. Calcium, magnesium, potassium and so-
dium levels should be monitored and corrected as required [404,409]. 
Acetylcholine enhances motor transit and peristalsis in the human 
colon [457]. Therefore, any disturbance or reduction in acetylcholine 
production increases the risk of pseudo- obstruction. Accordingly, a 
careful review of prescribed medications is required to exclude, where 
possible, any opiate or anticholinergic medications [404,409,458]. 
Nasogastric tube decompression may be considered along with in-
creasing patient mobility or simple frequent positional changes in bed 
including lying on the abdomen, if possible.
Caecal diameter is crucial. As long as the patient remains stable 
with no peritonism and the caecal diameter is <12 cm conserva-
tive management can be continued for 48– 72 h. This conservative 
management will lead to resolution of the pseudo- obstruction in 
as many as 70% of patients [459]. In patients with a caecal diam-
eter >12 cm or signs of peritonism then intervention as outlined in 
Question 5.10 may be necessary.
Question 5.9
Colonoscopic decompression, whereby the gaseous disten-
tion is removed from the colon by a colonoscope, and place-
ment of a flatus tube has been demonstrated to successfully 
alleviate the symptoms associated with pseudo- obstruction 
[404,409,451,454,460]. The procedure should be done with mini-
mal insufflation and preferably with caecal intubation. An alterna-
tive is the anticholinesterase drug neostigmine which has been 
demonstrated to be effective for this condition [451,455,461– 
467]. The seminal paper demonstrating the benefit of this medi-
cation was from Ponec et al. [467] where 2 mg of neostigmine, 
given intravenously in saline over 3– 5 min, was shown to suc-
cessfully manage pseudo- obstruction compared with saline injec-
tion. The current data demonstrate that it is a safe medication in 
this field [466,468]. Caution should be used in asthmatic patients 
and those predisposed to dysrhythmias. Patients should be made 
aware of the side effect profile, including bradycardia, of this 
medication before its use. If no initial response is seen in the first 
3 h repeated doses can be given every 3 h for up to three doses 
[469– 471]. Once there is resolution, oral polyethylene glycol so-
lution should be given to prevent recurrence [472]
The choice of colonoscopy or neostigmine as initial manage-
ment has been debated [451,465]. In one retrospective review 
[451] colonoscopic decompression performed by clinicians with 
the appropriate skill set as a first- line treatment was more effec-
tive as initial therapy in avoiding a second treatment modality. 
However, advocates of neostigmine point out that colonoscopic 
decompression requires access to emergency endoscopy and spe-
cific expertise, is more costly and takes more time than neostig-
mine administration.
Question 5.10
Surgery should be considered in all patients who fail conserva-
tive, medical pharmacological and endoscopic measures or who 
elicit evidence of peritonism or features in keeping with ischae-
mic bowel, but only if the patient is felt to be fit enough for op-
erative intervention and a higher level of postoperative support 
is agreed and available. The specific operation is dependent on 
the operative findings and should follow the principles of an EGS 
laparotomy.
It should be emphasized that this cohort of patients often tends 
to be frail and mortality associated with operations is likely to be 
high [405,460,473]. This information should be used to counsel the 
patient and their family.
What are the treatment options if conservative manage-
ment fails to resolve pseudo- obstruction?
Recommendation: Pharmacological intervention with ne-
ostigmine in a cardiac- monitored setting or endoscopic 
decompression in conjunction with a flatus tube should 
be considered if conservative management fails.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 88.8%, A 22.2%)
When should a surgical approach be considered?
Recommendation: Only if all conservative, pharmacologi-
cal and endoscopic measures fail to achieve resolution, 
or there is clinical evidence of deterioration in a fit indi-
vidual, should surgical intervention be considered. The 
decision to perform an operative intervention should take 
into account the underlying physiology and comorbidities 
of the patient. Where frailty is identified there should be 
documentation of a best interest meeting when planning 
definitive care, with the poor outcomes of surgery fully 
discussed and documented.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 88.9%, A 11.1%)
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Percutaneous caecostomy is described in small case series [474– 
478] and has a reported high success rate. It should be considered 
in those patients deemed to be very high risk for open surgical in-
tervention. However, it is associated with a high morbidity and mor-
tality rate [469].
LOWER GA STRO - INTESTINAL BLEEDING
The emergency management of lower GI bleeding has been consid-
ered extensively by the BSG and is comprehensively covered in the 
BSG Guidelines.
Link: BSG Guidelines in GUT
Link: Oakland score calculator
STOMA S
Introduction
It has been estimated that in 2011 there were 176 824 people liv-
ing with a permanent stoma in the UK [479]. Around half of these 
were colostomies, 40% ileostomies and the remainder urostomies 
[480].
The incidence of complications related to stomas is difficult to 
define due to variable reporting and use of definitions. A systematic 
review into the incidence of stoma complications found that only 14 of 
21 studies defined complications at all and the definitions were incon-
sistent across these studies [481]. One of the most commonly used 
classification systems for parastomal hernias is the European Hernia 
Society classification, which has the benefit of being applicable to all 
stomas and can be used for intra- operative findings as well as radio-
logical [482]. There are no standardized definitions for any other sto-
mal or peristomal skin complication.
A recent systematic review of the incidence of stoma- related mor-
bidity found the incidence of all stoma- related complications was sig-
nificant at 26.5% (2%– 100%) although this should be interpreted with 
caution as there was wide variability across studies [483]. Ileostomies 
have a higher rate of total complications than colostomies, mainly due 
to skin irritation and high stoma output [484]. A retrospective case– 
control study of 202 patients in the UK found that performance sta-
tus and BMI were risk factors for patients developing a stoma- related 
complication, as was having the stoma formed during an emergency 
operation [485]. Studies of patients with IBD have shown that stoma 
complications are twice as common in patients with Crohn's disease 
compared with ulcerative colitis; this includes a rate of peristomal fis-
tulation of up to 20% [486,487].
Common causes of stoma- specific complications presenting as 




A stoma can be considered to be retracted if it is below the level 
of the skin. The estimated incidence is 1.3%– 4.8% [483]. Retraction in 
the immediate postoperative period is usually due to tension on the 
bowel or its mesentery secondary to inadequate mobilization. Factors 
that predispose the patient to poor wound healing and obesity can 
also contribute and ischaemia at the distal part of the stoma can lead 
to a later presentation of retraction and stenosis [488]. Retraction is 
commonly seen without significant separation of the mucocutaneous 
junction.
In this case the main difficulty faced is in obtaining an adequate 
seal with stoma appliances. Use of a convex stoma appliance may 
result in decreased leakage and so decreased skin irritation [489].
Question 7.2
Complete stoma dehiscence and retraction can occur in the early 
postoperative period leading to superficial, subfascial or intraperi-
toneal contamination causing peritonitis [488]. CT may be useful to 
identify sepsis within the abdominal wall in the event of incomplete 
dehiscence and guide decision- making around drainage and revi-
sional surgery. An acute complete dehiscence and retraction may be 
diagnosed by inspection in the context of an unwell patient and will 
not necessarily require further investigation.
Do all retracted stomas need intervention?
Recommendation: Acute retraction of a stoma in the 
early postoperative period requires close observation by 
an experienced surgeon and stoma therapist to detect 
signs of stomal dehiscence.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
When is operative intervention required for stoma 
dehiscence?
Recommendation: Dehiscence resulting in acute retrac-
tion of the stoma within the abdominal fascia needs as-
sessment by an experienced surgeon and stoma therapist. 
Retraction into the abdominal cavity requires immediate 
operative intervention to prevent peritonitis.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 88.9%, A 11.1%)
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In some situations, it may be possible to drain superficial sepsis 
in a local fashion but revision will probably be required, either locally 
or by laparotomy.
Question 7.3
Complete retraction into the abdomen requires washout and refash-
ioning of the stoma including mobilization of additional length as required. 
Retraction into the abdominal wall may be managed by local revision if 
there is sufficient viable bowel without tension but as excessive tension is 
a risk factor for retraction laparotomy is frequently required [488]. If there 
is significant local contamination then stoma re- siting may be advised.
There have been a number of small case series describing mini-
mally invasive techniques using a linear stapler to revise a retracted 
ileostomy [489,490]. These techniques will only be successful if the 
retraction is due to sliding serosal surfaces on an everted stoma and 
not underlying tension on the bowel proximal to the stoma. They 
are therefore not recommended for acute emergency management.
Prolapse
Question 7.4
Stoma prolapse occurs when the full thickness of the bowel pro-
trudes through the stoma lumen [489]. Prolapse frequently coexists 
with parastomal herniation [491]. It occurs when there is redun-
dancy in the intestine related to the proximal, distal or single lumen 
of a stoma. It is a considerably more common complication for trans-
verse colostomies than for other types of stomas with rates of up to 
42% in these cases [482,483,492]. The aetiology in these cases is 
thought to relate to redundant highly mobile distal transverse colon 
with prolapse of the distal limb with increases in intra- abdominal 
pressure (IAP) [493]. The rate is around 4%– 5% for other types of 
stomas [482,492].
There are a number of techniques described for non- operative 
management of an acute prolapse in viable bowel. First- line man-
agement is gentle manual reduction which should ideally be under-
taken promptly prior to the formation of significant oedema [494]. 
There are several reports of successful use of sugar as osmotic 
therapy to aid in treatment of oedema to allow manual reduction 
[495– 498] as well as hyaluronidase [499]. Some simple devices 
have been described in case series to prevent recurrence of stoma 
prolapse [500].
Question 7.5
CT should be considered to aid operative planning if concurrent 
repair of a parastomal hernia is planned or if there is doubt of the 
cause of the patient's symptoms.
Question 7.6
What is the optimal operative approach for stoma 
dehiscence?
Recommendation: Re- look laparotomy or laparoscopy is 
required for an early acute dehiscence associated with re-
traction of a stoma into the abdomen. Mobilization and/
or resection of sufficient proximal bowel to enable a vi-
able stoma to be fashioned is probably necessary. In cases 
of delayed dehiscence, assessment by an experienced 
surgeon and stoma therapist is needed.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 100%)
What is the management of an acutely symptomatic pro-
lapsed stoma?
Recommendation: Attempts should be made to promptly 
reduce an acute stoma prolapse to prevent worsen-
ing oedema and ischaemia. Osmotic therapies such as 
sugar are safe to use and may be helpful in aiding manual 
reduction.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
Is there a role for imaging a patient with an acutely symp-
tomatic prolapsed stoma?
Recommendation: Patients presenting with a new 
acute irreducible stoma prolapse should undergo cross- 
sectional imaging to confirm there is no concurrent diag-
nosis such as obstruction due to adhesions or parastomal 
hernia to allow better operative planning.
Level of evidence: GP
Grade of recommendation: D
Consensus: 100% (SA 66.7%, A 33.3%)
What are the indications for operative intervention of an 
irreducible stoma prolapse?
Recommendation: Ischaemia and obstruction are indica-
tions for urgent operative repair of an irreducible stoma 
prolapse.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 88.9%, A 11.1%)
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An irreducible stoma prolapse complicated by ischaemia or ob-
struction requires urgent operative repair [489]. Symptoms such as 
pain and difficulty fitting appliances are also relative indications for 
urgent operative intervention.
End stomas can be disconnected at the mucocutaneous junction 
and the everted bowel re- inverted and resected to an appropriate 
length [489]. Loop stomas can be converted to end stomas and simi-
larly the redundant bowel can be excised. Patients with a temporary 
stoma that is no longer required in whom it is otherwise appropriate 
can have intestinal continuity restored.
There are several described options to manage loop stoma 
prolapse via a minimally invasive technique including narrowing 
of the distal limb with a suture [501,502]. In patients not fit for 
resection and refashioning it may be possible to excise the excess 
bowel and mesentery without reduction using a linear stapler. 
Variations of this technique are described under general anaes-
thetic [503,504] and sedation [505– 508]. A Delorme's prolapse 
technique involving muscularis plication has also been described 
as successful [509,510].
In severely comorbid patients not fit for more definitive re-
pair there are several described options for simple local repair 




Stoma ischaemia is an early complication caused by vascular 
compromise to the portion of bowel brought out as a stoma. It is 
commonest in end colostomies at around 5%– 6% [483,484]. Mild 
ischaemia can be due to tissue trauma or vasospasm but infarction 
and necrosis can occur due to inadequate arterial supply due to liga-
tion or damage of the end arterial supply with poor collateral circula-
tion. Less commonly venous outflow obstruction can cause venous 
congestion with later necrosis [488].
Blood tests including inflammatory markers can help judge 
when there is likely to be significant ischaemia extending beyond 
the superficial stoma, as can a CT scan, which is good at assessing 
proximal ischaemia [361– 363,511].
Mild ischaemia can lead to mucosal sloughing and a purple, grey-
ish or dusky discolouration of the mucosal surface. This can prog-
ress to mucocutaneous separation, retraction and/or full thickness 
necrosis. Stomas of doubtful viability can be examined internally by 
use of a blood tube, proctoscope or similar to visualize the mucosa 
below the surface of the skin, which can demonstrate whether the 
ischaemia is superficial (and may recover) or extends more proximally 
[488].
Ischaemia may lead to areas of mucocutaneous separation which 
usually heal by secondary intention with appropriate stoma care [512]. 
Stomal stenosis and stricture may occur as delayed complications [488].
Question 7.8
Question 7.9
Patients with stomas that are infarcted below the level of the 
fascia require revision to determine the extent of the necrosis and 
prevent complete stoma separation and early retraction [488].
It may rarely be possible to revise the stoma locally if sufficient vi-
able bowel can be brought out without tension but most cases require 
a laparotomy, assessment of the extent of the ischaemia, further mo-
bilization and refashioning. If there is doubt about the point of viability 
of the remaining bowel in a critically unwell patient then a re- look lap-
arotomy following a period of stabilization may be appropriate.
Is imaging useful in the assessment of an ischaemic/in-
farcted stoma?
Recommendation: Clinical and endoscopic assessment 
are more useful than imaging such as CT in the assess-
ment of postoperative stoma ischaemia. Appearances 
on CT cannot be relied upon to exclude more proximal 
ischaemia.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 55.6%, A 44.4%)
What are the indications for operative interventions for 
an ischaemic/infarcted stoma?
Recommendation: Where the stoma is judged to be non- 
viable below the level of the fascia emergency operation 
should be considered.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 100%)
Which operative intervention?
Recommendation: Revisional surgery by laparoscopy or 
laparotomy with the intention of further mobilization and 
probable resection is likely to be required. Local revision 
can be considered but is often not possible or appropriate.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 100%)
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Peristomal skin complications
Question 7.10
Peristomal skin complications are commonly a combination of 
chemical dermatitis from the stoma contents and damage to the per-
istomal skin from frequent appliance changes. They are commoner in 
ileostomies than colostomies due to the caustic nature of the small 
bowel effluent [488]. They are experienced by up to 47% of patients 
in the first 2 months after surgery [513] although reported rates vary 
considerably in the literature [483,484,488,489].
Irritant contact dermatitis from the stoma effluent usually takes 
the form of a mild rash of peristomal skin but can lead to ulceration. 
Allergic contact dermatitis towards the adhesive used in the stoma 
appliance can also occur [513]. Many patients with peristomal skin 
complications may not recognize or self- report these problems 
[479]. A minority of around 20% may have exacerbation of pre- 
existing skin diseases such as psoriasis and eczema [514].
A rare differential for peristomal ulceration is peristomal pyo-
derma gangrenosum, which is a neutrophilic dermatosis of unclear 
aetiology that is rare but most commonly occurs in patients with IBD. 
It is usually characterized by pain and undermined violaceous irregu-
lar borders. Investigations of the remaining bowel for signs of active 
IBD may be useful in patients with suspected peristomal pyoderma 
gangrenosum as the majority have active systemic disease at presen-
tation [515].
The majority of these conditions are managed by expert stoma 
care nurses with the aim to remove or reduce the skin irritant and 
halt the progression of the condition. Topical corticosteroids can 
sometimes help [512,513]. Peristomal pyoderma gangrenosum can 
be treated with topical steroids but often respond well to systemic 
immunosuppressive therapies [516]. Difficult cases including those 
where a systemic dermatosis or peristomal pyoderma gangrenosum 
is suspected should be referred for specialist management by 
dermatology.
Question 7.11
Rarely some patients may come to revisional surgery for peri-
stomal skin complications. In nearly all cases this is planned as an 
elective or expedited procedure. In these cases, it is likely that the 
stoma may need to be re- sited and, if any other complication such as 
retraction or parastomal hernia is thought to be contributing, then 
this requires addressing.
A number of case series of patients with peristomal pyoderma 
gangrenosum found that surgical closure of the stoma, if possible, 
cured the disease in all affected patients. In those in whom stoma 
closure was not feasible then resection of residual bowel with ac-
tive inflammation also cured the large majority of patients but the 
disease recurred in 67% of patients treated with stoma revision and 
relocation as the sole procedure [514].
Stoma stenosis/stricture
Question 7.12
Stoma stenosis is a narrowing of the opening of the stoma; stric-
turing is a narrowing that usually occurs at the level of the fascia. 
Early ischaemia is the most common contributing factor but it can 
also occur due to recurrence of Crohn's disease, malignancy or after 
mucocutaneous junction separation [513], as well as from technical 
error when determining the size of the fascial defect [489]. The inci-
dence is around 1.7%– 10% [483,484,493].
How should persistent unexplained peristomal skin ul-
ceration be managed?
Recommendation: Patients should undergo incision/core 
biopsy of a large area of ulceration or excision biopsy of a 
localized ulcer to exclude an underlying malignant process.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
Recommendation: A multidisciplinary approach should be 
taken to patients with troublesome peristomal skin condi-
tions including stoma therapists and dermatology specialists.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 88.9%, A 11.1%)
Is there any indication for emergency surgery for peri-
stomal skin problems?
Recommendation: There is no absolute indication for 
emergency surgery for peristomal skin conditions.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
What are the underlying causes of stoma stenosis?
Recommendation: Always consider causes other than is-
chaemia, such as inflammatory and malignant diseases, in 
a new acute stomal stenosis.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 100%)
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Stenosis does not usually occur in the immediate postoperative 
period but can occur after a few weeks if due to ischaemia. Many 
cases occur after a number of years and may be due to chronic peri-
stomal dermatitis, which can be exacerbated by concurrent retrac-
tion and difficulties obtaining a seal [493]. In rare cases of severe 
stenosis, obstruction and perforation are possible.
Biopsy, luminal and cross- sectional imaging may be helpful to 
exclude recurrent inflammatory or malignant disease [489].
Question 7.13
Initial treatment is usually conservative with stoma appliances. 
Dilatation performed under the care of a stoma care nurse can pro-
vide temporary improvement but may need to be performed repeat-
edly [513] and the tissue trauma involved can lead to further fibrosis 
and stricturing [489].
There has been a case report of the use of a SEMS used in the 
palliative management of a malignant stricture causing large bowel 
obstruction [517].
Depending upon the cause of the stenosis, it is usually possible 
to perform a local correction by excising the scar tissue surrounding 
the mucocutaneous junction and mobilizing sufficient bowel to form 
a new stoma at the surface. Recurrent stenosis is common and in 
these patients re- siting should be considered [492]. An alternative 
is the use of a dermoplasty or skin flap technique although this has 
not been commonly described in the literature [518]. If the stenosed 




A parastomal hernia is an incisional hernia related to an abdom-
inal wall stoma [519] and is recognized to be a common problem 
in patients who undergo stoma formation. The reported incidence 
varies widely in the literature depending upon whether the defini-
tion is dependent upon symptoms, physical examination or radio-
logical assessment, but may be up to 59% at long- term follow- up 
[483,520– 522]. It is likely that parastomal hernias are commoner 
in end colostomies than in other types of stomas [523,524].
The ongoing CIPHER study aims to answer these questions 
together with the impact of the surgical technique on subsequent 
parastomal hernia formation. Strategies to prevent and treat para-
stomal hernia were voted the second most important non- cancer- 
related research question on a Delphi exercise undertaken on behalf 
of the ACPGBI [525] and a recent position statement on this topic 
has been published [526].
Link: CIPHER study
Link: ACPGBI Position Statement
Parastomal hernias can be asymptomatic but more commonly 
cause symptoms such as bulging and effect on body image, pain, 
symptoms of intermittent partial bowel obstruction and reduction 
in overall physical functioning and quality of life [527,528]. Patients 
can present as an emergency with an obstructed or strangulated 
hernia with pain, vomiting and reduced stoma output with an irre-
ducible parastomal hernia [524,527].
There is no gold standard examination or test for parastomal 
hernia but in the non- emergency setting CT and MRI may diagnose 
some hernias missed on clinical examination [529] and prone CT has 
lower interobserver variability than examinations performed supine 
[530]. There is no evidence regarding the role of CT in patients who 
present acutely obstructed with an incarcerated parastomal hernia 
but it very probably has a role in high risk patients with complex 
What are the management options for a stenosed stoma?
Recommendation: Dilatation of stomal stenosis can be 
performed under the guidance of a stoma therapist but 
patients should be counselled that this is unlikely to be a 
successful long- term solution.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 66.7%, A 33.3%)
Recommendation: Patients with stomal stenosis who 
develop complete obstruction require urgent operative 
management.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
Recommendation: Local revision will be possible in most 
patients with a small number requiring more extensive 
surgery to mobilize sufficient bowel length to form a vi-
able stoma. In patients with recurrent stomal stenosis use 
of a dermoplasty technique should be considered.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
Is imaging useful in the assessment of an obstructed/
strangulated parastomal hernia?
Recommendation: CT scan is recommended as part of 
the assessment of a patient with a suspected obstructed 
or strangulated parastomal hernia.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 88.9%, A 11.1%)
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abdominal wall pathology to confirm the site of obstruction and 
aid operative planning. This should not delay the resuscitation and 
management of an acutely unwell patient. In patients with acute 
worsening of chronic pain and intermittent symptoms of obstruc-
tion, contrast- enhanced CT scan in combination with inflammatory 
markers may be used to help aid decision- making about urgent in-
tervention; if coexistent intestinal ischaemia is considered a multi-
phase CT maybe beneficial [360– 362]
Question 7.15
Patients who present with an irreducible parastomal hernia with 
associated obstruction that does not resolve or signs of strangula-
tion require immediate operative intervention [530]. Unlike other 
abdominal wall hernias, a large proportion of patients who have an 
operation for a parastomal hernia have this performed as an emer-
gency. This group of patients have a considerable mortality and mor-
bidity [531].
Question 7.16
In the emergency situation where operative intervention is re-
quired for non- resolving bowel obstruction or bowel ischaemia 
there are three goals to be met:
1. save life,
2. minimize complications,
3. tissue preservation in order to allow attempt at future definitive 
repair.
Local suture repair has the advantage of being relatively simple 
to perform with less morbidity than that associated with an oper-
ation involving laparotomy [523]. However, a laparotomy may be 
necessary in order to allow or facilitate local repair. In a systematic 
review of retrospective series, the recurrence rate for planned non- 
emergency surgery was up to 70% [532]. Despite this it is recognized 
that this technique may be the only real option in the emergency 
situation where a 30- day mortality rate of 10% (>20% in elderly pa-
tients) is reported [531].
Stoma relocation is fraught with challenges. The great majority 
of this group of patients will have ES, often out of hours. A stoma 
nurse is unlikely to be available for re- siting. Stoma relocation is not 
to be recommended because of the high rate of parastomal hernia 
development at the new stoma site and incisional hernia develop-
ment at the old site [533,534].
A variety of methods are used to perform mesh repair of 
parastomal hernias in the elective setting including laparoscopic 
intraperitoneal, preperitoneal/subfascial and fascial onlay [523]. 
Some retrospective case series have included the use of syn-
thetic and biologic meshes to repair parastomal hernias as an 
emergency [535,536] but currently there is not sufficient ev-
idence to recommend this over suture repair in emergency 
patients.
As well as a high rate of early mortality, there is around a 50% 
total morbidity rate in patients undergoing emergency repair with 
higher rates of systemic inflammatory response syndrome, sepsis 
and prolonged ventilatory requirements compared with elective pa-
tients [531].
Having ES has been found to be the single strongest predictor 
of reoperation or death following parastomal hernia repair [537]. 
However, patients that do recover sufficiently well from an emer-
gency procedure would have the option of a more definitive repair 
as a planned elective procedure which is likely to entail much less 
perioperative morbidity.




Leaving the abdomen open after an emergency laparotomy in a 
critically ill surgical patient is a recognized life- saving manoeuvre. 
However, the OA or laparostomy is associated with significant mor-
bidity including fluid loss, infective complications, spontaneous 
intestinal fistulation (5%– 17%) and mortality (28%); its immediate 
management is resource intensive [538,539]. It should be looked 
upon as a temporary measure rather than a definitive event. Failure 
What are the indications for emergency surgery?
Recommendation: Patients with parastomal hernias 
causing strangulation or unresolving obstruction should 
have urgent surgery.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
What is the operation of choice in the emergency setting?
Recommendation: Emergency surgery for a parastomal 
hernia is aimed at saving life and not definitive hernia 
management. Minimal intervention, for example suture 
repair, that allows the pathology to be dealt with and the 
patient's life to be saved is recommended.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
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to close the abdomen results in a ‘planned’ ventral hernia that re-
quires subsequent reconstruction [540]. In the UK, peritonitis is by 
far the commonest indication for OA. This will form the focus of 
these guidelines.
A practical classification of the OA and its complications was 
developed by expert consensus in 2009 [541] and revised in 2013 
[542] Table 4 describes the revised classification of the OA. The 
classification is used throughout these guidelines to describe the 
management of the OA (Kirkpatrick et al. 2013 [542], open access 
publication; written permission for reproduction was obtained by 
ASM 18 July 2020).
The classification has practical value in describing the OA that 
may be suitable for delayed primary closure (DPC). It is also dynamic 
in that patients may move between the different grades as their 
wounds evolve. Studies which have used this classification system 
have also demonstrated a correlation between mortality and rising 
grade of OA [543,544].
The vast majority of the world literature concerning the OA and 
abdominal wall management is derived from trauma patients. As 
such, not all conclusions are applicable to the septic abdomen, as 
trauma patients more frequently achieve definitive abdominal clo-
sure within 48 h of creation of the OA compared with patients who 
have an OA for peritonitis [545].
Patients with peritonitis are more likely to require an OA for lon-
ger, require more returns to theatre and have increased risks of vis-
ceral injury and failure of DPC. As a consequence, they have worse 
postoperative morbidity, including higher intestinal fistulation and 
wound complication rates.
There are only a handful of published RCTs specifically focused 
on the management and outcomes of patients with an OA. The lack 
of Level I evidence in many cases therefore restricts the Grade of 
recommendations produced by these guidelines.
Question 8.1
The primary role of an abbreviated damage control laparotomy (DCL) 
is to arrest life- threatening haemorrhage and limit enteric contamination. 
It allows resuscitation and reversal of the lethal triad of hypothermia, 
acidosis and coagulopathy prior to definitive surgical management. It is 
well established in trauma guidelines [538,546– 548]. Others have con-
firmed the reduced mortality rates with DCL and OA [549]; consequently 
these principles have readily been transferred to general surgery and are 
widely used. In the last decade recognition of the significant morbidity 
associated with OA has led to suggestions that this approach should be 
used more selectively [550– 552]. The specific indications for OA fol-
lowing DCL in trauma can be reviewed in separate trauma guidelines 
[547,552– 554].
However, DCL does have a role in non- trauma patients. Achieving 
drainage of sepsis and definitive source control in peritonitis is crucial. This 
may require resection of all non- viable gut using bowel staplers to secure 
the intestinal contents, proximal gastric drainage via nasogastric tube, 
avoiding intestinal anastomosis and performing TAC at the index laparot-
omy. If control is not achieved, this inevitably leads to the development of 
organ failure which can result in death [389,555– 557]. Re- laparotomy and 
further peritoneal lavage may be required. Early reports on the use of a 
damage control approach for severe peritonitis followed by an OA and re- 
laparotomy until source control could be achieved suggested a reduction 
in mortality [558]. Subsequent studies have shown that the benefits of an 
OA in reducing mortality may be less than previously thought.
More recent comparative studies have suggested that OA is as-
sociated with higher healthcare costs, postoperative complications 
What are the indications for leaving an abdomen open?
Recommendation: Indicated as part of the definitive 
management of
Trauma following damage control laparotomy
Level of evidence: II
Grade of recommendation: B
Vascular events to allow reassessment of intestinal ischaemia
Level of evidence: II
Grade of recommendation: B
Selective cases of peritonitis/gross peritoneal 
contamination
Level of evidence: II
Grade of recommendation: C
Primary or secondary abdominal compartment syndrome 
(sustained elevation of intra- abdominal pressure above 
20 mmHg associated with new organ dysfunction)
Level of evidence: II
Grade of recommendation: B
As a consequence of massive abdominal wall tissue loss 
from trauma, necrotizing fasciitis
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% for all above recommendations (SA 100%)
TA B L E  4  Classification of the open abdomen
Grade Description
1 No fixation
1A Clean, no abdominal wall fixation or bowel adhesions 
to abdominal wall
1B Contamination, no abdominal wall fixation or bowel 
adhesions to abdominal wall
1C Enteric leak, no abdominal wall fixation or bowel 
adhesions to abdominal wall
2 Developing fixation
2A Clean, developing abdominal wall fixation or bowel 
adhesions to abdominal wall
2B Contamination, developing abdominal wall fixation or 
bowel adhesions to abdominal wall
2C Enteric leak, developing abdominal wall fixation or 
bowel adhesions to abdominal wall
3 Frozen abdomen
3A Clean, frozen abdomen
3B Contaminated, frozen abdomen
4 Frozen abdomen with established entero- atmospheric fistula
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and mortality and may often be used inappropriately where primary 
closure of the abdomen should have been practised [559,560].
Abdominal compartment syndrome (ACS), defined as a sustained el-
evation of IAP above 20 mmHg associated with new organ dysfunction 
[542], may be seen after trauma, peritonitis, ruptured abdominal aortic 
aneurysm, acute severe pancreatitis and mechanical bowel obstruction 
often in combination with aggressive fluid resuscitation. Patients in 
these high risk groups should have regular IAP measurements, which 
must be clearly documented in the patient's clinical record [543]. Clinical 
assessments of IAP are unreliable. However, once ACS is recognized, it 
should be treated by a decompressive laparotomy within 24 h [561,562].
The routine use of OA for patients with severe intraperitoneal con-
tamination undergoing emergency laparotomy for intra- abdominal 
sepsis is not recommended by the World Society of Abdominal 
Compartment Syndrome unless IAH is a specific concern [542].
There is very limited evidence to recommend a standard approach 
to the use of the OA in patients who require extensive emergency 
abdominal wall debridement due to trauma or necrotizing soft tissue 
infections (NSTIs). In the case of NSTIs, the GI tract can be an import-
ant source for causative organisms and intra- abdominal exploration 
may be required for treatment of the NSTI [563]. The use of the OA in 
these clinical settings should be guided by expert clinical judgement 
and no specific recommendations could be drawn from the literature 
on the best surgical approach to this challenging problem.
Question 8.2
TAC refers to any method of dressing an OA. It is a misnomer 
in that in most cases it is just a dressing, not a closure method. The 
ideal TAC dressing should
1. be simple and quick to deploy,
2. cost- effective,
3. prevent loss of domain,
4. manage/prevent fluid losses,
5. protect abdominal contents,
6. prevent fascial retraction to facilitate primary closure,
7. prevent visceral injury and adhesions to the anterior abdominal 
wall.
Many different TAC methods have been described; however, 
most fail to meet the criteria of an ideal device. These techniques 
can be either ‘static’ or ‘dynamic’ depending on whether they ac-
tively prevent the retraction of the oblique abdominal wall muscles 
after the linea alba is divided at laparotomy.
Static techniques by their nature lead to delayed primary fascial 
closure and fail to prevent loss of domain and the development of 
visceral adhesions to the abdominal wall. They should be avoided 
if at all possible and really only have a role in the stabilization of 
an emergency patient prior to transfer. They include the following.
1. Deep retention sutures— heavy gauge, non- absorbable sutures, 
passed through all layers of the abdominal wall and tied tightly 
at the midline— have been shown to generate increased postop-
erative pain, skin and muscle damage. They do not reduce the 
risk of incisional hernia following closure of a burst abdomen 
(BA) [564,565]. There is no evidence to support their continued 
use.
2. A skin only closure fails to deal with the volume of fluid exudate 
produced, has a high risk of dehiscence and evisceration and may 
not lead to adequate decompression of ACS.
3. A Bogotá bag involves suturing a sterile plastic sheet to the fascia 
to cover the viscera. This technique fails to deal with the volume 
of fluid exudate produced and allows the formation of visceral 
adhesions to the abdominal wall as well as loss of domain.
4. A wound management bag is a very large sized bag needed to 
completely incorporate the wound and often requires specialist 
wound care nursing to apply.
5. Wound packing with gauze requires frequent changing and fails 
to deal with the volume of fluid exudate. In addition, after only a 
few hours, the gauze can adhere to the viscera causing serosal 
injury and subsequent fistulation on removal.
Dynamic TAC methods are preferred wherever possible. They 
provide traction to the anterior abdominal wall and facilitate de-
layed primary fascial closure. However, their use as stand- alone 
techniques fails to prevent visceral adhesions to the anterior ab-
dominal wall, and shearing forces which are applied during pro-
gressive tensioning of the fascia may generate intestinal fistulation 
[566]. They include the following:
What is the preferred temporary abdominal closure for 
the open abdomen and when should it be changed?
Recommendation: Negative pressure wound dressings 
with a visceral protection sheet (non- adherent sheet that 
covers the viscera and prevents the formation of adhesions 
to the anterior abdominal wall) should be placed at the con-
clusion of the initial laparotomy for all open abdomens.
Level of evidence: II
Grade of recommendation: A
Consensus: 100% (SA 100%)
Recommendation: Commercially available negative pres-
sure wound therapy dressings designed for the peritoneal 
cavity should be used in all cases when available.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 100%)
Recommendation: Intraperitoneal negative pressure 
wound dressings should be changed when there is heavy 
contamination or a requirement to return to the operating 
theatre due to other clinical needs. (Commercial company 
recommendation is that negative pressure wound ther-
apy should be changed every 24– 72 h.)
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 100%)
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1. dynamic retention sutures which are placed through the fascial 
edges and sequentially tightened;
2. the ABRA™ abdominal re- approximation anchor system [567] 
which uses elastomer bands and buttons and skin traction to ap-
proximate the fascia;
3. the Wittmann™ patch [568] which is a Velcro™ patch sutured to 
the fascial edges that can be sequentially tightened;
4. mesh- mediated fascial traction between the fascia edges that 
again is sequentially tightened and ultimately removed.
It is important to recognize that negative pressure wound ther-
apy (NPWT) dressings used alone are static with regard to the fascia 
but provide some traction on the skin and subcutaneous tissues.
Commercially available intraperitoneal NPWT systems specifi-
cally designed for the OA are now widely available across the UK 
and Ireland. Even in environments where resources are limited, 
there are cost- effective methods of creating customized ‘in- house’ 
intraperitoneal NPWT dressings for the OA (the Barker method, for 
example [569] often referred to as a ‘sandwich pack’ [570].
The components of an NPWT dressing for the abdominal cavity 
include
1. a non- adherent visceral membrane that is fenestrated to allow 
peritoneal fluid to be removed (e.g., mobile fluoroscopy unit 
cover— C- arm cover),
2. drains connected to low pressure suction,
3. an impermeable adherent dressing to completely cover the entire 
OA wound and secure the dressing to the skin surface,
4. a porous material that creates a space between the visceral mem-
brane and impermeable outer dressing (this space collects fluid 
and the material prevents complete collapse of the space be-
tween the visceral membrane and outer dressing when negative 
pressure is applied),
5. a collection system for the exudate removed by the drains to 
monitor fluid losses.
Current NICE guidance together with several international 
guidelines support the safety and efficacy of NPWT dressings for 
management of the OA wound [547,554,571,572].
The use of a visceral protection sheet, placed deep into the lateral, 
pelvic and costal recesses, has been shown to reduce visceral adhesions 
to the anterior abdominal wall and to reduce the rate of spontaneous 
intestinal fistulation associated with OA from 26.5% to 2.9% [571].
It is imperative that the foam used in the interface between 
the visceral and impermeable outer layer is never able to come into 
contact with the bowel. If this is allowed to happen then the foam 
becomes densely adherent and may result in bowel damage when 
it is removed with subsequent enteric fistulation. Intestinal anasto-
moses or serosal repairs performed at previous operations must be 
protected by positioning them deep in the peritoneal cavity away 
from direct contact with the dressing surface. If present, the omen-
tum can also be positioned to serve as an interface between the 
dressing or wound surface and the viscera.
There have been seven systematic reviews examining methods 
of TAC in the OA over the last 10 years [539,542,570,573– 577] and 
three RCTs [559,578,579]. The overall strength of the reported out-
comes is low due to the small number and poor quality of compara-
tive observational studies.
With a variety of commercial dressings available it is recom-
mended that all surgeons become familiar with their locally available 
technique [571].
Newer proprietary systems have been developed that also allow 
for the instillation of fluids with or without antibiotics into the peri-
toneal cavity [580– 582]. This may reduce the requirement to return 
to theatre to perform peritoneal lavage for heavily contaminated 
abdomens but currently there is insufficient evidence to recom-
mend their routine use.
Early concerns that NPWT in the OA increased the rates of in-
testinal fistulation have not been demonstrated in any of the sys-
tematic reviews comparing NPWT to other methods of TAC. The 
rates of fistula formation in the systematic review of TAC methods 
after OA for non- trauma indications (74 studies) varied from 5.7% 
after NPWT with fascial traction, 14.6% for NPWT only and 17.2% 
after mesh inlay [539]. The most recent systematic review compar-
ing NPWT to non- NWPT techniques for all indications did not find 
any statistically significant difference in EAF rate (2.1% vs. 5.8%, 
P = 0.57) [576].
There is no evidence regarding the timing of dressing changes. 
The frequency of dressing changes is frequently not reported in 
NPWT studies but in most observational studies 2– 3 days is used. It 
would seem prudent to avoid unnecessarily revisiting the operating 
theatre to change a dressing in the absence of heavy contamination 
or clinical need.
All dressing changes should involve an experienced multi-
disciplinary team and there should be clearly documented plans 
with regard to the timing of planned returns to the operating 
theatre.
Question 8.3
What are the short- term goals in managing a patient with 
an open abdomen?
Recommendation: Patients do not need to remain ven-
tilated for the specific purposes of open abdomen 
management.
Level of evidence: III
Grade of recommendation: D
Consensus: 100% (SA 88.9%, A 11.1%)
Recommendation: Patients with an open abdomen can 
be fed enterally if the GI tract is in continuity and there 
are no other contraindications to enteral feeding; other-
wise patients should receive parenteral nutrition.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
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Management of the OA requires a multidisciplinary approach, 
led jointly by the surgical and intensive care teams with input from 
a nutritional team, physiotherapists, complex wound and stoma 
nurses and guided by microbiology.
Patients remain intubated following the creation of an OA 
after index laparotomy, primarily to facilitate repeated returns to 
the operating theatre for second look procedures or to perform 
delayed fascial closure and dressing changes. A concern that pa-
tients may fail extubation, because of disruption of the abdomi-
nal wall musculature, is often used as a further reason to prolong 
intubation. However, prolonged mechanical ventilation beyond 
48 h increases the risk of ventilator- associated pneumonia in sur-
gical patients by approximately 10%– 20% and at least doubles 
the mortality risk [583]. Retrospective studies of OA patients 
have demonstrated that extubation prior to definitive closure 
of the abdomen is feasible and is associated with a significantly 
lower incidence of ventilator- associated pneumonia [583,584]. 
Early extubation, a joint decision between surgical and intensive 
care teams, should therefore be considered in patients with an 
OA.
Critically unwell patients following a significant inflamma-
tory insult or sepsis are hypercatabolic and are at high risk of 
developing malnutrition. There are well- established guidelines 
for the management of nutrition in the critical care environment 
[585,586] and there are benefits for the early establishment of 
enteral feeding [587]. There is an established practice of with-
holding enteral feedings in OA patients that is not supported by 
the literature; however, the feasibility and safety of enteral feed-
ing in OA patients is from retrospective studies mainly involving 
trauma patients [588– 593]. There is some evidence that early en-
teral feeding may even improve rates of delayed primary fascial 
closure with subsequent reduction in intestinal fistulation follow-
ing the OA for trauma [588,590].
Enteral feeding can commence in a patient with an OA if 
the GI tract is in continuity and there are no other contraindi-
cations to feeding. This can safely occur via oral, nasogastric or 
nasojejunal routes. If there is a clinical concern about the de-
velopment of an intestinal fistula or an anastomotic leak from 
a prior bowel repair, enteral feeding should be ceased until this 
can be excluded. If patients cannot tolerate enteral feeding or 
if GI continuity cannot be confirmed, early parenteral feeding 
should be considered. Parenteral nutrition does not have to be 
exclusive; if the enteral route is safe then small amounts of tro-
phic enteral feed (15– 30 ml/h) can be started and increased 
as enteral function returns. The routine placement of enteros-
tomy feeding tubes (gastrostomy and jejunostomy) in the OA 
is discouraged because, at least in trauma patients, this is a 
risk factor for intestinal fistulation especially if NPWT is used 
[578,594].
Question 8.4
There are no studies that have shown the optimum time for 
return to theatre following the index laparotomy for non- trauma 
patients. Intervals of 24 to 72 h between the index and first re- 
laparotomy are reported [595]. Earlier returns to the operating room 
following the initial laparotomy should be considered for patients 
who require definitive surgical arrest of bleeding or source control 
following correction of coagulopathy, development of significant en-
teric contamination of the OA wound or a failure of clinical improve-
ment following the initial laparotomy.
A single retrospective study has reported that patients with 
secondary peritonitis who had returned to theatre after 48 h had 
a significantly higher mortality rate than patients who had returned 
within 48 h (77% vs. 28%, P < 0.0001) [596]. The trauma literature 
reports that the timing of the first take back after DCL is important. 
After the first 24 h, for every additional hour delay there was a 1.1% 
decrease in the odds of primary fascial closure and after 48 h there 
was an increase in intra- abdominal complications [597]. The limited 
evidence available suggests that patients should return to theatre 
within 48 h of the index laparotomy.
Definitive primary closure of the abdominal fascia should be 
performed at the time of the first re- look laparotomy, if appro-
priate. If there is still an ongoing requirement for the abdomen 
to be left open, then the patient should be returned to theatre 
based upon their clinical progress— the so- called ‘on- demand’ 
re- look. The long- standing debate of on- demand vs. planned 
re- laparotomy for patients with peritonitis has largely been re-
solved by the Dutch Peritonitis Study Group RCT. Patients hav-
ing an index laparotomy for severe secondary peritonitis were 
When should a patient with an open abdomen return to 
theatre?
Recommendation: Return to theatre after the index 
laparotomy should be tailored to the individual patient's 
clinical condition with prioritization of resuscitation but 
should not be longer than 48 h from the index laparotomy.
Level of evidence: III
Grade of recommendation: D
Consensus: 100% (SA 88.9%, A 11.1%)
Recommendation: Further returns to theatre after the 
first re- look laparotomy should be ‘on demand’ and 
guided by the patient's condition rather than planned to 
occur after a certain period of time.
Level of evidence: I
Grade of recommendation: A
Consensus: 100% (SA 88.9%, A 11.1%)
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allocated to either planned re- laparotomy every 36– 48 h (116 
patients) or re- laparotomy on- demand (116 patients). It demon-
strated improved outcomes in favour of the on- demand group 
[598]. Patients in the planned re- laparotomy group had signifi-
cantly more laparotomies (P < 0.001), a higher number of negative 
laparotomies (66% vs. 31%, P < 0.001), longer stays in intensive 
care (median 11 vs. 7 days, P = 0.001), prolonged requirements 
for intubation (median 8 vs. 5 days, P = 0.007) and a longer stay 
in hospital (median 32 vs. 29 days, P = 0.008) [598]. Planned re- 
laparotomy did not reduce the need for percutaneous interven-
tions (37% vs. 24% in on- demand, P = 0.02) [598]. There were no 
differences in all- cause mortality at 12 months, however (36% 
in planned vs. 29% in on- demand, P = 0.22), or major morbidity 
in survivors (44% planned vs. 40% on- demand, P = 0.58) [598]. 
Not unexpectedly, on- demand re- laparotomy is also associated 
with significantly lower healthcare utilization costs [599]. An 
earlier meta- analysis of observational studies (1266 patients 
with secondary peritonitis) reported similar outcomes and a non- 
significant trend towards lower mortality rates in patients who 
had on- demand re- laparotomy [595].
Clinical assessment can be difficult in the ventilated, uncon-
scious patient and a low threshold for CT scanning is essential to 
determine the presence of collections or the development of a new, 
unexpected complication. Patients failing to progress without ob-
vious alternative explanations or those who develop a new intra- 
abdominal complication that requires operative management may 
require re- laparotomy.
Question 8.5
Once the decision to create an OA has been made, it is the im-
mediate responsibility of the surgical team to plan how and when to 
close it.
DPC refers to primary closure of the abdominal fascia in the OA 
at a subsequent procedure performed after the index laparotomy. 
DPC should always be considered in order to avoid the ‘planned 
ventral hernia’. The ventral hernia defects following non- closure of 
the OA often require complex abdominal wall reconstruction tech-
niques to restore abdominal wall integrity and function.
Once the linea alba is divided at laparotomy, the unopposed 
action of the oblique abdominal wall muscles immediately cre-
ates lateral retraction of the fascial edges. Over time there is also 
gradual shortening of the lateral abdominal wall muscles, muscle 
atrophy and fibrosis that results in further retraction of edges of 
the laparotomy wound. These changes are evident histologically 
as early as 35 days after the linea alba is divided in animal studies 
[600].
The OA is also inherently fistulogenic and fascial closure is cru-
cial in limiting fistula formation. There is a strong relationship be-
tween reduced fistulation and successful DPC. The inability to close 
the abdomen and intestinal fistula are the two parameters that carry 
the highest mortality rates following the OA in both trauma and 
non- trauma patients. It is therefore essential to plan and achieve 
closure as early as is practically possible. The incidence of intesti-
nal fistulation in the OA varies depending on methods of TAC and 
DPC from 0% to 17.2% [575,601]. In a UK- wide survey of OA for 
predominately non- trauma indications, the overall rate of intestinal 
fistulation was around 12% [538].
There are no RCTs addressing the most appropriate timing of 
DPC. A systematic review and meta- analysis of 32 mostly retro-
spective studies (3125 patients) for all OA indications identified 
that early fascial closure (2.2– 14.6 days) was associated with a 
significantly lower mortality rate (12.3% vs. 24.8%, relative risk 
0.53, P < 0.0001) than delayed fascial closure (32.5– 300 days) 
[602] Overall complications were lower in the early fascial closure 
group (relative risk 0.68, P < 0.0001) and overall hospital length 
of stay and intensive care stays were significantly shorter but the 
heterogeneity of the included studies for these outcomes was 
very high [602].
When fascial closure is not possible at the first reoperation 
because either the fascial edges cannot be approximated or there 
is an ongoing requirement for the abdomen to be left open, mea-
sures need to be put in place to prevent further lateral retraction 
of the fascial edges. Expert consensus suggests that this should 
not happen at the index laparotomy as resuscitation and resto-
ration of physiological derangements take priority. TAC with 
intra- abdominal NPWT alone should be performed at the index 
laparotomy and on further reoperations if the patient remains un-
stable or there is a risk of IAH or ACS. Following fascial closure, 
When should delayed primary closure of the open abdo-
men be attempted?
Recommendation: The goal of open abdomen man-
agement is to achieve delayed primary closure of the 
abdomen as soon as the patient is clinically stable and 
definitive management of the primary problem has been 
achieved. Ideally this should occur as soon as possible 
after the index laparotomy.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 77.8%, A 22.2%)
Recommendation: Once fascial closure has been 
performed it is good clinical practice to monitor 
intra- abdominal pressure for the development of intra- 
abdominal hypertension.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 77.8%, A 22.2%)
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routine measurement of IAP is recommended to monitor for the 
development of ACS.
Question 8.6
The final stage in the management of the OA is fascial closure to 
prevent intestinal fistulation and planned ventral hernia. Following 
the decision to form an OA, most patients will fall into one of three 
categories:
1. definitive management of the primary problem has been 
achieved and abdominal fascia can be closed;
2. definitive management of the primary problem has been achieved 
and abdominal fascia cannot be closed;
3. there is an ongoing problem and requirement for the abdomen to 
be left open.
If definitive management of the primary problem has been 
achieved and the abdominal fascia can be re- approximated with-
out tension, primary suture closure of the abdominal fascia should 
be performed. There is no high quality evidence to support any 
particular suture technique for laparotomy closure in the emer-
gency setting but there are a small number of low quality studies 
which consistently report that the technique of continuous small 
bites with a slowly absorbable monofilament suture and a 4:1 
suture to wound length ratio is safe and is not associated with 
an increased risk of fascial dehiscence [603– 605]. Current best 
practice for elective laparotomy closure suggests that the ideal 
midline laparotomy closure is a continuous suture technique using 
a slowly absorbable monofilament suture with a suture to wound 
length ratio of at least 4:1 [606].
If the abdominal fascia cannot be closed at the first return to 
theatre due to tension or lateral retraction, or if there is an ongoing 
requirement to keep the abdomen open, a dynamic method of re- 
approximating the edges of the abdominal wall to oppose the lateral 
retraction of the abdominal wall should be employed to assist with 
closure at a later time. Excessive tension at the time of laparotomy 
closure is a risk factor for the development of incisional hernia and 
in the immediate postoperative period it can lead to the develop-
ment of IAH and ACS.
Intra- abdominal NPWT alone if placed correctly can facilitate 
skin closure but on its own does not promote re- approximation of 
the fascial edges. It is crucial, however, in preventing the formation 
of adhesions to the anterior abdominal wall which, if allowed to 
form, contribute to fixation of the abdominal wall (OA Grades 2−3) 
preventing DPC. Intra- abdominal NPWT alone does not increase 
rates of DPC as it generates no significant traction on the fascial 
edges of the wound. Rates of DPC with NPWT alone in non- trauma 
patients are around 51% [539].
A number of different techniques and devices have been devel-
oped to achieve DPC of the OA. These include
1. dynamic retention sutures which are sequentially tightened,
2. an ABRA™ abdominal re- approximation anchor system [567],
3. a Wittmann™ patch [568]
4. mesh- mediated fascial traction (MMFT).
Historically, many of these techniques were used without a 
non- adherent visceral membrane to prevent the formation of 
acute adhesions to the anterior abdominal wall. This practice is 
considered likely to contribute to the development of intestinal 
fistulation due to shearing forces created when the abdominal 
wall is progressively tensioned. These techniques have evolved 
with time and are mostly now used in combination with either 
NPWT or a protective visceral membrane that is eventually re-
moved when the fascial edges can be re- approximated without 
undue tension. Fascial closure using a dynamic fascial closure 
technique improves DPC rates. In a systematic review of out-
comes from non- trauma patients, the highest primary fascial 
closure rates were seen in NPWT in combination with fascial 
traction (73.1%, 95% CI 63.3– 81.0) and dynamic retention su-
tures (including ABRA™) (73.6%, 95% CI 51.1– 88.1) [540]. The 
fistulation rate is lower in NPWT with fascial traction than with 
What is the preferred technique for delayed primary clo-
sure of the open abdomen?
Recommendation: When definitive management of the 
primary problem has been achieved and the abdominal 
fascia can be closed without tension, the abdominal fas-
cia should be sutured closed according to best practice 
guidelines.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 88.9%, A 11.1%)
Recommendation: When definitive management of the 
primary problem has been achieved and the abdominal 
fascia cannot be closed at the first return to theatre but 
there is likelihood of delayed primary closure, mesh- 
mediated fascial traction in conjunction with negative 
pressure wound therapy should be employed to achieve 
delayed primary closure.
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
Recommendation: When there is an ongoing requirement 
for access to the peritoneal cavity and further returns to 
theatre are anticipated, mesh- mediated fascial traction 
in conjunction with negative pressure wound therapy 
should be employed to avoid fascial retraction and the 
abdomen should be closed once the patient is clinically 
stable.
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
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dynamic retention sutures (5.7%, 95% CI 2.2– 14.1 vs. 11.6%, 95% 
CI 4.5– 26.9) [539]. Dynamic retention suture systems can also 
lead to ischaemia of the abdominal wall muscles or skin and are 
not well tolerated by patients. Wittmann™ patches have high 
DPC rates [607] however, the patch is not widely available and 
management of fluid exudate from the OA is difficult as the patch 
is an impermeable synthetic sheet. Inlay or bridging with meshes 
should be avoided as this technique is associated with the high-
est fistulation rates (17.2%, 95% CI 9.3– 29.5) [539] and mesh ad-
hesions to bowel can make subsequent planned ventral hernia 
repair risky.
NPWT- MMFT progressively re- approximates the linea alba to 
allow primary fascial closure while limiting damage to the abdom-
inal fascia [608]. At each successive dressing change the mesh is 
windowed centrally and tightened using a strong non- absorbable 
running suture, such as No. 1 prolene. NPWT with a visceral pro-
tection sheet prevents the formation of adhesions to the abdom-
inal wall and the abdomen can be reassessed as required prior to 
fascial closure. It is a simple, easily reproducible technique and 
any permanent synthetic mesh can be used. When primary fas-
cial closure is achieved all the remaining mesh is removed and the 
fascia is closed directly. Observational studies of NPWT- MMFT 
across all OA indications are consistently associated with high 
rates of DPC (80%– 100%) and low intestinal fistula formation 
(0%– 10%) [609]. A recent comparative study of NPWT- MMFT and 
NPWT alone suggested that NPWT- MMFT was associated with 
significantly higher rates of DPC (95% vs. 5%, P < 0.001), better 
survival and shorter hospital and intensive care admissions [610]. 
Longer- term outcomes such as incisional hernia formation are un-
commonly reported but range from 20% to 50% (follow- up range 
20– 63 months) [609].
Question 8.7
There are a number of reasons why DPC might not be achiev-
able including extensive loss of abdominal wall fascia and muscle 
(e.g., in the case of necrotizing fasciitis), pre- existing ventral her-
nia, and a failure to prevent abdominal wall retraction and visceral 
adhesions to the anterior abdominal wall during early management 
of the OA. The traditional method of managing the OA involved 
wound dressings until a layer of granulation tissue formed over the 
surface of the bowel prior to placement of a split thickness skin 
graft (STSG) [541]. This technique typically requires prolonged in-
patient wound management and is very resource intensive [611].
The inherent problems of applying an STSG directly to the 
viscera are the issues related to shearing forces that occur due to 
How should the open abdomen be managed if delayed 
primary closure is not achieved?
Recommendation: If delayed primary closure of the ab-
dominal fascia cannot be achieved in a Grade 3 open ab-
domen (frozen abdomen, clean/contaminated), skin and 
subcutaneous fat should be approximated over the vis-
cera, if possible. Split thickness skin grafting can be used 
on a granulating wound (± use of an absorbable mesh) to 
create a planned ventral hernia.
Level of evidence: III
Grade of recommendation: GP
Consensus: 100% (SA 66.7%, A 33.3%)
Recommendation: If delayed primary closure of the ab-
dominal fascia cannot be achieved in a Grade 3 open ab-
domen (frozen abdomen, clean/contaminated) negative 
pressure wound therapy can still be used provided there 
is a non- adherent interface between the negative pres-
sure wound therapy dressing and the viscera and direct 
contact with intestinal anastomoses is avoided.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 66.7%, A 33.3%)
Recommendation: Expert wound care is recommended 
to manage wound healing and prevent intestinal fistula-
tion, if delayed primary closure cannot be achieved.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 77.8%, A 22.2%)
Recommendation: Acute component separation and 
myofascial releases should be avoided as they restrict po-
tential surgical options for future incisional hernia repair.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 88.9%, A 11.1%)
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constant movement of the abdominal wall, and if applied too early 
it arrests the natural cicatrization of the wound preventing the de-
fect from shrinking significantly. This leads to STSG failure in the 
short term as the abdominal wall cannot be splinted to reduce its 
movement and in the long term these shearing forces can result in 
a chronic non- healing skin wound due to disruption of the fragile 
blood supply from the bowel surface.
The end result is a ‘planned ventral hernia’, and after recov-
ery from the acute insult patients will typically require further 
reconstructive surgery to restore abdominal wall integrity and 
function. Despite this being a historically established technique 
for the management of the OA, there are very few published 
outcomes and the majority of studies in the literature are ret-
rospective case series or cohort studies with small patient 
populations.
Application of the STSG is usually performed after a layer 
of healthy granulation tissue has formed to cover the bowel. 
Polyglactin 910 (Vicryl™) mesh has been used to serve as a frame-
work for the formation of granulation tissue [540,612]. This syn-
thetic rapidly absorbable mesh can safely be placed directly onto 
the surface of the bowel and does not require removal prior to 
STSG as it is completely reabsorbed by hydrolysis. Three studies 
using polyglactin 910 with the largest sample sizes have inconsis-
tent findings with respect to intestinal fistulation: 0% vs. 4% vs. 
6% [612,613].
The expert consensus panel involved in the review of these 
guidelines recommends that polyglactin 910 mesh in a single, dou-
ble or quadruple layer can be safely sutured to the edges of the 
fascia prior to skin and subcutaneous fat closure without risk of in-
testinal fistulation [614,615]. Polyglactin mesh may also serve as a 
framework for granulation tissue formation to prepare the wound 
for STSG.
NPWT can continue to be safely used when there has been 
failure of DPC providing that there is a non- adherent interface be-
tween the dressings and the visceral surface. This manages the ex-
udate produced by the peritoneum and wound surface and allows 
wound healing to progress. Any areas of superficial skin dehiscence 
should be managed with caution as the absence of abdominal fas-
cia increases the risk of inadvertent intestinal injury and absorbable 
meshes do not offer durable protection of the viscera.
Management of complex abdominal wall defects in the elective 
setting of planned ventral hernia management has seen the adop-
tion of component separation techniques to achieve fascial closure 
[616,617]. A number of small case series were identified in the lit-
erature reporting on the outcomes of these techniques [618,619] 
and other myofascial releases [620,621] in the acute setting for the 
purpose of achieving DPC in OA for peritonitis. These techniques 
should be discouraged in the acute setting due to the increased risk 
of incisional hernia formation following OA and the impact it has on 
future reconstruction.
Question 8.8
Early accounts of the use of permanent synthetic meshes for 
TAC without visceral protection barriers and subsequent removal of 
these materials for DPC were associated with fistula rates as high as 
75% [610] and this practice has been largely abandoned. Permanent 
synthetic mesh or biological collagen grafts as a bridge or inlay be-
tween the fascial edges continue to be used in some settings [537]. 
This technique is not recommended as a method for either TAC or 
DPC due to the high rate of associated intestinal fistula formation. 
It is also well established that mesh placed as a bridge or inlay con-
figuration for incisional hernia repair is associated with a high rate of 
incisional hernia recurrence [622,623].
The expert consensus panel also expressed particular concern 
about the specific use of heavily crosslinked biological meshes 
placed in any plane where they are in direct contact with the vis-
cera. These products in particular are associated with the formation 
of dense adhesions between the mesh and viscera and associated 
intestinal fistulation when used to achieve abdominal wall closure 
[624,625]
There is insufficient evidence to recommend mesh reinforce-
ment as an onlay following delayed fascial closure. The majority 
of patients from four observational studies identified where onlay 
mesh was employed were predominately trauma patients and there-
fore not applicable to the current clinical question. There appears 
to be sufficient evidence to recommend the use of mesh reinforce-
ment of midline elective laparotomy closure with RCTs and com-
parative studies all showing a reduced incidence of incisional hernia 
formation in the long term [626,627]. A recently reported RCT of 
an onlay permanent synthetic mesh in emergency laparotomies 
showed that it reduced fascial dehiscence at 30 days but was as-
sociated with a high rate of SSI (20.6% vs. 7.7%; P = 0.05), seroma 
What is the role for prosthetic mesh in achieving delayed 
primary closure of the open abdomen?
Recommendation: The use of mesh placed in either a 
bridging or inlay configuration to achieve delayed primary 
closure should be avoided due to risks of mesh infection, 
intestinal fistulation and incisional hernia formation.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 66.7%, A 33.3%)
Recommendation: The placement of heavily crosslinked 
biological collagen grafts directly in contact with the vis-
cera should be avoided.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 66.7%, A 33.3%)
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(19.0% vs. 5.8%; P = 0.03) and non- healing incisional wound (23.8% 
vs. 5.8%; P = 0.008) compared with the non- mesh group [628].
Question 8.9
Intestinal fistulation is one of the perils associated with the OA 
and its development can result in recurrent peritonitis, sepsis, intes-
tinal failure and death. The aetiology for the development of intesti-
nal fistula is multifactorial and can occur due to
1. anastomotic leak,
2. unrecognized enterotomy,
3. desiccation from inadequate visceral protection,
4. damage during dressing changes for TAC or DPC and
5. shearing forces due to the development of acute adhesions to the 
abdominal wall.
Intestinal fistulas opening into the OA are termed EAFs and com-
monly arise at the margins of the OA wound. It has been postulated 
that this is due to shearing forces between the abdominal wall and 
intestinal adhesions that have been allowed to develop [566]. EAFs 
can also develop following the breakdown of previous anastomoses 
or unrecognized intestinal injury from preceding laparotomy.
The initial management of an EAF includes control of sepsis, con-
trol and collection of effluent from the wound, skin protection and 
safe parenteral nutritional support. The mnemonic SSNAP (Sepsis/
Skin/Nutrition/Anatomy/Plan) encapsulates this approach [629]. This 
will often involve the input of a wound specialist nurse or stoma ther-
apist. Initially if the fistula cannot be isolated or if there are multiple 
fistulas, a wound management bag is placed over the wound to collect 
the effluent, protect the skin and also protect the bowel from further 
desiccation. The details of further intestinal fistula management are 
covered completely in the ASGBI ‘Issues in Professional Practice: 
The surgical management of patients with acute intestinal failure’, 
September 2010.
Link: ASGBI Issues in Professional Practice: The surgical man-
agement of patients with acute intestinal failure
If EAF formation has occurred early during the staged closure of 
an OA, it may be possible to convert the fistula into a stoma which can 
greatly assist with wound management. Usually, however, there are 
multiple interloop adhesions that prevent this from being safely accom-
plished. At this stage it is prudent to abandon DPC and if MMFT has 
been instituted it is recommended that all residual mesh be removed.
Ongoing management and healing of the OA wound should 
be performed as for a Grade 3 OA, and the goal of management 
changes to that of a planned ventral hernia. NPWT is not contra-
indicated in the presence of an EAF and it can continue to be used 
to promote granulation of the abdominal wound providing that all 
measures are put in place to protect the exposed viscera from dress-
ing foam. If possible, isolating the fistula from the negative pressure 
component of the wound dressing can also accelerate the formation 
of granulation tissue and wound healing. There have been a number 
of retrospective case series which have demonstrated that NPWT is 
safe and may contribute to healing of some enterocutaneous fistulas 
[630– 632]. Once granulation has been achieved and wound contrac-
ture is obvious, STSG may be used to achieve skin coverage of the 
wound.
Patients with an EAF may be suitable for enteral feeding if there 
are no concerns about feeding abscess cavities, unidentified per-
forations and if fistula outputs can be controlled. Distal feeding 
into the fistula (fistuloclysis) may be appropriate in some patients 
[633]. Fistuloclysis should be delayed until the EAF has matured 
and distal obstruction is excluded. Patients who develop an EAF 
should be referred to a specialized intestinal failure unit for further 
management.
Question 8.10
What are the management principles of enteric leak or 
entero- atmospheric fistula in the setting of the open 
abdomen?
Recommendation: If an entero- atmospheric or enterocu-
taneous fistula develops as a complication of managing an 
open abdomen, immediate management should be guided 
by the Sepsis/Skin/Nutrition/Anatomy/Plan principles as 
for the management of any enterocutaneous fistula.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 100%)
Recommendation: Delayed primary closure of the ab-
dominal fascia cannot be achieved in a Grade 4 open 
abdomen with entero- atmospheric fistula formation. 
Management consists of expert wound care which may 
include wound management pouches, negative pressure 
wound therapy and split thickness skin graft with result-
ant planned ventral hernia formation.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 100%)
What is the management of a patient with a burst 
abdomen?
Recommendation: If fascial dehiscence is early and there 
is an absence of intra- abdominal infection and abdominal 
wall adhesions, primary re- suturing of the fascia is recom-
mended if this can be achieved without tension.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 66.7%, A 33.3%)
Recommendation: If fascial dehiscence is late, there is 
intra- abdominal infection and/or adhesions to the ab-
dominal wall or the fascia cannot be re- approximated, the 
wound should be managed as for a Grade 3 open abdomen.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 66.7%, A 33.3%)
516  |    MILLER Et aL.
The BA or abdominal fascial dehiscence is an early postoperative 
complication where there is unintended disruption or failure of the 
abdominal wall fascial closure. Despite advances in suture materials 
and studies of abdominal wall closure methods, the incidence of BA 
following colorectal surgical operations has remained relatively un-
changed and is around 1.3% [634]. Risk factors for BA include older 
age, ES, peritonitis, SSI, malignancy, hypoalbuminaemia, ascites, cor-
ticosteroid use, smoking, severe chronic obstructive pulmonary dis-
ease and obesity [564,634,635]. Fascial disruption is typically seen 
around 8– 10 days postoperatively and heralded by the sudden dis-
charge of pink serous fluid from the wound [564,634].
The consequences of a BA are akin to those of a deliberately 
created OA. It carries a significant mortality of up to 45% and a 
risk of intestinal fistulation of around 20% [636,637]. Other early 
postoperative complications including deep venous thrombosis, 
intra- abdominal infection, sepsis and septic shock are all increased 
in patients with a BA [634]. In the long term, the frequency of inci-
sional hernia formation is up to 80% [638,639].
A number of retrospective studies (mostly case series of small 
numbers of patients) have reported the outcomes of several dif-
ferent closure techniques. Deep retention sutures appear to be 
associated with increased incisional hernia formation at 12 months 
and should be consigned to the surgical museum [564]. The pooled 
proportion of cases from four observational studies developing 
an incisional hernia with continuous suture techniques was 33.6% 
(95% CI 19.3%– 49.7%) vs. 33.6% using interrupted sutures (95% CI 
25.1%– 42.6%) [575]. An early abdominal wall dehiscence probably 
represents a technical failure and the fascia may be partially dam-
aged by the previous suture.
The expert consensus panel was in agreement that the tech-
nique for re- suturing the fascia should aim to distribute tension 
as much as possible; therefore, using a greater than 4:1 wound to 
suture length ratio and small bites is the most appropriate way to 
achieve this, which is also in accordance with other guidelines [572]
Permanent synthetic mesh for repair of dehiscence should be 
avoided as wounds are often contaminated and there is a high in-
cidence of postoperative complications including mesh infection 
(77%) without any significant reduction in the prevention of inci-
sional hernia [636]. If the fascia cannot be approximated due to ten-
sion or damage to the fascial edges, then intraperitoneal placement 
of a polyglactin 910 mesh and closure of the skin and subcutaneous 
fat over it is entirely reasonable but will lead to a planned ventral 
hernia.
The use of TAC in the BA is not well evaluated; however, if re- 
suturing of the fascia cannot be achieved due to adhesions, tension 
or intra- abdominal infection being present, the viscera need to be 
protected and treated as for an OA to prevent the development of 
EAF. NPWT can be safely extended to the BA. NPWT as a static 
technique has been described in the BA in a small number of retro-
spective series [640,641]. NPWT- MMFT as a dynamic technique to 
achieve fascial closure has also been described but the small patient 
numbers, retrospective studies with disease and patient heteroge-
neity do not allow any recommendation to be made [642,643].
Due to the critical condition of potential study participants and 
the heterogeneity of their clinical presentation, high quality ran-
domized clinical trials in this field are uncommon. We anticipate fur-
ther useful data from current trials recruiting patients [644].
ANOREC TAL PROBLEMS
Introduction
Anorectal abscesses are common, with 18 000 patients affected 
annually in England [645]. English HES data show that a primary 
abscess has an incidence of 20/100 000 and are more common in 
men than women [646]. The location of the anorectal abscess may 
indicate a likely pathogenesis, with superficial ‘perianal’ abscesses 
arising from a superficial source and ischio- anal fossa and inter-
sphincteric abscesses more commonly leading to fistula formation 
and probably arising according to the cryptoglandular hypothesis 
[647,648]. In patients presenting with an anorectal abscess, 2.8% 
will ultimately be diagnosed with Crohn's disease [646].
An anal fistula occurs, following primary anorectal abscess, in 
17% of patients, usually within the first year (67%), and is more likely 
in patients with underlying IBD [646].
An anorectal abscess is a painful condition but the abscess is not 
always apparent to the patient or initial treating clinicians, and some 
patients are treated empirically with antibiotics or for other anorec-
tal conditions (such as fissure or haemorrhoids) before the abscess is 
diagnosed. Intersphincteric abscesses seem to present earlier, with 
pain as the predominant symptom, whereas abscesses in the ischio- 
anal fossa may present later and with inflammatory or septic fea-
tures as well as pain, perhaps due to the larger space within which 
the abscess may expand without meeting restrictive structures.
Acute anal fissures are longitudinal tears in the anal mucosa and 
present with symptoms of duration less than 6 weeks and without 
features of chronicity (visible internal sphincter fibres in the base of 
the wound, a hypertrophied anal papilla at the apex of the fissure 
(cephalad) and a sentinel tag at the caudad extent of the fissure). 
They cause pain, particularly during and after defaecation, and may 
also present with bright red rectal bleeding. The majority of anal 
fissures occur in the posterior midline with the anterior midline the 
second most common location, particularly in women. Multiple or 
lateral fissures should prompt a search for an underlying condition 
such as IBD or infective causes. Such atypical features will usually 
present in the chronic setting.
Haemorrhoids are common and often asymptomatic, but 30 000 
interventions are nevertheless undertaken annually in the UK [649]. 
Prolapsing haemorrhoids are those which are likely to present 
acutely with pain, usually caused by strangulation or thrombosis. 
Management is usually conservative.
Rectal prolapse or procidentia is an intussusception of the rec-
tum externally through the anal sphincter complex. It should be dis-
tinguished from an internal rectal intussusception and solitary rectal 
ulcer syndrome. Whether internal rectal intussusception and rectal 
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prolapse form a spectrum of conditions or are two separate condi-
tions is still widely debated [650,651].
Although it is a benign condition, rectal prolapse can be debil-
itating, mainly due to the discomfort associated with the physical 
presence of the prolapse, passage of mucous and blood, together 
with the symptoms of faecal leakage and incontinence and on occa-
sions constipation [652].
Rectal prolapse is most commonly seen at the extremes of 
age. In children it usually presents under the age of 4 years and 
is seen equally in boys and girls. The peak incidence in adults is in 
the seventh decade of life with in excess of 90% of cases occur-
ring in women. Although it is seen less commonly in men, its age of 




NSTI, also known eponymously as Fournier's gangrene, carries a 
mortality of 7.5%– 16% in population studies and can result in signifi-
cant tissue loss, scarring and loss of function [653,654]. Early sur-
gical intervention improves outcome. Systemic illness should raise 
the suspicion of NSTIs. Evidence of tissue crepitus, ‘dishwater’ dis-
charge, visible ischaemia or a characteristic odour may be present 
in NSTI but may also be absent or hidden beneath cellulitic but not 
ischaemic skin initially. A high index of suspicion should be main-
tained, particularly in patients with risk factors such as immunosup-
pression or impaired microcirculation, diabetes, obesity and high 
alcohol intake [655].
Question 9.2
The treatment of NSTI is the immediate and complete debride-
ment of all necrotic tissue. Early surgery has been shown to improve 
outcomes [656,657]. Management of the patient's systemic sepsis, 
including the use of a sepsis bundle and involvement of the critical 
care team, should occur immediately and continue during and after 
surgery but no delay to surgical intervention should occur. Frequent 
assessment, under general anaesthesia initially in most cases, will en-
sure early detection of the need for further debridement, which may 
be required two to three times during the hospital stay [655,657]. 
Defunctioning of the urinary system, with urethral or suprapubic 
catheter, or bowel with a bowel management system or surgical os-
tomy may be needed. High quality wound care, sometimes including 
negative pressure dressings and plastic surgical reconstruction, will 
be required in the aftermath of NSTI.
Question 9.3
Which patients with perianal abscess/infection are at a 
higher risk of necrotizing soft tissue infections and should 
undergo expedited surgery?
Recommendation: Patients with diabetes, steroid use, 
immunocompromised, chronic renal failure, obesity, liver 
disease, peripheral vascular disease and intravenous drug 
abuse who have evidence of systemic sepsis should un-
dergo surgery as soon as possible after institution of a 
Sepsis Six bundle including broad- spectrum antibiotic 
administration.
Level of evidence: III
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
Recommendation: Patients with perianal abscess/infec-
tion who are at risk of necrotizing soft tissue infections 
but without systemic sepsis should undergo surgery at 
the earliest opportunity once appropriately starved and 
prepared for theatre; this should include overnight.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 77.8%, A 22.2%)
What is the immediate management of necrotizing soft 
tissue infections?
Recommendation: Immediate management of necrotizing 
soft tissue infections should include the use of a sepsis 
bundle, early broad- spectrum antibiotics, involvement 
of the critical care team and immediate wide surgical 
debridement.
Level of evidence: III
Grade of recommendation: D
Consensus: 100% (SA 88.9%, A 11.1%)
When should imaging precede examination under anaes-
thetic in the acute presentation of anorectal abscess?
Recommendation: MRI imaging could be performed in 
the setting of ‘occult’ or recurrent anorectal abscess to 
identify anatomy and determine appropriate drainage.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 66.7%, A 33.3%)
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In general, anorectal abscesses can be clearly identified on clini-
cal examination or during examination under anaesthetic (EUA). An 
MRI should not precede definitive incision and drainage in such a 
situation. However, occult abscesses, those undetectable on EUA, 
may be identified using MRI or endoanal US (the latter usually per-
formed under anaesthetic to avoid pain). One retrospective case se-
ries highlighted the value of MRI in detecting and classifying occult 
anorectal abscesses in 13 patients [658]. The MRI enabled appro-
priate drainage either via the ischio- anal fossa or internally based 
on the location of the abscess relative to the levator ani muscle. 
Needle aspiration may aid localization of an abscess which is dif-
ficult to locate.
If symptoms continue after incision and drainage, further EUA 
may be of value. A more senior surgeon undertaking EUA may iden-
tify an unappreciated and undrained cavity. If the patient is well and 
urgent imaging can be obtained, this may aid identification of occult 
abscesses, but should not delay further EUA with evidence of sys-
temic illness, spreading cellulitis or severe pain.
If no abnormality explaining the patient's symptoms is identified 
at EUA, MRI will exclude occult abscesses or aid localization.
Question 9.4
There is very little evidence to recommend one drainage tech-
nique over another. Expert opinion supports all of the above tech-
niques. Proctitis diagnosed at the time of EUA may point towards 
a diagnosis of Crohn's disease. Crohn's disease is present in 3% of 
patients undergoing drainage of a primary abscess in the UK [646].
Question 9.5
Question 9.6
Traditionally, abscess cavities have been ‘packed’ (had internal 
dressings applied) after drainage of the abscess, to ensure that the 
aperture remains open until the cavity has healed by secondary 
intention.
A Cochrane review [659] identified two studies reporting 64 pa-
tients randomized to packing or external dressings. Quality of life 
data were not assessed in these studies and no difference was seen 
in abscess recurrence, fistula occurrence or time to wound healing 
between the groups.
The PPAC observational study identified that packing is painful 
and expensive [645]. German [660] and US [661] guidelines do not 
support packing. Some centres in the UK eschew packing in favour 
of wound digitation which can be practised by the patient, aiming to 
prevent premature closure of the wound but avoiding the pain and 
expense of packing. On discharge, patients should be given written 
advice to return to their GP for referral to a colorectal surgeon if 
they have persistent problems. Approximately 17% of patients who 
What is the optimal technique for drainage of perianal abscess?
Recommendation: Operative techniques that should be 
employed are as follows.
1. Create an aperture wide enough to facilitate drainage 
without the need for packing.
2. Loculations should be broken down and the full extent 
of the abscess cavity should be drained.
3. Use a circumanal incision rather than radial incision to 
avoid damage to the external sphincter complex.
4. Incisions to drain ischio- anal fossa collections should 
be placed as close to the external anal sphincter as pos-
sible (whilst occurring over the fluctuant swelling and 
allowing adequate drainage in order to avoid an unnec-
essarily long potential fistula tract).
5. There should be internal drainage of intersphincteric 
abscesses which do not reach the perianal skin and also 
of supralevator abscesses.
6. The use of drains (Malecot catheters, Yates/corrugated 
drains) is sometimes advocated for deeper cavities with 
narrow necks which are at risk of early skin closure.
Microbiology sampling is of limited value in the manage-
ment of anorectal abscess and antibiotic use is not required 
in patients undergoing incision and drainage for uncompli-
cated anorectal abscess. A rigid sigmoidoscopy could be 
considered. It may detect underlying rectal inflammation.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 77.8%, A 22.2%)
What is the optimal timing of surgery?
Recommendation: Evidence of necrotizing soft tissue 
infection— operate within 30 min. Evidence of systemic 
features or risk factors for necrotizing soft tissue infec-
tions (diabetes, systemic immunosuppression, systemic 
inflammatory response syndrome, cellulitis)— operate 
within 6 h of decision. If patient is systemically well with 
no features or risk factors for necrotizing soft tissue 
infections— operate within 24 h of decision.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 88.9%, A 11.1%)
Should packing be used after drainage of perianal abscess?
Recommendation: There is insufficient evidence to rec-
ommend regular packing of perianal abscesses. Initial 
haemostatic packing can be used if there is bleeding. Dry 
dressing only can then be used.
Level of evidence: IV
Grade of recommendation: D/GP
Consensus: 100% (SA 77.8%, A 22.2%)
    | 519MILLER Et aL.
undergo primary abscess drainage will re- present with a persistent 
discharge/recurrent abscess suggestive of an underlying fistula.
Question 9.7
Traditionally, the frequency of fistula following abscess drainage was 
thought to be around 1 in 3. Recent data derived from the HES database 
suggests that this rate is 17% overall, 16% in patients without a diagnosis of 
IBD and 47% in those with Crohn's disease [646]. Two systematic reviews, 
one from the Cochrane library [662], have suggested that any fistula identi-
fied at the time of abscess drainage should be treated immediately, either 
by fistulotomy or by seton insertion, in order to prevent recurrent abscess 
and reduce the number of operations required to resolve the perianal sep-
sis, and that this practice is safe given only a modest risk of continence im-
pairment seen across the five to six randomized trials of abscess drainage 
vs. immediate fistula treatment included in the two reviews.
However, in these trials internal openings (IO) were identified in 83%– 
100% of patients (two of the trials only enrolled and randomized patients 
in whom an IO was seen), whereas fewer than a third of patients treated 
with simple drainage went on to develop a fistula during study follow- up, 
including 14% and 25% of patients in the two trials with ubiquitous IOs. 
More than half of patients with an ‘acute fistula’ therefore required no 
fistula treatment, immediately or subsequently. These patients would be 
put unnecessarily at risk of the continence impairment associated with 
fistulotomy or of a persistent fistula if a seton was inserted.
The perceived benefit of reduction in number of operations and 
abscess/fistula recurrence applies to around a quarter of patients or 
fewer, since between 14% and 31% of patients in the drainage- only 
arm developed a fistula, and around 5% of patients in the immediate 
treatment arm developed a recurrent fistula even after fistulotomy.
The authors of these reviews considered that this benefit outweighed 
the risk of fistula treatment since the difference in continence between 
the two groups was non- significant in half of the studies and overall. 
However, the fistulotomy literature is clear and consistent in identifying 
a risk of continence impairment, usually to wind and minor soiling, associ-
ated with sphincter division. The risk is reported at various rates but has 
been consistently reported at a level of around one in three patients in 
some studies [663]. Some of the trials of immediate fistula treatment vs. 
abscess drainage alone did identify a significant difference in continence 
disturbance between the two arms. Given this, and in the context of the 
fistulotomy literature, the risk of continence impairment is likely to be 
higher than estimated in the two reviews, so the balance of risk and bene-
fit upon which their recommendations are based is insecure.
Instead, in the context of primary abscess drainage, IO should 
not be sought and neither fistulotomy nor seton insertion (which 
also condemns the patient to the risks of future fistula treatment, or 
of lifelong fistula persistence) should be performed.
Postoperative antibiotics do not seem to prevent fistulas [664].
Question 9.8
In the context of recurrent abscess in the same location, it has 
been demonstrated that the underlying fistula will not resolve spon-
taneously and should be treated. In active inflammation, appropriate 
assessment of fistula anatomy is more difficult and full assessment 
of the risk of continence impairment which would follow fistulotomy 
is more difficult, so seton insertion rather than immediate fistulot-
omy may be safer if there is any uncertainty.
Question 9.9
Should an underlying fistula be sought and treated at the 
time of primary abscess drainage?
Recommendation: In a primary abscess, an internal open-
ing should not be sought nor should treatment of the 
underlying fistula (including with seton insertion) be per-
formed at the time of abscess drainage.
Level of evidence IV
Grade of recommendation B
Consensus: 100% (SA 88.9%, A 11.1%)
Should an underlying fistula be sought and treated at the 
time of recurrent abscess drainage?
Recommendation: In recurrent abscesses, insertion of a 
seton should be the routine management of the underly-
ing fistula, unless it is clearly superficial. An MRI is recom-
mended if no fistula is found.
Level of evidence IV
Grade of recommendation GP
Consensus: 100% (SA 100%)
What, if any, investigation for underlying disease (e.g., 
Crohn's) should be undertaken after abscess drainage?
Recommendation: Crohn's disease should be consid-
ered in patients with risk factors for Crohn's disease, 
complex fistula or fistula presenting at a younger age. 
Investigations where the risk of Crohn's is thought to be 
elevated include faecal calprotectin, luminal investiga-
tion and histological analysis of perianal fistula biopsy 
specimens.
Level of evidence: IV
Grade of recommendation: GP
Consensus: 100% (SA 88.9%, A 11.1%)
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There are limited data to support a recommendation in this area. 
Up to 5% of perianal Crohn's disease may be isolated and up to 10% 
of Crohn's disease may present with perianal symptoms. Recent 
HES data analysis found that luminal disease presented a median of 
14 months later [646]. Risk factors for Crohn's disease including fam-
ily history of IBD, complex fistula in younger patients and the pres-
ence of luminal symptoms should be sought. Options for identifying 
luminal disease include faecal calprotectin, colonoscopy and small 
bowel imaging. Isolated perianal Crohn's can be confirmed on the 
finding of granulomas in biopsy specimens. The frequency of this 
finding in confirmed Crohn's disease is unknown.
Fissure
Question 9.10
An anal fissure is a linear ulcer in the anoderm, most commonly 
found in the posterior or anterior midline. Acute fissures have an 
onset within 6 weeks of presentation and will not display features 
of chronicity such as sentinel tags or hypertrophied papillae. Most 
occur following mechanical trauma associated with constipation 
and straining at stool with sphincter spasm and relative ischaemia 
thought to contribute to persistence. Fissures in the presence of 
Crohn's disease are addressed in IBD guidelines.
A Cochrane review updated in 2012 considered non- surgical ap-
proaches to the management of acute (and chronic) anal fissures, based 
mostly on older studies examining high fibre diets and analgesia, or topical 
agents such as glyceryl trinitrate and calcium channel blockers [665]. US 
[666] and previous UK [667] guidelines have commented on the deficiency 
in evidence to support any specific management of acute anal fissures.
Some authors advocate early surgery (Botox or even sphincter-
otomy) in cases of severe pain [668], but the known risk of minor 
continence disturbance (up to 30%) and the recognized healing rate 
of acute fissures (around 50%) from simple measures do not support 
this approach.
In the 1980s, a high fibre diet was shown to induce healing in 
the majority of acute fissures [669] and reduce the recurrence if 
used as a maintenance therapy [670]. Dilators and more recently 
‘anal self- massage’ (10 min of intra- anal digitation twice a day) are 
reported to reduce the pain of acute fissures and encourage healing 
but are not in regular use in the UK.
It is important to note that a patient presenting with anal pain 




Haemorrhoids may become acutely thrombosed or strangulated 
and cause considerable pain. This is usually an acute event on a back-
ground of known haemorrhoidal disease and has a natural history 
with a peak of symptoms during the first week although symptoms 
may persist for much longer. The venous congestion and oedema as-
sociated with acute strangulation drive a conservative approach to 
management which includes bed rest, topical analgesia, ice packs, 
stool softeners and a myriad other interventions (warm baths, topical 
sugar, Trendelenburg position etc.).
Traditional and current advice tends to favour conservative man-
agement on the grounds of safety, since patients avoid the risks asso-
ciated with acute haemorrhoidectomy. Whilst patients usually require 
further intervention when initially managed conservatively [671], op-
tions in the elective setting may include less invasive procedures.
In retrospective studies, bleeding and recurrence do not seem 
elevated after surgery in the emergency setting but anal stenosis 
may be more common [672,673]. A more limited approach of exci-
sion of the problematic pedicle and leaving the others (without the 
anal stretch advocated in the original paper from 1986) may be a 
safer approach when surgery is required [674], facilitating a more 
limited subsequent approach in the elective setting.
How should acute fissures be managed in the emergency 
setting?
Recommendation: Acute anal fissure should be man-
aged using dietary modification and analgesia in the first 
instance, with a topical calcium channel blocker or nitric 
oxide donor added if symptoms do not settle.
Level of evidence II
Grade of recommendation B
Consensus: 100% (SA 77.8%, A 22.2%)
How should acutely thrombosed piles be managed in the 
emergency setting?
Recommendation: Acutely thrombosed or strangu-
lated haemorrhoids should initially be managed non- 
operatively in the majority of cases.
Level of evidence IV
Grade of recommendation D
Consensus: 100% (SA 100%)
Recommendation: In a very small number of patients who 
have ulcerated or ischaemic haemorrhoids a limited acute 
haemorrhoidectomy could be considered by an appropri-
ately competent surgeon.
Level of evidence IV
Grade of recommendation D
Consensus: 100% (SA 66.8%, A 33.3%)
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Whilst there is evidence to support acute limited haemor-
rhoidectomy, practice is generally centred around conservative 
management and that is the approach advocated within these 
guidelines. Factors which fall outside the remit of many inter-
ventional studies such as the training and seniority of surgeons 
staffing the Confidential Enquiry in Patient Outcome and Death 
(CEPOD) theatre which might undertake acute surgery, and the 
relative safety of an initial conservative approach with options for 
a less invasive definitive operation in the longer term, may drive 
a more conservative approach. Our recommendation is based on 
the principle that, whilst limited acute haemorrhoidectomy is safe, 
a more conservative initial approach can be followed safely in al-
most any setting and leaves options open for consideration at a 
later date by a patient who is not influenced by severe pain and 
strong analgesia.
Streptokinase suppositories have been compared with hydro-
cortisone suppositories for the treatment of acute haemorrhoids in 
a large randomized, non- blinded trial using mostly subjective out-
comes such as pain, bleeding and lesion size. The streptokinase sup-
positories were markedly superior to hydrocortisone alone [675]. 
This practice is not widely used in the UK and all evidence comes 
from a single centre.
Haemorrhoidal bleeding in patients on direct oral anticoagulants 
or warfarin can usually be treated non- operatively, with appropri-
ate advice from the haematology team regarding anticoagulant 
management. If surgery cannot be avoided because of persistent or 
life- threatening bleeding then a senior surgeon should be directly 
involved in any operative intervention. The recommendation would 
be to undertake the minimal effective procedure. This may be a sim-
ple suture rather than excision of a pedicle.
Rectal prolapse
Question 9.12
Rectal prolapse rarely presents as an emergency. Simple manual 
manipulation will often reduce a prolapse. If the prolapse has been 
‘out’ for some time, however, then application of an osmotic sub-
stance, for example sugar [676], can help reduce swelling and aid the 
reduction of an incarcerated prolapse. Other substances frequently 
used include honey or caster sugar. Occasionally, these simple ma-
noeuvres will result in resolution of the prolapse. However, in the 
majority of cases these are only temporizing and, in order to avoid 
frequent readmission, it is often pragmatic to expedite the prolapse 
repair within days of the presentation to the emergency surgical 
service.
Question 9.13
The operative approach will need to tailored to the individual 
patient, taking into account the patient's comorbidities, pre- existing 
bowel dysfunction and wishes. Laparoscopic ventral mesh rec-
topexy has been reported to be feasible and safe for emergency 
repair [677], although in all cases in this series the prolapse was al-
ways reducible and there were no cases of ischaemic or incarcerated 
bowel.
Perineal rectosigmoidectomy has also been reported for incar-
cerated prolapse [678,679]. All of the series reporting ES for rectal 
prolapse are small and so it is difficult to make a strong recommen-
dation for one approach over the other.
POSTOPER ATIVE PROBLEMS
Introduction
Complications are an inevitable consequence of surgery and are 
commonly seen after colorectal resections. The mortality of emer-
gency and elective colorectal resection although improved in re-
cent reports remains significant at 11% and 2% respectively [172]. 
In the emergency setting how should rectal prolapse be 
managed?
Recommendation: Initial treatment should be non- 
operative. A prolapse can usually be reduced and if ap-
propriate an early expedited procedure can be planned.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 66.7%, A 33.3%)
If emergency surgery for an acute rectal prolapse is nec-
essary, what operation should be performed?
Recommendation: If emergency surgery is unavoidable, 
both abdominal and perineal approaches are appropriate. 
The operative approach should be tailored to the indi-
vidual patient after a full risk assessment and discussion.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
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Complications cause significant problems for patients in terms of 
morbidity and quality of life. Clinicians are also affected and compli-
cations can be the cause of guilt, burnout and distress. The health-
care system is impacted too. Organizations vary in their ability to 
manage complications. The term ‘failure to rescue’ means the failure 
to prevent a death resulting from a complication of medical care, 
underlying illness or surgery. ‘Failure to rescue’ is a measure of in-
stitutional competence in this context [680]. The proactive man-
agement of complications and the open and honest discussion of 
organizational contributing factors is one way of addressing this. In 
the event of a complication, either intra- operatively or postopera-
tively, then a second opinion from a colleague is strongly advised. 
Colleague support is all the more important if a patient requires 
surgical intervention for a complication. All cases in which compli-
cations have occurred should be discussed at local morbidity and 
mortality meetings.
This guideline aims to emphasize practice that will lead to the 
early recognition and effective treatment of complications.
Question 10.1
There is little high quality evidence on this topic and most of it 
is extrapolated from trauma literature [681]. If the intraperitoneal 
colorectal damage has occurred during an elective colorectal proce-
dure, then asking for help and support from a colleague is advised. 
If the injury has occurred during surgery of a non- colorectal nature 
and a colorectal opinion has been requested, then the decision will 
be yours. The decision to be made is the same in both instances— is a 
primary repair appropriate or is a resection necessary?
If the injury requires resection then a primary anastomosis can 
often be performed safely. The decision to perform an anastomo-
sis depends on the patient's comorbidity, the state of the tissues 
(mechanism and extent of the injury) and the presence or absence of 
any significant physiological disturbance at the time of assessment. 
Should the patient be unstable then the surgeon should revert to 
a damage limitation approach of haemorrhage control and elimina-
tion of contamination first before considering any form of precision 
repair. Definitive surgery made need to occur at a later time. If the 
tissues are unhealthy due to malignancy, diverticular disease or 
prior radiotherapy then diversion should be considered. This should 
also be the case if the patient is frail or has comorbidity with limited 
physiological reserve to deal with a further complication.
Rectal injury may occur in the context of prostatic resection. In 
these cases, failed recognition at the time of surgery may lead to 
rectourethral fistula. Successful sutured repair can be performed if 
the injury is recognized at the time. If there are any concerns regard-
ing the physiological status of the patient then, again, a damage lim-
itation approach should be followed with proximal faecal diversion, 
and rectal irrigation should be considered.
Rectal injuries that occur during any pelvic surgery and which 
are recognized are treated in the same manner.
Question 10.2
The postoperative recovery of patients should have a recognized 
and anticipated course. In elective colorectal patients this may be 
quite rapid with no ileus and only a mild perturbation of blood tests 
and minimal systemic inflammatory response. In emergency patients 
or those in whom there was an abscess or phlegmon in the index 
operation there is a higher chance of a significant inflammatory 
response in the postoperative period— a high index of suspicion is 
needed in these patients.
Simple bedside manoeuvres should be performed to exclude 
problems such as acute urinary retention, acute gastric dilatation or 
inadequate analgesia. Increased abdominal pain, signs of systemic 
sepsis and increasing inflammatory markers may indicate the need 
for a scan. The threshold for a scan should be lower in those who 
have had an anastomosis formed at the index operation.
A catastrophic complication in any patient is that of an anas-
tomotic leak. This may affect any anastomosis. As already noted, 
the ESCP snapshot audit reported a rate of 14.3% for right- sided 
anastomoses [237]. There have been recent publications report-
ing the benefit of serial CRP measurements in the prediction of 
How should the surgeon deal with an intra- operative 
colorectal injury?
Recommendation: Primary repair can be performed if the 
injury is immediately recognized, the patient is haemody-
namically stable and there is no or minimal localized con-
tamination of the peritoneal cavity.
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 66.7%, A 33.3%)
Recommendation: If there is gross peritoneal contamina-
tion or the patient is haemodynamically unstable bowel 
diversion is recommended. A bowel resection may also 
be necessary if there is concern regarding bowel viability.
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
What are the indications for a postoperative CT scan?
Recommendation: A CT scan should be performed when 
the patient's recovery fails to follow the anticipated 
course and an intra- abdominal cause is suspected. It 
should only be omitted if the patient clearly needs im-
mediate life- saving surgery.
Level of evidence: IV
Grade of recommendation: D
Consensus: 100% (SA 77.8%, A 22.2%)
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anastomotic leak after anterior resection [682,683]. In the PREDICT 
study, a change in CRP level exceeding 50 mg/l between any two 
postoperative days had a sensitivity of 0.85 for detecting a leak and 
a high negative predictive value of 0.99 for ruling it out. A change in 
CRP concentration of more than 50 mg/l between either day 3 and 
4 or day 4 and 5 after surgery had a high specificity of 0.96– 0.97. 
In a separate study, Reynolds et al. [683] reported that a CRP value 
of 132 mg/l on postoperative day 5 had an area under the curve of 
0.75, corresponding to a sensitivity of 70%, a specificity of 76.6%, 
a positive predictive value of 16.3% and a negative predictive value 
of 97.5%.
If there is clinical suspicion of an anastomotic leak, then a 
contrast- enhanced CT scan is recommended. It is sensitive for the 
presence of anastomotic leak indicated by the finding of air and/
or fluid adjacent to the staple or suture line [684]; other findings 
include localized peritoneal enhancement and a ‘gap’ either in the 
staple line or in the mucosal enhancement at the anastomosis. The 
addition of enteric contrast, oral for right- sided anastomoses and 
rectal for distal anastomoses, improves diagnostic certainty for 
anastomotic leak when contrast is seen outside the bowel lumen 
[685,686]. However, it is important to appreciate that it is not in-
fallible and has a significant false negative rate. Moreover, a false 
negative scan may lead to a delay in definitive management with 
disastrous results [687]. A CT scan should never be performed 
when the patient clearly needs emergency life- saving surgery. If 
there is any uncertainty then a second opinion from an experi-
enced colleague should be sought. With the best will in the world 
it can be difficult for the surgeon who has created the anastomo-
sis to remain wholly objective.
The ACPGBI and ASGBI produced a detailed document entitled 
‘Issues in professional practice: prevention, diagnosis and manage-
ment of colorectal anastomotic leakage’, March 2016 [688]
Link: Prevention, Diagnosis and Management of Colorectal 
Anastomotic Leakage
There is some evidence that CT scans are more useful if per-
formed later in the recovery period. This appears to be the case 
with the detection of a walled off abscess which is usually a later 
complication. In the first 72 h following surgery CT is of less use and 
patients who are seriously unwell at this time should be re- explored. 
CT should not be used for the diagnosis of postoperative bleeding 
unless it is anticipated that this is to be treated by interventional 
radiological techniques.
In addition to an anastomotic leak, other iatrogenic injuries can 
befall the colorectal surgeon, in particular ureteric and vascular inju-
ries. Preoperative planning and liaison with the appropriate special-
ist, either a urologist or vascular surgeon, in cases where the ureters 
or vascular structures will be at risk during surgery is paramount in 
order to minimize the likelihood of inadvertent damage. This may be 
possible in some ES cases. However, in the majority of cases these 
injuries occur unexpectedly.
The European Association of Urology list surgery for diverticu-
litis, cancer and endometriosis together with redo surgery and prior 
radiotherapy as the highest risk groups [689]. However, the ureter is 
at risk in all abdomino- pelvic surgery. The commonest site of injury 
is the pelvic ureter. Prophylactic stenting does not prevent ureteric 
injury but does help with localization of the ureter [689]. If a ureteric 
injury is identified at the time of surgery then direct input by a urol-
ogist is recommended. If possible, immediate reconstruction gives 
the best long- term outcome for the patient.
However, if a ureteric injury is not identified at the time but sus-
pected in the postoperative period (urine in drain, worsening renal 
function together with abdominal pain and sepsis), then a CT abdo-
men and pelvis with intravenous contrast and a delayed urographic 
phase is the investigation of choice [690]. A delayed diagnosis of 
ureteric injury results in increased complications, both short and 
long term [691].
There is virtually nothing in the literature regarding major vascu-
lar injury during non- vascular abdomino- pelvic surgery. In the case of 
inadvertent vascular injury, the help of a vascular surgeon is recom-
mended. Most of the UK is served by regional vascular networks and 
so the help and input from a vascular specialist should be available.
Link: Guidelines for the management of urological trauma
Question 10.3
Postoperative ileus is a common problem after major abdominal 
surgery. Its causes are multifactorial. Peritoneal and bowel inflam-
mation, anaesthetic and opiate analgesic drugs, fluid and salt over-
load, preoperative starvation and lack of mobility may all contribute. 
Many measures have been trialled in an attempt to reduce ileus. 
Carbohydrate pre- loading, minimally invasive surgery, multimodal 
analgesia to minimize the use of opiate analgesia, lidocaine infusion, 
early mobilization, chewing gum, prokinetic agents such as metoclo-
pramide and erythromycin and the use of µ- opioid receptor antago-
nists such as alvimopan have all been used [692]. Some of these have 
shown benefits including chewing gum but the trials are all small and 
the evidence is not of high quality [693]. Lidocaine infusion and pro-
kinetic agents have not been shown to have any benefit on return 
to normal gut function [694]. Alvimopan has been shown to reduce 
What measures may reduce postoperative ileus following 
abdominal surgery?
Recommendation: Minimally invasive surgery and reduc-
tion in visceral inflammation may reduce postoperative 
ileus. Early feeding is of uncertain benefit. Trials in this 
area are ongoing.
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 66.7%, A 33.3%)
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length of stay and time to return of bowl function in patients un-
dergoing cystectomy and reconstruction although this has not been 
shown in a trial in colorectal or general surgery patients.
Question 10.4
Malnutrition and weight loss are associated with higher risks 
of surgical complications. Whilst total parenteral nutrition (TPN) 
may deliver a patient's metabolic needs it brings its own com-
plications and trials do not show any benefit from starting TPN 
early. It is essential, however, to consider the duration of preop-
erative starvation and the likely timing of resumed gut function. 
In many cases where there has been a prolonged degree of preop-
erative starvation, for example due to an impending obstruction, 
the duration of starvation may be much longer than simply the 
time from operation to resumption of normal gut function. A for-
mal assessment of the patient's nutritional status is essential. It 
is preferable to give nutritional supplementation enterally rather 
than by TPN as this is cheaper and, in some trials, has been as-
sociated with lower risks of infection [695]. Parenteral nutrition 
may be given to supplement inadequate enteral nutrition. It is not 
recommended to start TPN unless it is likely to be needed for a 
full 7 days [696].
Question 10.5
In the patient who has not recovered bowel function postopera-
tively, mechanical obstruction needs to be considered as a possible 
cause. This may be due to adhesions but an incisional hernia, internal 
herniation through a mesenteric defect and parastomal hernia should 
always be considered. In cases of a laparoscopic index procedure, port 
site hernias (especially with a 12- mm port) can and do occur early in 
the postoperative period. Surgery is nearly always necessary in cases 
where there is an obstructed hernia, in order to prevent strangula-
tion and bowel injury. CT scanning will clearly diagnose most of these 
cases. In cases where there is an equivocal obstruction administration 
of water- soluble contrast and an abdominal film after 4 h may help to 
determine if there is a complete mechanical obstruction [697]. Proven 
mechanical small bowel obstruction that fails to settle with non- 
operative management is likely to require surgery. After 2 weeks, the 
degree of inflammation and adherence particularly after open surgery 
may make reoperation very hazardous due to the risk of visceral injury 
[698], in particular small bowel. In this situation nasogastric drainage, 
TPN and careful operative planning is necessary (daytime CEPOD ac-
tivity, adequate time, direct consultant supervision or dual consultant 
operating). A second opinion from an experienced colleague is always 
useful and should be sought when there is uncertainty. A discussion 
with a regional intestinal failure unit is also an option.
Question 10.6
Despite the advent of enhanced recovery after surgery and mini-
mally invasive surgery the median length of stay for elective colorec-
tal surgery patients in the NHS remains high at 7 days in the National 
Bowel Cancer Audit annual report 2019 [699]. The most feared post-
operative complication for the colorectal surgeon is anastomotic 
leak and this is predominantly a late phenomenon occurring after 
3 days. A more commonly experienced complication is that of an SSI. 
Enhanced recovery programmes in most hospitals can mean that pa-
tients may be discharged home before an anastomotic leak or SSI 
becomes clinically apparent or problematic. As discussed previously 
the diagnosis of a leak depends on clinical features (increased pain, 
ileus, signs of sepsis and abnormal laboratory results). The intoler-
ance of oral intake on day 1 postoperatively is a strong risk factor for 
When should total parenteral nutrition be started in a pa-
tient with postoperative ileus?
Recommendation: Total parenteral nutrition should usu-
ally be given when the patient has had a non- functioning 
gut for over 7 days. This should include the period of pre-
operative starvation. A formal nutritional assessment of 
the patient is essential.
Level of evidence: II
Grade of recommendation: B
Consensus: 100% (SA 77.8, A 22.2%)
When should patients undergo reoperation for postop-
erative small bowel obstruction?
Recommendation: If small bowel obstruction occurs 
within the first 24 h of the index operation then re- 
laparoscopy or re- laparotomy will often identify a de-
finitive cause that requires surgical correction. If proven 
mechanical small bowel obstruction is identified later and 
it fails to settle with non- operative management, then 
surgery should be considered, accepting that there is an 
increased risk of small bowel injury.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 77.8%, A 22.2%)
When is it safe to discharge patients following colorectal 
surgery?
Recommendation: Discharge should be goal directed and 
is likely to be safe in a patient who is tolerating free oral 
fluids ± diet, has normal vital signs and satisfactory blood 
results, in particular a CRP <125 mg/l on day 3 postopera-
tively. Earlier discharge may be safe provided that there 
are adequate contingency plans for early review in the 
event of an unexpected deterioration.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
    | 525MILLER Et aL.
further problems. At day 3 postoperatively a CRP <125 has a good 
negative predictive value for leak [700]. The combination of clinical 
features and CRP should allow for early discharge on day 3. Earlier 
discharge is possible and even same day discharge has been de-
scribed following colorectal surgery [701]. Whatever day the patient 
is discharged on, there needs to be a clear contingency plan in the 
event of poor progress after discharge. This means that the patient 
must be able to be reassessed by a sufficiently qualified surgeon, to 
undergo CT scanning and reoperation in a timely fashion. Local ar-
rangements need to be robust and patients need a clear plan of who 
to contact or what to do in the event of poor progress.
Emergency colorectal surgery by its very nature is associated 
with a high incidence of SSI. The ongoing SUNRISE study is looking 
at the role of negative pressure dressings and the ROSSINI 2 trial at 
the impact of three interventions either individually or in combina-
tion on SSI.
Link: SUNRISE study
Link: ROSSINI 2 study
Question 10.7
Rectal bleeding is seen in a small but significant number of pa-
tients following colorectal resection. It is usually from the anasto-
mosis. The reported numbers vary from 0.3% up to 6.4% [702]. A 
significant number of these may settle spontaneously and may not 
need intervention or blood transfusion [703]. In those patients that 
have ongoing bleeding and need intervention, endoscopic control 
of the bleeding point may be achieved successfully by injection of 
adrenaline, clipping or by haemostatic spray [704]. There are in-
evitable concerns that endoscopic intervention may disrupt the 
anastomosis; however, this seems infrequent in the hands of expert 
therapeutic colonoscopists. Surgery is usually not required unless 
endoscopic means fail or if there are signs of failure of the anasto-
mosis at endoscopy. Angiography and embolization have been de-
scribed in this situation. There are concerns that whilst stopping the 
bleeding this may render the anastomosis ischaemic.
Question 10.8
Perforation is an infrequent but potentially fatal complication 
of colonoscopy. Its incidence in diagnostic colonoscopy is between 
0.016% and 0.2%. It is more commonly seen in patients undergo-
ing therapeutic colonoscopy, with an incidence up to 8%. The 
highest risk factors are larger lesions sited in the right colon [705]. 
Lower BMI, increased age and previous surgery are additional risk 
factors. Some patients develop a post polypectomy coagulation 
syndrome, where a full thickness burn of the colonic wall has oc-
curred at the time of the index colonoscopy, and this may result 
in pain, leucocytosis and sepsis without overt perforation. These 
symptoms can develop anywhere from a few hours to several days 
later [706]. Extraperitoneal perforations of the colon may result in 
similar symptoms as those seen in the post polypectomy syndrome 
with significant extraluminal air on cross- sectional imaging. This 
may be retroperitoneal, mediastinal or subcutaneous and has been 
described as a pneumothorax. Early recognition of a perforation 
is important as delay to definitive treatment is associated with a 
worse outcome [707]. Units should have a well- defined pathway 
for urgent surgical assessment of those patients who have suffered 
a perforation or if they develop symptoms days after the index co-
lonoscopy, particularly if they have had a high risk procedure. In the 
event of acute abdominal symptoms, a CT is essential to identify or 
exclude perforation.
Approximately 50% of colonoscopic perforations may be treated 
non- operatively [708], with antibiotics and close observation. This 
is particularly the case if there is no evidence of peritonitis, sys-
temic sepsis or free intraperitoneal fluid on CT. However, failure of 
initial non- operative management has been associated with poor 
outcome. Therefore, if there is any doubt, the patient should be ex-
plored to avoid undertreatment of the development of multiorgan 
failure. The surgical approach will be determined in part by the na-
ture of the injury, but both laparoscopic and open approaches may 
How should rectal bleeding that occurs after a colorectal 
resection be managed?
Recommendation: Postoperative rectal bleeding will usu-
ally settle spontaneously. If not, then it may be treated 
safely and successfully by an experienced therapeutic co-
lonoscopist without damage to the anastomosis.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 77.8, A 22.2%)
Should all colonoscopic perforations be treated by 
operation?
Recommendation: Colonoscopic perforations can be 
treated non- operatively in the absence of signs of gener-
alized peritonitis. Regular reassessment is needed. In pa-
tients with evidence of peritonitis, urgent surgery, either 
laparoscopic or laparotomy, is recommended.
Level of evidence: III
Grade of recommendation: C
Consensus: 100% (SA 100%)
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be used. Clean injuries may be repaired primarily as described above 
for intra- operative colonic injuries. Injuries with delayed recognition 
or in which there is significant contamination may need to be exteri-
orized. Whilst the main consideration is the immediate stabilization 
of the patient, the pathology of the lesion that has been removed at 
the time of the index colonoscopy may have a bearing. For example, 
if a complex polyp has a focus of cancer or is incompletely excised 
necessitating a resection it may be best to do it whilst treating the 
perforation rather than later. Knowledge of the colonoscopy and 
the histology result of any resected polyp will therefore be helpful, 
if it can be obtained.
EMERGENCY SURGERY DURING 
PREGNANCY
Introduction
Pregnant women frequently present to general surgical teams with 
abdominal pain and some of them will require surgery. The risks di-
rectly attributable to surgical intervention are miscarriage in early 
pregnancy or premature labour. However, the surgical pathology it-
self has similar or worse risks. Pregnancy does not obviate the need 
for ES but it raises the stakes and calls for careful multidisciplinary 
decision- making, communication and planning. A fully informed 
consent process is mandatory.
Question 11.1
Pregnant patients commonly present to surgical teams with abdom-
inal pain. It is important that all women of child bearing age present-
ing with abdominal pain have pregnancy excluded on the basis of 
urinary beta human chorionic gonadotropin. Those who are preg-
nant should have the diagnosis of an ectopic pregnancy excluded by 
US. US has no known risk in pregnancy [709]. MRI also is safe [710]. 
There are few human data regarding the use of gadolinium- based 
contrast agents in pregnancy. Current available data are reassuring 
but gadolinium- based contrast agents should not be used in preg-
nancy unless the clinical condition of the patients makes their use 
absolutely necessary [711]. Radiation has both deterministic and 
stochastic effects on the foetus. Deterministic effects are those 
of tissue damage which can result in foetal death, growth retarda-
tion and learning difficulties. These do not occur below a dose of 
100 mGy. Stochastic effects such as teratogenesis or childhood 
leukaemia may result from damage to individual cells. The risk is in-
creased at higher doses. For a chest X- ray the exposure of 0.01 mGy 
leads to a very small increased risk of 1 in 1 000 000. For a CT 
of chest abdomen and pelvis the exposure of 50 mGy leads to a 
doubling of the background childhood cancer risk to 1:200. Any de-
cision to use CT should therefore be taken only if absolutely nec-
essary. A fully informed discussion with the patient (and partner) 
and a clinical radiologist and full exploration of alternative imaging 
techniques are all essential.
Question 11.2
Surgery in pregnancy may be complicated by miscarriage in 
the first trimester or later by premature labour. This risk is small. 
In a UK cohort study of 6.5 million operations performed dur-
ing pregnancy there was an increased risk of one extra stillbirth 
for every 287 operations and one additional preterm delivery for 
every 31 operations [712]. The condition which requires surgery 
may itself risk the health of both mother and foetus. In the case 
of appendicitis, it has been found that non- operative management 
is associated with higher rates of peritonitis, sepsis and venous 
thromboembolism compared with surgery. Appendicitis is associ-
ated with a higher risk of preterm labour, abortion and caesarean 
section compared with normal pregnancies. However, the risk of 
preterm labour is higher in those with a diagnosis of appendicitis 
who are treated non- operatively compared with those who are 
treated by surgery [713]. Recent trials in non- pregnant patients 
have identified a group of patients with uncomplicated appendi-
citis on CT who may be treated non- operatively. This approach 
may be hazardous in pregnancy especially as CT should not be 
used. It is difficult to be exact about the magnitude of the risk in 
Which imaging modalities can be used in the acute abdo-
men in pregnancy?
Recommendation: Ultrasound and MRI are safe at all 
stages in pregnancy. CT should only be used in emer-
gency situations after multidisciplinary discussion.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 100%)
Can emergency surgery be carried out safely during 
pregnancy?
Recommendation: Emergency surgery during pregnancy 
has small increased risks for both the mother and foe-
tus which need to be balanced against the risks of not 
treating the surgical problem. When surgery cannot be 
delayed, careful discussion with the patient and partner 
together with agreed shared decision- making between 
the obstetric, neonatal, surgical and anaesthetic teams is 
essential.
Level of evidence: III
Grade of recommendation: B
Consensus: 100% (SA 88.9%, A 11.1%)
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conditions less common than appendicitis. In these cases, care-
ful shared decision- making is mandatory. In patients who have a 
viable foetus there should be both neonatal and obstetric teams 
available on site in the event of the preterm labour or if there is 
a need for emergency caesarean section. Tocolytic drugs should 
not be given routinely unless the patient goes into labour. Those 
patients in the third trimester should be managed on their left- 
hand side to minimize compression of the vena cava [714]. These 
patients need prophylaxis against venous thromboembolism.
Question 11.3
There are concerns that laparoscopic surgery may be associ-
ated with higher rates of pregnancy loss than open appendicec-
tomy. It has also been observed that pneumoperitoneum causes 
foetal hypoxia in pregnant ewes. This has not been observed in 
humans and the most recent studies have shown no increased risk 
with laparoscopy. No difference in preterm labour was observed 
in a large Australian study of 1024 mothers who underwent ap-
pendicectomy during pregnancy [715]. Differences in previous 
studies may well be explained by the fact that laparoscopy may be 
used more frequently in early pregnancy where rates of miscar-
riage are higher.
During later pregnancy the height of the fundus should be 
carefully assessed whilst planning the point of trocar insertion 
and may need to be supraumbilical. There is no evidence that an 
open Hasson or closed Veress needle approach is superior but the 
surgeon must be confident and safe with the particular technique 
[715,716].
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